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ABSTRACT
This study investigates the mechanism by which CPZ lowers the cation

content of rat and toad liver cells. Results indicate that, even in the presen
of ouabain, high concentrations of CPZ are able to decrease the intracellular

sodium content of isolated liver cells by activating a sodium efflux pathway.
CPZ was able to decrease total intracellular sodium (flame photometry), as

well as sodium activity (22Na+), indicting that the activation of sodium efflu
was not due to an enhancement of sodium: sodium exchange activity.
Although sodium efflux occurred in the presence of saturating concentrations
of ouabain, or in the absence of potassium, activation of the sodium pump by
CPZ was considered as a possible mechanism. However, CPZ was seen to
decrease intracellular potassium, along with sodium, and inhibit ATPase
activity in liver and kidney homogenates, therefore, it was considered
unlikely that the sodium pump was involved in the activation of sodium
efflux by CPZ.

The involvement of an energy requiring system, such as an active transporter
was investigated according to four specific attributes: 1) sensitivity to
metabolic inhibition, 2) dependence on cellular oxygen consumption, 3)

ability to transport ions against a concentration gradient and 4) temperature

sensitivity. A sensitivity of CPZ activated cation transport to treatments wh
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inhibit active transport w a s determined. Sodium efflux seen in the presence

of CPZ, occurs against the natural sodium concentration gradient that exists i
living cells. In addition, CPZ activated sodium transport was seen to be
completely inhibited by pre-incubation of liver cells in cyanide or by

incubation of liver cells in the cold (0°C). In contrast, CPZ activated potass
efflux occurs down a naturally occurring concentration gradient. The decrease
in intracellular potassium seen in the presence of CPZ, showed partial
sensitivity to cyanide and the cold. However, the CPZ induced potassium

efflux was not affected by increasing concentrations of extracellular potassi
(5 to 150mM) suggesting, that potassium efflux in the presence of CPZ can
occur against an inwardly directed potassium concentration gradient.

A decrease in cell volume following CPZ treatment is demonstrated.
However, the decrease in cell volume is not sufficient to account for the
decrease in intracellular cations measured following CPZ treatment, as
indicated by the decrease in the sodium concentration in CPZ treated cells.

Considering the results of this investigation it is possible that a non-specif
cation transport mechanism may exist in liver cells and may be activated by
CPZ to lower intracellular sodium and potassium.
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CHAPTER 1

INTRODUCTION

"Whenever

a new discovery is reported

to the scientific world they say at first, 'It is
probably not true'. Thereafter when

the

truth of the new proposition has been
demonstrated
'Yes, it may

beyond question, they say,
be true, but it is not

important'. Finally, when
has

elapsed

importance,

to fully

sufficient time
evidence

its

they say, 'Yes, surely it is

important, but it is no longer new'
Michel de Montaigne (1533-1592)
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1.1

A n investigation into liver cell sodium permeability

This investigation began when the antipsychotic drug chlorpromazine (

demonstrated an apparent ability to decrease sodium activity in isola
and toad liver cells. This unexpected property of CPZ was first seen

study where pharmacological inhibitors: amiloride, furosemide and CPZ

were being used to quantify the contribution of specific sodium entry

pathways to the sodium permeability of rat and toad liver cells. In t
investigation, amiloride an inhibitor of sodium channels, Na+/H+ and
Na+/Ca2+ exchangers (Arias & Forgac, 1984), was used to determine the
amount of sodium that enters the cell through these exchangers.

Furosemide, an inhibitor of the Na+/K+/Cl" co-transporter (Jayme et al
1984), was being used to determine the amount of co-transport driven

sodium entry and an inhibitor of sodium channels, CPZ (Bolotina et al

1992; Ogata et al., 1990), was being used to determine the amount of s
that enters the cell through sodium channels.

In these experiments isolated rat and toad liver cells were treated w

inhibitors of sodium entry pathways for 20 minutes in a balanced elec
medium (BEM) containing ouabain (a specific inhibitor of the sodium
pump, ImM) and

22

Na+, as a radioactive tracer of sodium movements.

Following treatment, cells were washed (5 x 30 seconds) in ice cold B
remove extracellular

22

Na+. The inclusion of ouabain in the incubation

results in an increased accumulation of intracellular

22

Na+. In the pre

of ouabain, sodium enters the cell through sodium entry pathways

(exchangers, co-transporters, channels), but is unable to leave the ce
2

inhibition

of the sodium

(Na+K+-ATPase). Results for these

pump

experiments are shown in figure 1.1.

Normal

Ouabain Ouabain-!- Ouabains- Ouabain
Amiloride Furosemide +CPZ
Figure 1.1 Inhibition of sodium entry pathways in rat and toad liver cel
Isolated rat and toad liver cells were incubated for 20 minutes in B E M alone (Normal) or
medium containing ouabain (ImM) and inhibitors of sodium entry pathways: amiloride
(ImM), furosemide (ImM) and C P Z

(5mM). All

incubations contained

22

Na+

(0.5mCi/mL) as a radioactive tracer of sodium movements. At the conclusion of the
experiment cells were washed (5 x 30 seconds) in ice cold B E M to remove extracellular
22

Na + . 2 2 N a + activity was determined by g a m m a counting and protein content by the

Lowry method (Lowry et al., 1951). Results were converted to nmoles N a + / m g Protein.
(N>8, Values are mean ± S E M )

It can be seen from the results presented in figure 1.1 that ouabain ( I m M )

causes an increase in the accumulation of sodium (22Na+) in both rat
toad liver cells, due to inhibition of the sodium pump. The increase

intracellular sodium in the presence of ouabain is greater in rat tha

liver cells, indicating the greater activity of rat sodium pumps, and
higher sodium permeability of rat liver cells (Else et al, 1996).
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Figure 1.1 also shows that amiloride (ImM) significantly inhibits sodium

entry in both rat and toad liver cells. Amiloride inhibits both Na+/H
Na+/Ca2+ exchanger activity. Therefore the amiloride analogue
dimethylamiloride (DMA, 500(iM), that specifically inhibits Na+/H+
exchange activity, was used to determine if the amiloride-sensitive
entry was caused by the activity of the Na+/H+ exchanger or Na+/Ca2+

exchanger. The amiloride analogue, DMA had the same effect on sodium

entry as amiloride. It was concluded that Na+/H+ exchange activity wa
responsible for the amiloride-sensitive portion of sodium entry. In

furosemide (ImM), which inhibits Na+/K+/Cl" co-transport did not have

any significant inhibitory effect on sodium entry which can be taken

indicate that Na+/K+/Cl" co-transporters are either not present in ra

toad liver cells, or that they are not active under the conditions u
experiments (Jayme et al., 1984).

The results described for ouabain and amiloride were consistent with

known effects of these drugs on sodium activity. However, the effect

on liver cell sodium activity was unexpected. In the presence of oua

CPZ was able to reduce liver cell sodium activity to a level signifi
below that seen in normal cells (p<0.009). This result was not only

unexpected, but was a novel result, not previously described for thi
other drug. An investigation into the mechanism by which CPZ lowers
intracellular sodium became the basis for this dissertation.

4

1.2

Chlorpromazine - a historical perspective

Chlorpromazine (2-chloro-10-[3-dimethylaminopropyl]-phenothiazine) was
first synthesised in the early 1950's by the French pharmaceutical company
Rhone-Poulenc. The structure of CPZ is shown in figure 1.2.

.s.

(CH2):

N
H,C

CH,

Figure 1.2 Chemical structure of chlorpromazine

When CPZ was first introduced into psychotherapy in 1952 it was said that a
new era in psychopharmacology began (Baldessarini, 1990; Mitchell, 1993).
CPZ was said to induce a "veritable medical lobotomy" and rapidly became

the therapy of choice for the treatment of depression and schizophrenia. In
1985 CPZ was still frequently prescribed, being the third most commonly
used antipsychotic drug in the United States (Wysowski & Baum, 1989).

Although CPZ is primarily used for its antipsychotic effect, CPZ is also us
post-operatively as an anti-emetic and in the alleviation of intractable

hiccups. In addition, CPZ also has other more esoteric uses,as a sedative f

fractious camels (Singh et al, 1993) and as a treatment to prevent anti-soc
behaviour in vicious dogs (Blackshaw, 1991).

A s well as beneficial effects, C P Z therapy is associated with m a n y unwanted

side effects, including hypotension, tardive dyskinesia, sedation, cholestat

jaundice (Keefe et al, 1980) and weight gain (Bernstein, 1988; Doss, 1979).

The use of CPZ is based on clinical effectiveness rather than a comp
understanding of the mechanisms behind its therapeutic action. This

together with the side effects seen with CPZ therapy has led to nume
investigations into the cellular basis of CPZ action.

The antipsychotic effects of CPZ appear to be related to its ability

dopamine (D2) receptors (Sato et al, 1995). Additionally, CPZ is able
to a variety of neurotransmitter receptors including, dopamine,
noradrenaline, muscarinic, histamine and serotonin receptors. It is

binding to these receptors that is thought to be associated with the
physiological side effects of CPZ therapy. For example sedation has

associated with histamine receptor interactions and hypotension with
binding to the adrenergic receptors (Palmer et al., 1988).

In addition to effects on these neurotransmitter receptors, CPZ has

associated with effects on enzymes, channels and intracellular regul
CPZ has been reported to inhibit many enzymes including membrane
bound ATPases such as the Na+K+-ATPase (Akera & Brody, 1970;
Hackenberg & Krieglstein, 1972; Mazumder et al, 1990; Van Dyke &

Scharschmidt, 1987), Ca2+-ATPase (Agarwal et al, 1992; Mazumder et al

1991) and the Mg2+-ATPase (Mazumder et al, 1991; Samuels & Carey, 197

CPZ has also been shown to inhibit mouse neuroblastoma and guinea pi

striatal neuron sodium and calcium channels and myocardial potassium

channels (Kon et al, 1994; Ogata & Tatebayashi, 1989; Ogata et al, 1
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et al, 1989). Additionally, C P Z is known to interact with the intracellular

regulator calmodulin (Roufogalis et al, 1982). Therefore, CPZ exhibit

plethora of effects on many different cellular components. This diss

outlines experiments investigating a novel cellular action of CPZ, t
ability to lower intracellular sodium in rat and toad liver cells.

1.3 Project Aim and Outline of Thesis

The aim of this project was to examine the mechanism by which CPZ lo
intracellular sodium in isolated liver cells. This project involved

"classical" style investigation into a novel result, that is CPZ's a

ability to lower intracellular sodium levels. Due to the novel natur

study, no previous work was available. The presentation of results a

discussion follows the logical progression of the investigation. Dur

progression pertinent literature will be reviewed as it becomes rele
the investigation.

Chapter 3 begins with the characterisation of the decrease in intrac
sodium seen in the presence of CPZ. The Na+K+-ATPase was then

considered as a possible site of CPZ action. The Na+K+-ATPase (EC num
3.6.1.37), which is the enzymatic form of the sodium pump, is the

predominant mode of sodium extrusion from cells. This membrane bound

protein couples the energy derived from the breakdown of ATP, with t

transmembrane movements of sodium and potassium ions, to maintain th

sodium and potassium concentration gradients across the cell membran
(Glynn & Chir, 1968; Leaf, 1956; Skou, 1965).
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In addition to investigating the sodium p u m p as the site of C P Z action, the
energy requirements of CPZ activated sodium lowering were determined
according to four specific attributes: 1) their sensitivity to metabolic
inhibition, 2) their dependence on cellular oxygen consumption, 3) their
ability to transport ions against an electrochemical gradient and 4) their
temperature sensitivity. These experiments are outlined in chapter 4.

In chapter 5 the effect of cell treatment on CPZ was examined. This chapter
outlines results from experiments where CPZ was first exposed to isolated
liver cells and then examined for an ability to activate cation transport.
generation of potential CPZ metabolites by liver cells was considered, and
other phenothiazines and related tricyclic compounds were also examined
for their ability to lower intracellular sodium.

The possibility that CPZ activation of cation transport was due to cell
damage related to the high CPZ concentration used in this study was
considered and results from these experiments are presented in chapter 6.

Liver cells were treated with agents known to result in cell damage, that i

detergents and pore forming agents, and their effect on intracellular catio
determined. Pharmacological inhibitors of cation transport pathways were
used to determine any role for these pathways in the cation efflux seen in
the presence of CPZ. In addition in chapter 6, the activation of a volume
regulatory mechanism was considered as a possible explanation for the
removal of intracellular cations in the presence of CPZ.
8

CHAPTER 2

METHODS

9

2.1. Isolation of Liver Cells

Isolated and short term cultured liver cells have been frequently us

investigations into the metabolic and toxicological effects of thera
agents (Berry et al, 1997; Van Dyke & Scharschmidt, 1987; Abernathy

1977). Liver cells have also been used as a model cell for the determ
of physiological responses (Scharschmidt et al, 1986; Van Dyke &

Scharschmidt, 1983; Van Dyke et al, 1982; Corasanti et al, 1990; Gle

al, 1990) such as volume regulation (Busch et al, 1994; Wassler et a

and investigations into the functions of various ion channels and ac

transporters (Graf & Haussinger, 1996; Hardison & Weiner, 1980; Hend

et al, 1989; Kristensen, 1986; Weinman & Weeks, 1993). Isolated liver

were used in these experiments as these cells are easy to prepare an

for a variety of different treatments to be performed on cells obtai
the same animal thus allowing for internal controls.

2.1.1 Animals

Liver cells were isolated from two species: the laboratory rat (Ratt
norvegicus, Sprague-Dawley strain) and the cane toad (Bufo marinus).

Adult rats (6-14 weeks old, 200-600g) were obtained from Gore Hill R

Laboratories and cane toads were obtained from a commercial supplier

(Peter Kraus, Mareeba QLD). All animals were maintained at the Unive

of Wollongong in the Animal House under a 12 : 12 light : dark photo
at 22°C with free access to food and water. All animals appeared to

good health at the time of the experiments. All animal experiments w
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carried out according to the N H & M R C code of practice as approved by the
University of Wollongong animal ethics committee.

2.1.2 Isolation and Short-Term Culture of Liver Cells
The methods relating to the isolation and short-term culture of liver cells
have been well characterised and were conducted as previously described
(Berry, 1974; Van Dyke & Scharschmidt, 1987; Else & Mansfield, 1997).
Animals

were

anaesthetised

and

heparinised

(Nembutal®,

sodium

pentobarbitone, 60 mg/kg and 700 units of heparin, i.p. for Rattus
norvegicus, and tricaine methanesulfonate {MS222} 0.5% at p H 7.4, absorbed
across the skin and 500 units of heparin, i.p. for Bufo marinus) and the
hepatic portal vein cannulated. Livers were cleared of blood, using a nonrecirculating carbogenated (95% O2: 5 % CCb_) wash solution (in m M , NaCl
137, KC15.4, M g S 0 4 0.8, N a 2 H P 0 4 0.85, K H 2 P 0 4 0.15, N a H C 0 3 25, glucose 15,
phenol red 0.001%, p H 7.4, 37°C). After clearing, livers were digested with
collagenase for 20 (rat) or 45 (toad) minutes via a recirculating enzyme
solution (as for wash solution but with I m M

CaCLi and 0.05-0.1%

collagenase enzyme, Type 1 added). Following enzyme treatment, digested
livers were gently teased apart in oxygenated wash solution to release the
isolated cells. Cell preparations were washed through a 200uxn nylon gauze
and centrifuged twice using a Hettich Universal 16R bench top centrifuge at
50g for 5 minutes. Cell pellets were resuspended in Dulbecco's Modified
Eagle's medium (supplemented with 2 0 % [v/v] newborn calf serum, O.lmM
non-essential amino acids and penicillin, streptomycin at 50 m g / L and

11

gentamycin at 20 (ig/L). Liver cells were cultured overnight on collagencoated plastic Thermanox® coverslips (24x32mm) at 25°C in a 95% O2: 5%
CO2 environment. Collagen-coated coverslips were used because the

isolated cells adhered to the collagen to form liver cell monolayers. Cells

were used within 24 hours of isolation and had viabilities greater than 85%
as indicated by trypan blue exclusion.

Collagen used to coat cover slips was prepared from rat tail collagen fibre
previously described (Michalopoulos & Pitot, 1975). Rat tails were skinned
and the collagen fibre tracts removed. Collagen fibre tracts were cut into
pieces before being placed into 1:1000 dilution of glacial acetic acid for
hours at 4°C to dissolve the collagen fibrils. The solution was allowed to

settle for 24 hours before the supernatant, containing collagen fibrils, wa

poured off. The collagen containing solution was stored frozen (-20°C) unti
used. The collagen-coated coverslips were exposed to ammonia for 2 hours
to polymerise the collagen, washed in distilled water to remove ammonia
and acetic acid residue, then sterilising under U.V light for 2 hours. The

collagen coat of the coverslips did not exceed 60(ig protein (as determined
the Lowry method [Lowry et al, 1951]) which was subtracted from cell
protein content in all further measurements.

12

2.2. Measurement of Liver Cell Ion Content
As this thesis is an investigation into an unusual effect of CPZ on
intracellular cation content the development of the methods for the
measurement of intracellular cations has been included. To do this

methods, results and some discussion of these results are included in
section.

Intracellular cation content was determined in two ways. First, radio
sodium, that is

22

Na+, was used as a radioactive tracer for the moveme

sodium across the cell membrane and second, flame photometry was used

to measure the total content of intracellular sodium and potassium. T
of

22

Na+ to estimate intracellular sodium required cells to be incubat

the presence of

22

Na+ for sufficient time to allow steady state to be

between influx and efflux of the radioactive tracer and, to allow ade
accumulation of

22

Na+ to allow for accurate measurement. Furthermore,

cells were washed in unlabelled medium to remove extracellular
the intracellular sodium measured using

22

22

Na+.

Na+ is dependent on the

permeability of the cell membrane for sodium, intracellular sodium

determinations by this method will be referred to as sodium activity.
contrast, the intracellular sodium (or potassium) measured by flame

photometry includes all intracellular sodium (or potassium), that whi

available for transport and that which is bound within the cell. Ther

intracellular sodium (or potassium) levels which have been determined

flame photometry will be referred to as sodium (or potassium) content
13

methods used for the determination of intracellular cations have been
described previously (Else & Mansfield, 1997).

2.2.1 Measurement of liver cell sodium activity
The

22

Na+ content of isolated liver cells was measured by incubating

cell monolayers at 37°C in a physiological balanced electrolyte medi
(BEM, in mM: NaCl 150, MgS04 0.8, CaS04 1.2, K2HP04 0.8, KH2P04 0.14,

2-hydroexyethyl-piperazine-N'-2-ethanesulfonic acid [HEPES] 10, adj
pH 7.4 using KOH, raising K+ level to 5mM) and with added
uCi/mL). The time course for the accumulation of

22

Na+ (@ 0.5

22

Na+ within the cell

was initially examined, and the results from these experiments are s

in figure 2.1. In these experiments, liver cells were incubated in e
normal, BEM alone, or medium supplemented with ouabain (ImM), a

specific inhibitor of the sodium pump. The presence of ouabain in th
medium blocks the sodium efflux that would occur in the presence of
sodium pumps allowing for an enhanced accumulation of
liver cells.
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22

Na+ within the

\

• Ouabain
0 Normal

20

40

60

Time (minutes)
Figure 2.1 Time course for 22Na+

accumulation in isolated rat liver cell

Rat liver cells were incubated, for 0 to 60 minutes, in either normal, B E M alone, or
medium supplemented with I m M ouabain (a specific inhibitor of the sodium pump).
Following incubation, liver cells were washed in 20mL of ice-cold B E M (5 times, 30
seconds/wash) to remove extracellular 2 2 Na + . (N=6, values are mean+SEM)

From the results shown in figure 2.1 it was determined that there is

equilibration between sodium influx and efflux is reached by 20 minut

normal incubations. This is indicated by the plateau in the normal cu
The amount of

22

Na+ accumulated within liver cells at this time would b

indicative of, or proportional to, the amount of intracellular sodium

contrast, in ouabain containing incubations at 20 minutes, there is s
ongoing accumulation of

22

Na+ occurring, that is sodium influx and eff

have not yet reached a plateau indicating equilibrium. It was decided
future experiments, liver cell

22

Na+ activity would be measured over a

minute period.
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The measurement of liver cell sodium activity over 20 minutes time period

was chosen for a number of reasons. First, this time period was long enou

to allow a sufficient amount of 22Na+ to accumulate within the liver cells,
so that it could be easily measured. Second, 20 minutes proved to be a

sufficient time to allow for sodium influx and efflux to reach equilibriu
normal incubations therefore the amount of 22Na+ can be correlated with

intracellular sodium. Third, the response of liver cells to drug treatmen
such as ouabain, could be measured over a 20 minute period. Finally, the
accumulation of 22Na+ during a 20 minute incubation is not maximal

therefore changes in intracellular sodium in response to drug treatments,
either increases or decreases, could be examined during a 20 minute
incubation.

In order to determine accurately the amount of 22Na+ accumulated within

the liver cells it was necessary to remove extracellular sodium. This was
done by washing cells in excess (20mL) ice-cold BEM. The ice-cold medium

was used to inactivate cation transporting proteins, therefore decreasing
possibility that intracellular sodium would be lost during the wash

procedure. Coverslips were dipped in a series of washes (up to 7) to remo
all extracellular 22Na+ into the wash medium. The number of washes
required to remove the extracellular sodium was determined by measuring
the amount of 22Na+ removed into the wash medium during a 30 second
wash. Results from these experiments are shown in figure 2.2.
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Figure 2.2 Removal of extracellular

22

Na+

during sequential washes

After a 20 minute incubation in normal B E M , liver cells attached to coverslips were
dipped in a series of washes to remove extracellular

22

Na + . The number of washes

required to remove extracellular sodium was determined by measuring the amount of
^ N a * removed into the wash medium. The amount of2 2 N a + lost into the wash medium
is presented as a percentage of the radioactivity present in the first wash. (N=6, values
are mean±SEM)

It can be seen from figure 2.2 that the amount of 22Na+ in the wash medium

decreases most rapidly in the first 3 washes suggesting that these washes ar
where the majority of the extracellular sodium is being removed. In the
final washes there is relatively little 22Na+ being removed into the wash
medium, suggesting that the extracellular sodium has been removed and

intracellular sodium is beginning to be lost from within the cells. Based on
these experiments a wash protocol comprised of 5, 30 second, washes was
chosen as the best compromise between removing extracellular sodium and
losing intracellular sodium.
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Following the washes, coverslips were placed into counting vials with 2 m L
of protein extraction solution (Lowry's base solution, Na2C03 2% in NaOH
0.4%). 22Na+ content was determined using a Wallac Wizard 1480 3" Nal
crystal gamma counter (88% efficiency for 22Na+). Protein content was
estimated using the Lowry method (Lowry et al, 1951). The 22Na+ in the
incubation medium was measured to determine the specific activity of the
incubation medium (22Na+ CPM/ nM non radioactive sodium) and the
22

Na+ content of the coverslips was converted to nmoles Na+/mg protein. A

flow diagram for the procedure relating to the measurement of

22

Na+

content of isolated liver cells is given in figure 2.3.

Figure 2.3 Flow diagram outlining the method for the measurement of
sodium activity of liver cells
Liver cells are cultured onto collagen coated
,r: f\*\*\*\*\f\*\

coverslips in D M E M and incubated overnight
in 9 5 % 0 2 / 5 % C 0 2
Sodium activity is measured in the presence of
22

N a + in balanced electrolyte medium, with or
without drugs, over a 20 minute period

Incubation media sample taken to determine
CPM/nmole N a +

Following incubation in 2 2 N a + cells are washed
5 x 30secs in 20mL B E M to remove extracellular 2 2 N a +
After washing cells are placed in 2 m L of
Lowry's base solution

22

N a + content is determined on the y counter

Protein content is determined as m g
protein/ coverslip

Results are presented as nmoles Na+/ mg Protein
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2.2.2 Modifications to the method for measuring sodium activity
In some experiments liver cells were loaded with

22

Na+ (0.5uCi/mL) and

22

Na+ measured. For loading

then the efflux, rather than influx, of

experiments, cells were pre-incubated in the presence of ouabain (Im
22

Na+ for 20 minutes. After loading, cells were subjected to a further

minute incubation in normal K+-free medium or ouabain containing BEM,
with or without CPZ, in the absence of
determined by comparing the amount of

22

Na+. The efflux of

22

Na+ was

22

Na+ present in loaded cells (

the first 20 minute incubation in the presence of

22

Na+) compared to t

retained by the cells at the conclusion of the second 20 minute incu
(in the absence of

22

Na+).

In order to determine the effect of CPZ on the taurine content of li
isolated cells were loaded with

22

Na+ and 3H-taurine as described by

Ballatori & Boyer (1992). In these experiments cultured rat liver cel
incubated in oxygenated BEM containing

22

Na+ (0.5|iCi/mL) and 0.5mM

taurine (0.5}iCi 3H-taurine/mL) at room temperature for 1 hour. After
loading, cells were incubated in BEM (no

22

Na+ or 3H-taurine), in the

presence or absence of CPZ and ouabain, and the efflux of

22

Na+ and 3H-

taurine was followed over a 20 minute period. Efflux of sodium and t
was determined by comparing the sodium and taurine content of cells
end of the experiment with that in loaded cells.
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In further experiments aimed at determining the effect of C P Z on cell

volume, the uptake of 3-O-methyl [3H] -D-glucose was measured accordi
to the method described by Kletzien and associates (1975). In these
experiments 3-O-methyl-D-glucose was used at either 1 or 5 mM (with

0.5|xCi/mL 3-O-methyl [3H] -D-glucose used as a tracer along with 0.
22

Na+) and uptake measured over 10 or 20 minutes in normal or CPZ

treated cells. These time periods were based on reports (Kletzien et

Van Dyke & Scharschmidt, 1987) that 3-O-methyl-D-glucose equilibrates
across the cell membrane within 20 minutes.

2.2.3 Measurement of total intracellular sodium and potassium
content

In addition to measuring sodium activity (22Na+), total intracellular

and potassium content of isolated liver cells were determined. The f

in determining a reliable method for the measurement of intracellular

sodium and potassium content was to determine whether the intracellu
levels of cations changed during the incubation. Results from these
experiments are shown in figure 2.4. In these experiments rat liver
were incubated in normal BEM (no additions) for up to 30 minutes and
level of intracellular cations determined by flame photometry.
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Figure 2.4 Effect of time on intracellular cation levels in rat liver cells.
Rat liver cells were incubated in normal B E M , at 37°C, for 0 to 30 minutes prior to the
content of sodium and potassium being determined by flame photometry. At the
conclusion of the incubation, liver cells were washed (5 times, 30 seconds each) in icecold isotonic MgCl 2 (lOOmM, p H 7.4 with tris base) to remove extracellular cations.
After washing cells were placed into distilled water and left overnight to release
intracellular cations prior to cation content being determined by flame photometry.
(N=4, values are mean+SEM)

It can be seen from figure 2.4 that the level of intracellular cations (sodi
and potassium) does not change significantly over the duration of the
experiment. This result indicates that rat liver cells are able to maintain
their levels of intracellular cations in normal incubations for longer than
minutes.

The results presented in figure 2.4 provides the answers to two important
questions. First, the fact that intracellular cation levels are maintained for
greater than 20 minutes indicates that cation content can be measured over
the same time period that sodium
21

activity was measured

providing

consistency in the experimental methods used. Second, liver cells have been
seen to maintain viability throughout the incubation as indicated by their

ability to maintain their intracellular cation content for the duration of t
experiment. All incubations are performed in air equilibrated BEM, with or
without the addition of drugs, which may alter intracellular ion levels.
Although our incubation period of 20 minutes is shorter than that used by
other investigators (60 minutes, Van Dyke & Scharschmidt, 1987; Van Dyke
& Scharschmidt, 1983), it was important to confirm that the cells were able
to survive the duration of the experiment. One very stable indicator of

cellular viability is potassium content (Macknight, 1987). As liver cells lo
viability they are unable to .maintain active transport resulting in an
increase in intracellular sodium and a decrease in intracellular potassium.

Therefore, cells that are able to retain their intracellular ionic compositi
can be considered viable (Claret & Mazet, 1972). Therefore, intracellular
cation content was routinely determined after a 20 minute incubation
period.

The removal of extracellular sodium and potassium following incubation
in BEM was based on the method used to remove extracellular 22Na+. Liver
cells were washed in an ice-cold isotonic MgCl2 solution (lOOmM, pH 7.4
with tris base). The number of washes required to remove extracellular
cations was determined. The results of these experiments are shown in
figure 2.5.

22

X 170
V)
«

£
in
h
UH

100

•
°

• IH

Sodium
Potassium

"+H

o 80
C
01
C

*J

o 60
Uc
o
40
U
<+H
O

.*->

c
01

7.0

u
h

0)
PH

0

Figure 2.5 Removal of extracellular cations during sequential washes
After a 20 minute incubation in normal B E M rat liver cells were placed in 5, 30 second
washes in 20mL isotonic M g C l 2 (lOOmM, p H 7.4 with tris base) to remove extracellular
cations. The amount of sodium and potassium lost into the wash medium is presented as
a percentage of the cation content of the first wash. (N=4, values are mean±SEM)

In these experiments liver cells were washed, 5 times, sequentially i
(20mL) MgCl2. This wash protocol was the same as that used to remove
extracellular

22

Na+, with the exception that it was carried out in a s

and potassium free MgCl2 solution instead of BEM. It can be seen from

wash out curves in figure 2.5 that the initial washes contained rela

large amounts of sodium and potassium indicating the effective remov
extracellular cations. Five washes were used to remove extracellular
and potassium prior to flame photometry to bring this protocol into
alignment with that used for the removal of extracellular
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22

Na+.

Following the washes, coverslips were placed in 2 m L distilled water and left

overnight to allow for the release of intracellular cations. The med

containing the released intracellular cations was diluted 1:2 and c
content measured using a Corning 410 Flame Photometer. The

concentration of Na+ and K+ in liver cell dilutions was determined b

comparing unknowns with standard curves produced for NaCl (0.01-lmM,

r2=0.999) and KC1 (0.001-0.75mM, r2=0.997). The concentration (in mM
Na+ and K+ was then converted to nmoles Na+ or K+/mg protein.

In all experiments where intracellular cation content was measured,
by

22

Na+ or by flame photometry, normal or control incubations are th

where no drugs or inhibitors are included. Table 2.1 allows direct

comparison to be made between the values determined for the intrace
sodium and potassium by the two methods used. In other experiments,

drugs and inhibitors were used and their effects on liver cell cati
determined. Table 2.2 outlines the drugs employed, the maximal
concentrations used, and their target system or reason for use.
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Table 2.1 Comparison

of intracellular cation content of rat liver cells

measured by flame photometry and

22

Na+

Cation content of normal cells
(nmoles N a + or K + / m g Protein)
Sodium activity (22Na+)

72.6+5.1

Sodium content

146.5±28.2

Potassium content

368.8±31.6

Table 2.2

Drugs and inhibitors used during this study
Compound
Maximum
Use
Concentration

Amiloride

ImM

Na + /H + exchanger
inhibitor

BaCl 2
Bumetanide
CPZ
Colchicine
Cyanide
Cytochalasin B
Cytochalasin E
Deoxycholate (DOC)
2,4-dinitrophenol
Ethacrynic Acid
Gadolinium Chloride
(GdCl3)
Iodoacetate
3-O-methyl-D-glucose
Metyrapone
Monensin
a-Naphthoflavone
Ouabain
Paraformaldehyde
Proadifen
Taurine

ImM
O.lmM
5mM
ImM
2.5mM
100ng/m.L
50ug/mL
5mM
0.5mM
ImM
50uM
ImM
5mM
0.5mM
80fig/mL
10\LM

ImM
4%
20|iM
0.5mM
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K + channel inhibitor
Na+/K+/Cl- co-transport
inhibitor
?.

Microtubule inhibitor
Electron transfer inhibitor
Microtubule depolymeriser
Microtubule depolymeriser
Detergent to permeabilise
the cell membrane
Uncoupler of oxidative
phosphorylation
|
Na + -ATPase inhibitor
Non-specific cation
channel inhibitor
Inhibitor of glycolysis
Cell volume determination
Cytochrome P450 inhibitor
N a + ionophore
Cytochrome P450 inhibitor
Na+K+-ATPase inhibitor
Fixative
Cytochrome P450 inhibitor
Osmotically active amino
acid

2.3. Protein Determination
Protein content of isolated liver cells was measured using the Lowry
method (Lowry- et al, 1951). A standard curve was produced (25-200ug
bovine serum albumin, fraction V, r2=0.994) and the absorbance in
unknown samples was compared to the standard curve to determine the

protein content (mg)/coverslip. Coverslip protein content less than 5

cellular protein per coverslip were excluded from further calculation

protein content was routinely used as the denominator for measurement
intracellular ion content (ie nmoles Na+ or K+/mg Protein).

2.4. ATPase Activity of rat liver and kidney homogenates

ATPase activity of liver and kidney homogenates was measured accordin

the method of Akera (1984) as described by Else and associates (1996)
accordance with this method, ATPase activity was measured as the
breakdown of ATP to form inorganic phosphate and ADP.

Rat liver and kidney were homogenised (1:10 or 1:49 w:v dilutions) us
glass: glass homogeniser and ice cold homogenisation medium (in mM:

sucrose 250, EDTA 5, imidazole 20 and sodium deoxycholate 2.4 at pH 7

Homogenates were diluted (O.lmL into lmL final assay volume) into the

assay medium (in mM: tris(hydroxymethyl)amine methane.HCl 83.8, MgCl2
83.8, NaCl 100, KC1 15 and NaN3 5 , pH 7.4) and equilibrated at 37°C
minutes. The reaction was started with the addition of ATP (final
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concentration 5 m M ) . After 15 minutes, the reaction was stopped with the
addition of lmL ice-cold perchloric acid (0.8M). The reaction mixture

centrifuged at 2000g for 20 minutes at 2°C using a Hettich Universal 1
bench top centrifuge. The phosphate concentration of the supernatant
determined by adding 0.5mL of colour reagent (1% ammonium molybdate,
4% FeS04 and 3.3% H2S04) to 0.5mL of a 1:2 aqueous dilution of
supernatant. Colour was allowed to develop for 10 minutes before
absorbance was read at 750nm on the Shimadzu 1601 UV
spectrophotometer. Absorbance in tissue samples was compared to

absorbance in phosphate standards (25-250 nmoles Pi, r2=0.999). Na+K+-

ATPase activity was taken as the difference in the phosphate liberate
normal assay medium compared to that liberated in assay medium
supplemented with ouabain (ImM).

2.5. Oxygen Consumption of Isolated Liver Cells

Oxygen consumption of cultured liver cells was determined in the pres

or absence of CPZ (5mM) using a Strathelvin 781 oxygen meter connected
a Maclab® system. Air saturated water at 37°C (214 nmoles 02/mL,

[Carpenter, 1966]) was used to determine the upper limits of readings

oxygen depleted water (sodium thiocyanate treated water) provided the

level. After electrode calibration, isolated liver cells were added t

respiration well, in the presence or absence of CPZ, and oxygen consu
measured over 20 minutes.
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2.6. 3 H-Ouabain Binding

The number of 3H-ouabain binding sites were determined for rat liver
previously described (Else et al, 1996). The liver was removed and
immediately cut into small samples (<25mg) which were pre-incubated
twice in excess ice-cold K+-free medium (in mM: NaCl 125, MgS04 1.2,

NaHC03 25, NaH2P04 1.2, CaCl2 1.3, and glucose 5 at pH 7.4) for 10 minu

Samples were then incubated for 2 hours at 37°C in fresh K+-free med

containing ljiCi of 3H-ouabain and either 5|iM ouabain (a concentrat

previously shown to saturate all specific ouabain binding sites in r

[Else et al, 1996]) or excess unlabelled ouabain (lOmM) in the prese

absence of CPZ (5mM). Incubations were gassed continuously with carb

(95% 02 : 5% C02) to maintain pH and to move medium around the tissue

Incubations were performed in the presence of ImM veratrine (veratri

a potent inhibitor of the steroid carrier system present in mammalia

cell membranes yet does not affect ouabain binding to the sodium pum

[Petzinger & Fischer, 1985]). After incubation, all tissues were rem

washed five times (8 minutes/wash) in 3mL of ice-cold K+-free medium

After washing, tissue samples were blotted dry, weighed and placed i

Soluene 100® tissue solubiliser overnight. 3H activity was determine
a Wallac 1409 liquid scintillation counter (88% efficiency for 3H).

The 3H activity of each tissue was expressed as disintegrations/minu
mL of incubation medium/gram of tissue. Non specific 3H activity was
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accounted for by subtracting the

3

H activity in the presence of excess

unlabelled ouabain (lOmM). Remaining 3H activity was taken to represen
specific uptake and was converted to pmoles of ouabain bound/gram of
tissue.

2.7. Preparation of Isolated Cells for Microscopy
2.7.1 Light microscopy

Isolated rat liver cells were treated for 20 minutes with either norm

or medium containing 5mM CPZ. After treatment, cells were washed in i

cold BEM (5 x 30 seconds in 20rnL, as per flux measurements) and then

for 30 minutes in 2.5% glutaraldehyde (in BEM at room temperature). A

fixation, cells were dehydrated using a graded series of ethanol (50%
95%, 100% x 2, 5 minutes each). Fixed and dehydrated cells were then
to Wollongong Hospital where they were stained with a modified
Papanicolau stain.

2.7.2 Preparation of cells for scanning electron microscopy

Rat liver cells that were prepared for scanning electron microscopy w

treated as for light microscopy except that they were further dehydra
two washes in 100% acetone. After fixing and dehydration, cells were

overnight in a desiccator containing silica gel. Coverslips were moun

onto blocks, and sputter coated with gold before being placed into th
Stereoscan 440 scanning electron microscope.
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2.8. Statistics

As this examination is primarily concerned with a comparison of the resul
in the presence or absence of CPZ any differences were compared using

simple T-tests. All values are expressed as means ± standard error of the
mean.
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2.9. Materials
Chemical N a m e

Supplier

General chemicals
Collagenase (Type 1)

Worthington Biochemical
Corporation (Freehold USA).

Dulbecco's modified Eagles medium Sigma Chemicals (St. Louis, USA).
H E P E S (cell culture grade)

Sigma Chemicals (St. Louis, USA).

Cell culture chemicals (serum, amino

Life Technologies (Melbourne, Aust.).

acids and antibiotics)
Nembutal

Boehringer Ingelheim Australia

A T P special quality

Boehringer Mannheim

Soluene 100®

Canberra Packard (Zurich,
Switzerland).

Scintillation fluid

Canberra Packard (Zurich,
Switzerland).

Specific inhibitors ie. Ouabain,

Sigma Chemicals (St. Louis, U S A )

furosemide, ethacrynic acid,
chlorpromazine and monensin
Radiochemicals
22

NaCl (99.9% pure, specific activity " D u Pont (Boston, USA).

831mCi/mg at 17.73MCi/mL)
[3H]-Ouabain

D u Pont (Boston, USA).

(specific activity 15-30 Ci/mmol)
D u Pont (Boston, USA).

[3H]-Taurine
(specific activity 5-30 Ci/mmol)
3-O-methyl -[3H]-D-Glucose

~~

D u Pont (Boston, U S A ) .

(specific activity 60-90 Ci/mmol)
Gases
Carbogen (95% 0 2 / 5 % C0 2 )

B O C Gas, Australia

Medical Oxygen

B O C Gas, Australia
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CHAPTER 3

EFFECT OF CPZ O N
INTRACELLULAR SODIUM CONTENT OF
ISOLATED LIVER CELLS

"I do not feel obliged to believe that
the same God who endowed

us with

sense, reason, and intellect had
intended for us to forgo their use"
Galileo Galilei
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3.1. Effect of C P Z on intracellular sodium
3.1.1. Effect of C P Z on the sodium activity of liver cells
In this chapter the effect of CPZ on the sodium activity of isolated
was characterised using

22

Na+. The results of initial experiments are s

in figure 3.1. Normal or control incubations were carried out in B E M alone,
with no drug additions. In other incubations liver cells were subjected to
drug treatments, including combinations of the sodium p u m p inhibitor
ouabain (ImM) and C P Z (5mM), to examine the effect these drugs had on the
sodium activity of isolated liver cells.

Normal

Ouabain

Ouabain
+CPZ

Figure 3.1 Effect of drug treatments on sodium activity of liver cells.
Isolated rat and toad liver cells were incubated, for 20 minutes in the presence of 2 2 N a +
at 37°C, in normal (BEM alone) or medium supplemented with ouabain (ImM) with or
without C P Z (5mM). At the conclusion of the incubation cells were washed 5 times in
20mL of ice cold B E M to remove extracellular

22

Na + . Intracellular 2 2 N a + (determined

by y counting) and cellular protein content was measured and results converted to nmoles
N a + / m g Protein. (N>14, values are mean±SEM)

33

Liver cells in normal incubations, in B E M alone, had 72.6±5.1 and 74.9+4.0
nmoles N a + / m g protein for rat and toad respectively. In the presence of
ouabain, a specific inhibitor of the sodium p u m p , an accumulation of
intracellular sodium was seen. The difference between normal and ouabain
containing incubations is a measure of the sodium that would normally
have been removed by the activity of the sodium p u m p . The third column
in figure 3.1 shows the level of intracellular sodium seen in incubations
containing ouabain ( I m M ) and C P Z (5mM). From these results it can be seen
that there was a large decrease in intracellular sodium in incubations
containing C P Z . This level of sodium is significantly lower than that seen in
ouabain containing incubations (p<0.0001 for both rat and toad) and also
significantly lower than the sodium level in normal incubations (p<0.009 for
rat and toad). The decrease in intracellular sodium seen in the presence of
C P Z is surprising because the ability to decrease intracellular sodium, in the
presence of ouabain, to a level below jhtat seen in normal cells has not been
previously described for this or any other drug.

The ability of CPZ to lower intracellular sodium, as shown in figure 3.1, i
contrast to the effect shown for C P Z on the same cell system by VanDyke and
Scharschmidt (1987). In their experiments, lower C P Z concentrations
( m a x i m u m of 300|nM) were associated with an increase in intracellular
sodium, possibly due to sodium p u m p inhibition. Apart from concentration,
the differences in experimental protocol was the time of incubation (60
minutes compared to 20 minutes used in this investigation) and the n u m b e r
of washes used to remove extracellular 2 2 N a + (8 compared to 5 used in these
34

experiments). D u e to the different effects seen with

different C P Z

concentrations, the concentration dependence of the sodium lowering effect
of C P Z was examined. The results from these experiments are shown in
figure 3.2.
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Figure 3.2 Concentration dependence of the effect of CPZ on the sodium
activity of rat liver cells.

Rat liver cells were incubated with varying concentrations of CPZ (5mM to 5(xM) in t
presence of ouabain (ImM) for 20 minutes and the effect on sodium activity ( 22 Na + )
determined. (N>4, values are mean+SEM)

The dose response curve shown in figure 3.2 indicates that the ability of C P Z
to lower intracellular sodium is dependent on C P Z concentration. Probit
analysis indicates that 5 0 % of the sodium lowering ability (IC50) of C P Z has
been removed by 100(xM. However, the increase in intracellular sodium,
described by VanDyke and Scharschmidt (1987) is not seen.
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3.1.2. Effect of C P Z on sodium efflux from 2 2 N a + loaded cells

The amount of intracellular sodium (22Na+) that accumulates within th

cells is a balance between the influx and efflux of sodium. Therefore

decrease in sodium activity seen in the presence of CPZ could be due t

either an increase in the efflux of sodium out of the cell, or a decre

influx of sodium into the cell. In the literature there is some suppor

either possibility. A decrease in the influx of sodium, through sodium
channels, is supported by reports that low concentrations (<10uM) of

able to block sodium channels in mouse neuroblastoma cells (Ogata et a

1990; Ogata et al, 1989) and isolated guinea pig striatal neurones (O
Tatebayashi, 1989). Conversely, an increase in sodium efflux has also

suggested to explain the reduced intracellular sodium seen in human re

cell ghosts in the presence of relatively high concentrations (>0.1mM

(Askari & Rao, 1970). All of the experiments described so far have bee

performed in the presence of ImM ouabain. This concentration of ouaba

known to fully inhibit sodium pump activity. Therefore, an increase in

sodium efflux in the presence of ouabain, which blocks the predominant
mode of sodium efflux, would be unexpected.

In order to determine whether CPZ was decreasing sodium activity by
increasing sodium efflux, liver cells were loaded with

22

Na+ by incubat

them in the presence of ouabain for 20 minutes. Loaded cells were then
incubated for a further 20 minutes, in the absence of

22

Na+ and the amo

of sodium retained at the conclusion of the post-loading incubation
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measured. The difference in intracellular sodium between post-loading and
loading incubations gives an indication of the sodium efflux. If CPZ were

decreasing intracellular sodium, by activating a sodium efflux pathway, then
a decrease in the amount of 22Na+ retained by the cells would be expected.
These experiments would therefore distinguish between an activation of
efflux or an inhibition of influx as the mechanism behind the decrease in
intracellular sodium seen in the presence of CPZ. The result of experiments
with sodium loaded liver cells are shown in figure 3.3.

The first column in figure 3.3 show that cells, from both animals,
accumulated 22Na+ during the 20 minute loading period (loading compared
to ouabain values in figure 3.1). When the loaded cells were subsequently
incubated in normal medium (in the absence of 22Na+ and ouabain,
therefore with reactivating sodium pumps), cells lost 70% of their sodium
load. This loss was increased to 80% in incubations containing CPZ although

the sodium efflux, in this case, was not significantly different in normal a
CPZ containing incubations (p>0.06).
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Figure 3.3 Effect of CPZ on efflux of 22Na+ from pre-loaded liver cel
Liver cells (rat, upper panel and toad lower panel) were loaded with
incubating them for 20 minutes with

22

22

N a + by pre-

N a + in the presence of ouabain (ImM). Loaded

cells were then incubated for a further 20 minutes, in the absence of 2 2 N a + , in postloading medium: normal (BEM alone) with or without C P Z (5mM), K+-free medium
with or without C P Z or B E M supplemented with ouabain with or without CPZ, and the
amount of 2 2 N a + retained at the conclusion of the incubation period measured. The
difference in intracellular sodium between post-loading and loading incubations was
taken as an indication of sodium efflux. (N>5, values are mean+SEM)
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Cells having a post-loading incubation in ouabain retained almost 5 0 % of

their sodium load (46% of their sodium load for toads and 38% for rat

contrast, cells incubated in ouabain and CPZ retained only 12% of the
22

Na+ load in both rat and toad. Similar results were also found where

were incubated in K+-free medium (where sodium pumps were inhibited).

In this medium CPZ resulted in a significant (p<0.007) increase in so

efflux indicating that CPZ maybe activating sodium efflux by a mechan

independent of extracellular potassium. These results demonstrate tha

rather than preventing sodium entry, that is blocking sodium channels
concentrations of CPZ generally result in an increase in the removal

intracellular sodium. This result is remarkable as the removal of sod

against the naturally occurring concentration gradient, and in the pr

saturating concentrations of ouabain, where the sodium pump, the acce

mode of sodium removal, is inhibited. Furthermore, CPZ activated remo

of intracellular sodium can occur in the absence of extracellular pot
situation where sodium pump activity is inhibited.

It can be seen from figure 3.3 that approximately 50% of the sodium l

liver cells was removed even in the presence of ouabain. Efflux of so

the presence of ouabain, or ouabain-insensitive sodium efflux, has be

previously described in liver (Claret & Mazet, 1972; Russo et al, 197

renal cortical tissue slices (Macknight, 1968). This efflux is thought

mediated, in part, by activation of sodium: sodium exchange across th
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m e m b r a n e (ie in this case exchange of

22

N a + for N a + ) . Using isolated

perfused rat liver and radioactive tracers, (Claret & Mazet, 1972), found
51% of sodium efflux was inhibited in the presence of ouabain and 28% was
dependent on sodium: sodium exchange, ie was inhibited when extracellular
sodium was removed. The remaining 21% of sodium efflux was
unexplained.

3.1.3. Effect of CPZ on sodium content of liver cells
The possibility that sodium: sodium exchange was enhanced in the presence
of CPZ was considered. This could explain the results seen in figure 3.3
exchange of radioactive sodium for normal sodium would give the
appearance of sodium moving out of the cell against its concentration

gradient. It would, however, not explain the initial decrease in intracell
sodium in the presence of CPZ (CPZ + ouabain, figure 3.1) as the sodium:
sodium exchange mechanism would have to distinguish between
radioactive

22

Na+ and normal sodium to selectively remove

22

Na+ from the

cell.

In order to determine any possible involvement of sodium: sodium
exchange in CPZ activated sodium transport, the effect of CPZ on absolute
intracellular sodium content was measured by flame photometry. In these
experiments

22

Na+ was not included in the incubations, therefore any abilit

of CPZ to lower intracellular sodium would be due to an actual activation
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sodium efflux rather than an enhancement of sodium: sodium exchange.
Results of these experiments are shown in figure 3.4.

Normal

Normal
+CPZ

Ouabain Ouabain
+CPZ

Figure 3.4 Effect of CPZ on sodium content of liver cells.
Rat and toad liver cells were incubated, for 20 minutes at 37°C, in normal (BEM alone) or
medium supplemented with ouabain (ImM) and C P Z (5mM). At the conclusion of the
incubations cells were washed 5 times in 20mL of ice cold MgCl2 (pH 7.4 with Tris base)
to remove extracellular sodium. Intracellular sodium (determined by flame photometry)
and cellular protein content were determined and results converted to nmoles N a + / m g
Protein. (N>7, values are mean+SEM)

CPZ clearly demonstrates the ability to lower the absolute level of

intracellular sodium. The values determined for total sodium content are
greater than those measured using

22

Na+ assays (eg compare values to thos

obtained for normal incubations in figure 3.1), as the flame photometry
method measures total intracellular sodium, both bound and unbound, not
simply the sodium that is active during the incubation period.
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These results show that C P Z is able to significantly lower intracellular
sodium in both normal (p<0.03 for rat and 0.001 for toad) and ouabain

(p<0.008 for rat and 0.031 for toad) containing incubations. The ability of
to lower intracellular sodium content in normal and ouabain treated cells
corresponds to the decrease in sodium activity seen in the presence of CPZ
and ouabain in figure 3.1. This suggests that CPZ is stimulating a sodium
transport mechanism rather than enhancing sodium: sodium exchange. To
further examine the potential activation of sodium transport by CPZ,
experiments were conducted to determine the extent to which CPZ could
remove intracellular sodium. The sodium ionophore monensin, was used

in the presence of ouabain to artificially increase the sodium content of l
cells. The results from these experiments are shown in Figure 3.5.

Incubation of liver cells in monensin (80|ig/mL) and ouabain (ImM)

resulted in a large increase in intracellular sodium demonstrating the abil
of monensin to act as a sodium ionophore, artificially increasing
intracellular sodium levels. This effect can be seen regardless of whether
intracellular sodium is determined using 22Na+, ie sodium activity or flame
photometry, ie sodium content. The result shown are for sodium content

only. The ability of CPZ to decrease intracellular sodium in the presence o
monensin demonstrates the large potential capacity for CPZ activated
sodium transport.
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+Ouabain +Ouabain
+CPZ

Figure 3.5 Capacity of CPZ to activate sodium transport in liver cells.
Isolated rat and toad liver cells were incubated, for 20 minutes, in normal (BEM alone) or
medium supplemented with ouabain (ImM), monensin (80fXg/mL) and/or C P Z (5mM).
The presence of the sodium ionophore monensin resulted in a large increase in the
intracellular sodium content of liver cells. (N>6, values are mean±SEM)

3.2. Effect of C P Z on Na+K+-ATPase activity
3.2.1. The sodium pump
Results so far have suggested that CPZ reduces intracellular sodium by
activating the efflux of sodium
concentration

gradient

from liver cells against the natural

for sodium

and therefore

requiring

energy

expenditure. The predominant m o d e of sodium extrusion from cells is
through the Na + K + -ATPase (EC number 3.6.1.37) which is the enzymatic
form of the sodium p u m p . The sodium p u m p is a membrane bound protein
which is responsible for the maintenance of sodium

and potassium

electrochemical gradients across the cell membrane (Glynn & Chir, 1968;
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Leaf, 1956). This protein couples the energy derived from the breakdown of
ATP with the transmembrane movements of three sodium ions out of the
cell in exchange for two potassium ions moving into the cell. Movement of
both cations occurs against their electrochemical gradients (Skou, 1965).
diagrammatic representation of the sodium pump is shown below in figure
3.6.

Outside

Ceil M e m b r a n e
Inside

ATP
A D P + Pi

Figure 3.6 A diagrammatic representation of the sodium pump
The sodium pump consists of an alpha (a) and a beta (p) subunit arranged

together to form a functional unit. The a-subunit contains the binding sit
for substrates including sodium, potassium, magnesium and ATP along with
the extracellular ouabain binding site. The p-subunit does not contain

recognised binding sites and is thought to have a regulatory or stabilisin
role (Ewart & Amira, 1995).
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Activation of sodium efflux in liver cells treated with CPZ, indicated by the
results shown in figure 3.3, suggests that CPZ may be activating the
pump to decrease intracellular sodium. However, activation of sodium
efflux has been shown to occur in the presence of high concentrations

ouabain. A similar activation of sodium efflux in cells (red cell ghos

treated with high concentrations (O.lmM) of CPZ (Askari & Rao, 1970) w

considered to result from the ability of CPZ to interfere with the bi
ouabain to the sodium pump. This interference would prevent sodium
pump inhibition allowing active sodium pumps to remove intracellular

sodium. Therefore, interference with ouabain binding was considered a

possible mechanism for CPZ lowering of intracellular sodium in isolat
and toad liver cells.

3.2.2. Interaction of CPZ with the ouabain binding site

The ability of CPZ to bind to the extracellular ouabain binding site w

investigated in order to determine whether an interaction between CPZ
ouabain binding to the sodium pump was responsible for the activation

sodium efflux seen in the presence of CPZ. The results of these exper

showed that, for rat liver, the number of ouabain binding sites (meas

the presence of 5uM unlabelled ouabain) was 575 ± 136 pmoles/gram. Thi

value is similar to those reported in the literature (Else et al, 1996

presence of CPZ (5mM) the concentration of ouabain binding sites fell

148 ± 123 pmoles/gram of tissue (N=7) indicating that chlorpromazine c

interfere with the specific binding of ouabain to the sodium pump. Whi
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this suggests that C P Z could be interfering with the inhibition of the sodium

pump by ouabain, the non-specific binding of ouabain (measured in the

presence of saturating concentrations of unlabelled ouabain) was not

by CPZ (p>0.5). The concentration of ouabain used to measure non-spec

ouabain binding (lOmM) is similar to the concentration of ouabain us

the sodium transport experiments therefore it is unlikely that the a

CPZ to lower intracellular sodium could be due to CPZ interference wi
ouabain binding to the sodium pump.

Furthermore, it is unlikely that CPZ is activating sodium efflux by

interfering with ouabain binding because CPZ is able to significantl

intracellular sodium to a level below that seen in normal cells rega

whether intracellular sodium levels are determined by sodium activity

(22Na+, p<0.009 for rat and p<0.0001 for toad) or sodium content (fl
photometry, p<0.03 for rat and p<0.001 for toad). If CPZ was simply

interfering with ouabain binding then sodium levels would be expected
return to normal (in the presence of active sodium pumps), but would

be expected to fall below normal. In addition, the activity of the so
pump is dependent on extracellular potassium. Therefore the ability
to activate sodium efflux in potassium-free medium suggests that the
sodium pump cannot be involved in CPZ activated sodium transport.

However, the sodium pump is the predominant mode of sodium efflux and

is considered by some investigators (Ewart & Amira, 1995) to be the o

mode of sodium efflux available. Therefore the ability of CPZ to cha
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activity of the sodium p u m p , even in the presence of ouabain, needed to be
investigated.

3.2.3. Effect of CPZ on the potassium content of liver cells
Increased sodium efflux in the presence of C P Z suggests that C P Z m a y be
activating the sodium p u m p to decrease intracellular sodium. It would be
expected that if C P Z was activating the sodium

pump

to decrease

intracellular sodium there would be a substantial increase in intracellular
potassium. Potassium influx can be estimated using the potassium analogue
rubidium (86Rb+) as an indicator of potassium permeability or intracellular
potassium content can be measured directly using flame photometry. T h e
effect of C P Z on the level of intracellular potassium was measured, by flame
photometry, and the results of these experiments are shown in figure 3.7.

•

Normal

Normal
+CPZ

Ouabain

Rat

Ouabain
+CPZ

Figure 3.7 Effect of CPZ on intracellular potassium content.
Rat and toad liver cells were incubated, for 20 minutes at 37°C, in normal (BEM alone) or
medium supplemented with ouabain (ImM) and C P Z (5mM). At the conclusion of the
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incubation cells were washed 5 times in 20mL of ice cold MgCL; (pH 7.4 with Tris Base) to
remove extracellular potassium. Intracellular potassium and cellular protein content was
determined and results converted to nmoles K + / m g Protein. (N>7, values are mean+SEM)

By comparing the potassium content seen in normal cells in figure 3
the sodium content measured in figure 3.4, it can be seen that normal cells
have a potassium content that is approximately three times higher than
their sodium content. As expected, sodium p u m p inhibition, in the presence
of ouabain ( I m M ) results in a fall (although not significant) in the
intracellular potassium content compared to those seen in normal cells.
Surprisingly, potassium content was also lowered in the presence of CPZ.
Intracellular potassium was decreased by greater than 9 0 % in normal and
ouabain incubations containing CPZ.

The decrease in both intracellular sodium and potassium suggests th
was not lowering intracellular sodium by increasing the activity of the
sodium pump. As a possible means of determining if sodium and potassium
transport were activated concurrently, a time course for C P Z lowering of
intracellular sodium

and potassium was determined. Results of these

experiments are shown in figure 3.8.

Activation of sodium and potassium transport by CPZ appears to occur
concurrently although the potassium content measured in the presence of
C P Z is significantly different from normal by 10 minutes (p<0.03) and
sodium content in the presence of C P Z is not significantly different from
normal until 20 minutes (p<0.05).
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of sodium

&
X

30

and potassium

Rat liver cells were incubated in normal (BEM alone) or medium containing C P Z (5mM)
for 0 to 30 minutes. The sodium and potassium content was determined at the conclusion
of the incubation. The results for potassium are shown in the upper panel and for sodium
in the lower panel. (Values are mean±SEM, N=4)

The concentration dependency of the effect of CPZ on intracellular

potassium was also determined and the results are shown in figure 3.9. The
dose response curve shown in figure 3.9 indicates that the ability of CPZ
lower intracellular potassium is dependent on CPZ concentration with an
IC50 of 100(iM, the same as that determined for sodium (see figure 3.2).
49

500"
-p
n
| 400'4->
01
4->
o
in
c PH
o bo300U
B « 200t/l

nj

4-1

O

&H

«3
0)

P-H

o
6 100-

£
U

T

'

i t ^ i iii| —

0.001

i

i i' i i n i|

0.01

i n. i

0.1

i , » m |

1

,

,

,-pi i r g

10

Concentration of C P Z ( m M )
Figure 3.9 Concentration dependence of CPZ lowering of intracellular
potassium in rat liver cells.
Rat liver cells were incubated with varying concentrations of CPZ (5mM to 5uM) in
normal B E M for 20 minutes and the effect on intracellular potassium determined. (N>4,
values are mean+SEM)

3.2.4. Effect of CPZ on ATPase activity of tissue homogenates

Activity of the sodium pump can be measured in isolated cells, tissue
cell fragments or in purified enzymes although the manifestation of that
activity changes depending on the system used. In isolated cells sodium
p u m p activity can be determined by measuring the cation transport activity
of the sodium p u m p . In cell fragments or purified enzymes the cation
transport activity is lost however the A T P hydrolysing ability of the sodium
p u m p remains and can be measured as an indication of sodium

pump

activity in these systems. Therefore, the effect of C P Z on the ability of the
sodium p u m p to hydrolyse A T P was examined by measuring the liberation
of inorganic phosphate

from

the breakdown

50

of ATP. Results

from

experiments measuring the effect of CPZ on ATPase activity of rat kidney
and liver homogenates is shown in figure 3.10.
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Figure 3.10 Effect of CPZ on ATPase activity of rat kidney and li
homogenates.
The total ATPase activity of rat kidney (upper panel) and liver (lower panel)
homogenates was determined from the amount of phosphate liberated from the
breakdown of A T P during a 15 minute incubation. Na + K + -ATPase activity was taken as
the difference in the phosphate liberated in normal assay medium compared to that
liberated in potassium free assay medium supplemented with ouabain (ImM). The effect
of C P Z (5mM) on ATPase assay medium was measured in normal or ouabain containing
incubations. (N = 4, values are mean±SEM)
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The normal incubations in figure 3.10 demonstrate the total ATPase activity
of the homogenates. It can be seen that the ATPase activity of kidney
homogenates (in the upper panel) is much larger than that of liver
homogenates (in the lower panel) as kidney has an intrinsically higher

ATPase capacity. In incubations that are potassium free or contain ouabain
the sodium pump is inhibited. Therefore, the difference in the amount of
inorganic phosphate (Pi) liberated in the presence and absence of ouabain
the ATPase activity normally associated with enzymatic expression of the
sodium pump, the Na+K+-ATPase. This difference is larger in kidney
homogenates than in liver homogenates, as kidney has a much greater
concentration of sodium pumps per mg tissue than liver does (Else et al,

1996). The remaining ATP breakdown is due to the activity of other ATPases
that would be present in homogenates, such as Mg2+-ATPase or the Na+ATPase. Although Ca2+-ATPase would be present in these tissues Ca2+ATPase activity would not be measured, as calcium was not present in the

incubation mix. In the presence of CPZ, the decrease in ATPase activity is

greater than the decrease seen in ouabain containing incubations suggesti
that CPZ not only inhibits the Na+K+-ATPase but other ATPases as well.

The ability of CPZ to inhibit ATPase activity is well supported in the

literature. CPZ has been shown to inhibit Na+K+-ATPase activity in rat bra
(Hackenberg & Krieglstein, 1972; Mazumder et al, 1990; Rocha et al, 1990;

Samuels & Carey, 1978) and liver microsomes (Keefe et al, 1980; Rocha et a
1990; Samuels & Carey, 1978). In rat brain microsomes, 82% of the sodium
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p u m p s have been reported to be inhibited with 0.75mM C P Z (Mazumder et
al, 1990) while in liver membranes O.lmM CPZ inhibits 68% of Na+K+-

ATPase activity (Samuels & Carey, 1978). In addition to inhibiting Na+

ATPase activity, CPZ has been shown to inhibit Ca2+ATPase activity of r

testes (Mazumder et al, 1991) and Mg2+ATPase activity of rat liver plas

membranes (Keefe et al, 1980; Samuels & Carey, 1978). Therefore, it ap

likely that CPZ has the ability to inhibit ATPase activity generally a
inhibition is not restricted to Na+K+-ATPase activity.

Two possible modes of ATPase inhibition have been suggested to explai

decreased ATPase seen in the presence of CPZ. In 1970, Akera and Brody

reported that 75% of the sulphydryl groups of the Na+K+-ATPase react wi

CPZ. They suggested that this reaction played an important part in the

inhibition of Na+K+-ATPase activity by CPZ. It was later shown that re
of the Na+K+-ATPase with agents that modify sulphydryl groups leads to

inhibition of Na+K+-ATPase activity possible through a reduction in the
number of ATP/ADP binding sites (Schuurmans Stekhoven & Bonting,

1981). Furthermore, it has been suggested that inhibition of Na+K+-ATP

activity by CPZ could be due to changes in the membrane fluidity (Adh

et al, 1991; Keefe et al, 1980; Schmalzing et al, 1981) This is suppo

suggestions that the hydrophobic nature of CPZ plays an important rol
Na+K+-ATPase inhibition (Hackenberg & Krieglstein, 1972).
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A n apparent paradox exists where C P Z is able to increase the efflux of
sodium in whole cells, while inhibiting sodium pumps in tissue

homogenates. This leads to a number of questions. First, how CPZ could

exerting a different effect on whole cells to that seen with homogena

Second, how could CPZ be causing such a large decrease in intracellula

potassium while activating sodium efflux through the sodium pump? Base

on these apparent paradoxical actions of CPZ, alternate possibilities
action were considered.

Sodium pump activity is dependent upon the membrane environment,
with changes in the membrane environment changing sodium pump

activity (Else & Wu, 1999; Simon et al, 1996). For example, cholestero
enrichment has been shown to decrease the sodium pump transport of

potassium in cultured endothelial cells (Lau, 1994). The converse is t
cholesterol depletion in human erythrocytes, which has been shown to

modify the kinetic parameters of the sodium pump, decreasing the affin

for sodium and increasing the translocation rate of the pump (Giaraud
1981). These changes in sodium pump kinetics were based on changes in

cation (24Na+) transport rates in cholesterol depleted human erythroc

this study, CPZ (O.lmM) was able to affect cation transport in the sam

manner as cholesterol depletion, that is, CPZ was seen to increased s
pump translocation rates.
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Sodium p u m p activity can also be modified by hormones such as insulin. In
this case, insulin is known to acutely (within 10 to 15 minutes) stimulate
sodium pump causing an ouabain-sensitive accumulation of potassium and
loss of up to 55% of intracellular sodium from isolated skeletal muscle
(Dorup & Clausen, 1995). The stimulatory effect of insulin on sodium pump
activity is not seen in purified sodium pump preparations (similar to CPZ)
suggesting that insulin may be acting via a receptor or second messenger
system rather than having a direct effect on the sodium pump. One
possibility that has been suggested for insulin stimulation of sodium pump
activity in rat hepatocytes depends on an increase in intracellular sodium
due to an insulin stimulated activation of Na+/H+ exchangers (Fehlmann &
Freychet, 1981). A similar increase in sodium pump activity has been
associated with the increase in intracellular sodium that follows from
sodium dependent uptake of the amino acid alanine (Van Dyke &
Scharschmidt, 1983). In adipocytes, insulin stimulation of sodium pump

activity has been associated with an increase in the affinity of the sodium
pump for sodium, possibly mediated by sodium pump dephosphorylation,
without an increase in intracellular sodium (McGill & Guidotti, 1991).

Another possibility suggested for the insulin stimulated increase in sodium

pump activity in skeletal muscle is that insulin stimulates the translocat
of sodium pumps to the cell membrane, increasing the number of active

pumps but not changing the activity of individual pumps (Grinstein & Erlij,
1974).

55

There are similarities between insulin stimulation of sodium p u m p activity
and CPZ activation of sodium transport. Both require the presence of whole

cells and are not seen in purified sodium pump preparations. Therefore it is
possible that CPZ and insulin could be utilising similar mechanisms to
stimulate sodium pump activity. However, unlike insulin, CPZ does not

cause an increase in intracellular potassium associated with the decrease in
intracellular sodium. While this suggests that a simple stimulation of
sodium pump activity by a secondary intracellular signal is not responsible
for the activation of sodium transport, the involvement of an intracellular
signal in the activation of another mechanism remains possible.

The ability of CPZ to antagonise ouabain binding to the sodium pump raises
the possibility that CPZ was binding to the sodium pump at the potassium

binding site. It has been postulated that ouabain binds close to or maybe ev
at the potassium binding site (Doris, 1994, #317), therefore it is possible
CPZ antagonised ouabain binding by competing for the potassium binding
site (Roufogalis, 1975). It has been reported that potassium binding is
inhibited at physiological pH by protonated amines (Carfagna & Muhoberac,
1993). At physiological pH CPZ contains a protonated amine (pKa = 9.3)
therefore, it is possible that CPZ was able to block potassium from binding
this site, blocking potassium transport by the pump, while allowing the
outward transport of sodium ions or uncoupled sodium transport.
Additionally, the concurrent decrease in intracellular potassium and
sodium, a situation which could not occur with normal functioning of the
sodium pump, could be explained. If the potassium site of the sodium pump
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were blocked there would not be any potassium returning to replace the
potassium that was lost through the passive potassium leak. However, this

possibility is unlikely because in order to bind to the potassium site, CPZ
would have to compete with saturating ouabain concentrations and 5mM
extracellular potassium, prior to stimulating uncoupled sodium transport.

3.3 Conclusions
Results so far have indicated that high concentrations of CPZ are able to

decrease the intracellular sodium content of isolated liver cells by activ
a sodium efflux pathway. This efflux is not due to an enhancement of
sodium: sodium exchange activity. Although sodium efflux can occur in the
presence of saturating concentrations of ouabain, or in the absence of
potassium, activation of the sodium pump by CPZ was considered as a
possible mechanism. However, as CPZ decreases intracellular potassium,
along with sodium, and inhibits ATPase activity in liver and kidney
homogenates, the sodium pump is unlikely to be involved.

3.4 Future work
While the ability of CPZ to activate sodium efflux, in the presence of
ouabain, without an apparent countercurrent movement of potassium ions
implies that the sodium pump is not involved in CPZ activated sodium

transport, the possibility exists that CPZ may be altering the normal cycli
the sodium pump.
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The sodium p u m p , operating in normal cycling, exists in two enzymatic
conformations, El and E2. Figure 3.11 is a simplified Albers-Post model of
sodium p u m p function modified from Horisberger and associates (1991).

Figure 3.11 A simplified Albers Post scheme of the Na+K+-ATPase

(modified

from Horisberger et al, 1991)
In the sodium pump reaction cycle three intracellular sodium ions are
bound to the phosphorylated El form of the p u m p . These ions are then
occluded and the p u m p conformation changed to E2 resulting in release of
sodium ions on the extracellular side of the membrane. T w o potassium ions
are then bound to the E2 form of the p u m p , the p u m p is dephosphorylated
and the conformation returned to El. Potassium ions are released to the
intracellular side of the p u m p and A T P binds. A T P is hydrolysed, releasing
A D P and leaving the p u m p phosphorylated ready to bind intracellular
sodium once again. This makes for an elaborate reaction cycle which

58

includes

enzyme

phosphorylation

linked

to sodium

extrusion

and

dephosphorylation linked to potassium uptake (Carfagna & Muhoberac,
1993; Johnson et al, 1986).

In 1965, Garrahan and Glynn suggested that "under abnormal conditions the
sodium pump behaves in unusual ways" therefore, unusual modes of
sodium pump action in the presence of CPZ need to be considered. Results
showing that CPZ interacts with the Na+K+-ATPase differently in the
presence of different substrates, suggest that CPZ may react differently
different forms of the enzyme (Mazumder et al, 1990). Therefore it is
possible that CPZ could alter the reaction cycle of the sodium pump.

Different transport modes of the Na+K+-ATPase can be seen with changes in
the ionic environment. A sodium only, uncoupled mode of pumping has
been described in the absence of extracellular potassium (Beauge & Glynn,
1979; Campos & Beauge, 1994; Cavieres & Glynn, 1979; Forgac & Chin, 1982;
Gadsby et al, 1993). It is hypothesised that with the uncoupled mode of
pumping ATP is dephosphorylated and ADP is phosphorylated so there is no
net hydrolysis of ATP, although ATP is required for the formation of the
carrier proteins (Garrahan & Glynn, 1965).

The different methods for measuring sodium pump activity measure
different parts of the Na+K+-ATPase reaction cycle. The standard ATPase
assay, as was used in this study, measures the liberation of inorganic
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phosphate (Pi) following a full cycle of the sodium p u m p . Another assay
determines the activity from the amount of ADP produced (Akera, 1984;

Scharschmidt et al, 1979). This ATPase assay links the ADP production t
NADH reduction via pyruvate kinase and lactate dehydrogenase. The
reaction cycle is shown below:

ATP - (Na+K+-ATPase) --> ADP + Pi

Phosphoenolpyruvic acid + ADP - (Pyruvate kinase) --> Pyruvate + ATP

Pyruvate + NADH - (Lactate dehydrogenase) --> Lactate + NAD

In this way ADP production can be linked with the decrease in absorbanc
340nm following the reduction of NADH to NAD. This assay measures the
transition of El to E1P. The transition from E2P to El can be measured
potassium dependent dephosphorylation of the E2 conformation of the
sodium pump. The potassium dependent phosphatase activity can also
stimulate the dephosphorylation of other substrates such as pnitrophenylphosphate (Akera, 1984; Carfagna & Muhoberac, 1993).

The effect of C P Z on these other methods for measuring Na + K + -ATPase

activity has not been performed in this study. Although an inhibitory e
of CPZ on Na+K+-ATPase activity has been demonstrated in rat brain
microsomes using the potassium-dependent p-nitrophenol phosphatase
activity assay (Mazumder et al, 1990).
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While results suggest that the sodium p u m p is unlikely to be involved in
CPZ activated cation transport, the fact remains that CPZ is able to activate
the efflux of sodium, against an inwardly directed sodium concentration
gradient. This suggests the involvement of an energy requiring system, such
as an active transporter. Active transporters have been characterised
according to four specific attributes: 1) their sensitivity to metabolic
inhibition, 2) their dependence on cellular oxygen consumption, 3) their
ability to transport ions against a concentration gradient and 4) their
temperature sensitivity. The involvement of an active transport process in
the lowering of intracellular sodium and potassium seen in the presence of
CPZ was determined and the results of these experiments are outlined in
Chapter 4.

The ability of CPZ to activate cation transport can be seen in whole cells but
activation of the sodium pump or increased ATPase activity can not be seen
in tissue homogenates. In chapter 5 the effect of cell treatment on CPZ is
examined. This chapter outlines results from experiments where CPZ is first
exposed to isolated liver cells and then examined for an ability to activate

cation transport. Results indicate that previous exposure of CPZ to liver cells
enhances the ability of CPZ to activate cation transport. The generation of

CPZ metabolites by liver cells is considered and other possibilities discussed.

In contrast to sodium, potassium efflux is occurring down a concentration
gradient. The possibility that potassium efflux was due to a simple increased
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permeability

of the

cell m e m b r a n e

for potassium

was

examined.

Pharmacological inhibitors of cation transport pathways were used to
determine if there was any role for these pathways in the efflux of sodium
and potassium seen in the presence of CPZ. In addition, the possibility that
cellular damage, from the high concentrations of CPZ used in these
experiments, was responsible for the apparent activation of cation transport
was examined. Liver cells were treated with agents known to result in cell
damage, that is, detergents and pore forming agents, and their effect on
intracellular cations measured. The results of these experiments are
presented in chapter 6.

Furthermore, the possibility that the removal of intracellular cations in the
presence of CPZ was due to the activation of a volume regulatory
mechanism was considered. Therefore, what appeared as an activation of
cation transport was rather activation of a volume regulatory response
leading to a decrease in cell volume but no change in intracellular cation
concentration. The concentration of intracellular sodium was determined by
measuring the volume of cellular water using 3-0-[3H-methyl]-D-glucose to

label intracellular water. The effect of CPZ on the taurine content of isolat
liver cells was also measured as taurine is an osmotically active amino acid
which responds to changes in cellular volume. Results from these
experiments are described in chapter 6.
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CHAPTER 4

ENERGY DEPENDENCE
OF THE

CPZ

ACTIVATION OF CATION TRANSPORT

"We all agree that your theory is
crazy, but is it crazy enough?"
Niels Bohr (Nobel Laureate/Physics)
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4.1

Characteristics of active transport

Ion transport can be accomplished by two means. The first is passive
transport. Passive transport is the movement of ions down their
electrochemical gradient either into or out of the cell, passive transport
occurs spontaneously and is not dependent on cellular energy. An example
of passive transport is the efflux of potassium and influx of sodium that
occurs when cells are incubated in cold medium. The second type of ion
movement is active transport. Historically, active transport has been

characterised according to the existence of specific attributes (Brown, 1965;

Ussing, 1949). First, an active transporter is dependent on cellular energy an

therefore can be inhibited by metabolic inhibitors. Second, the dependence of

active transport on cellular energy links active transport activity to cellu
oxygen consumption, in aerobic organisms. Third, an active transporter can

transport an ion, or ions against a chemical or electrical gradient. Finally,
active transporter is sensitive to temperature. Active transporters can be
characterised as either primary active transporters, such as the sodium
pump, where energy usage is directly linked to ion movements or secondary
active transporters, such as Na+/H+ exchangers, where the movement of
ions is dependent on the energy supplied by the concentration gradients set
up by the primary active transporters.
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4.1.1 Effect of metabolic inhibitors on C P Z activated cation transport
The efflux of sodium and potassium activated by CPZ indicates the
activation of a transport mechanism. Sodium efflux is occurring against a

concentration gradient and is therefore likely to require energy, suggesting
the involvement of an active transporter. Potassium efflux, on the other
hand, is occurring down a concentration gradient and could be due to a
simple increase in the passive permeability of the cell membrane to
potassium. The attributes of the pathways activated by CPZ to move sodium

and potassium out of the cell were determined according to their sensitivity

to metabolic inhibitors, requirement for oxygen consumption, their ability t
move ions against a concentration gradient and their sensitivity to cold.

In order to determine if cellular energy was required for the activation of
sodium transport by CPZ, cells were pre-incubated for 10 minutes in sodium
cyanide (2.5mM for rat and ImM for toad). Similar concentrations of cyanide

have been used previously to inhibit active transport in liver slices (Elsho
& van Rossum, 1963; Russo et al, 1977), kidney slices (Mudge, 1951) and
isolated nerve preparations (Hodkin & Keynes, 1955). This concentration of
cyanide inhibits oxygen consumption (Elshove & van Rossum, 1963; Russo
et al, 1977) by inhibiting the function of mitochondria, blocking the
production of ATP and therefore decreasing the ATP available for active
transport. The results of experiments determining the effect of cyanide on
CPZ activated sodium transport are shown in figure 4.1.
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Figure 4.1 Effect of cyanide on CPZ activation of sodium transport.
Isolated liver cells were pre-incubated for 10 minutes in cyanide (2.5mM for rat and I m M
for toad). The cyanide pre-incubated liver cells and fresh cells were then incubated in,
cyanide containing, normal (BEM alone) or medium supplemented with ouabain ( I m M )
and monensin (80|J.g/mL) in the presence or absence of C P Z (5rnM) and the effect on
intracellular sodium content determined by flame photometry. Results for rat liver cells
are in the upper panel and for toad liver cells in the lower panel. (N>4, values are
mean+SEM)
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The first three columns in figure 4.1 demonstrate the ability of C P Z to lower
intracellular sodium in incubations containing monensin and ouabain
(p<0.001 for both rat and toad). The ability of CPZ to lower intracellular
sodium was tested following a 10 minute pre-incubation with cyanide

(2.5mM for rat and ImM for toad). It can be seen from the last three columns
that, following pre-incubation in cyanide, the ability of CPZ to lower
intracellular sodium is removed, that is, when cyanide is included in
incubations containing monensin and ouabain the resulting liver cell

sodium content was the same regardless of CPZ inclusion (p>0.79 for both rat
and toad).

A sensitivity to metabolic poisons, and hence a requirement for cellular

energy, is the first characteristic of active transport. Therefore, this res
demonstrating the sensitivity of CPZ activation of sodium transport to

cyanide, suggests that CPZ activation of sodium transport requires the use o

cellular energy. In a similar manner the cyanide sensitivity of CPZ activate
removal of intracellular potassium was determined. The results of these
experiments are shown in figure 4.2.
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Figure 4.2 Effect of cyanide on CPZ activation of potassium tra
Isolated liver cells were pre-incubated for 10 minutes in cyanide (2.5mM for rat and I m M
for toad). The pre-incubated liver cells and fresh cells were then incubated in, cyanide
containing, normal (BEM alone) or medium supplemented with ouabain (ImM) and
monensin (80(ig/mL) in the presence or absence of C P Z (5mM) and the effect cn
intracellular potassium content determined by flame photometry. Results for rat liver
cells are in the upper panel and for toad liver cells in the lower panel. (N>4, values are
mean+SEM)
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The results in figure 4.2 demonstrate that the removal of intracellular

potassium by CPZ is only partially inhibited by cyanide pre-incubation. In th
presence of cyanide, CPZ induced potassium lowering was found to be
decreased as indicated by an increase in intracellular potassium in the CPZ
and cyanide treated cells (compared to CPZ in the absence of cyanide, p<0.02
for both rat and toad). However, the cyanide sensitivity of the CPZ induced
removal of intracellular potassium was not complete as shown by the
inability of cyanide to prevent all of the potassium lowering seen in the

presence of CPZ (p<0.01 for both rat and toad, compared to incubations in the

absence of CPZ). This result is not surprising as the removal of intracellula
potassium occurs down a naturally occurring concentration gradient and
would not necessarily be expected to require energy expenditure. A similar

inhibitory effect of cyanide on sodium efflux but not on potassium efflux has
been described previously (Hodkin & Keynes, 1955).

Although these results (figures 4.1 and 4.2) demonstrate the cyanide
sensitivity of CPZ activated sodium transport, it is surprising that normal

incubations are not altered by pre-incubation in cyanide. It would be expecte
that if cyanide was able to inhibit CPZ activation of sodium transport by
decreasing the availability of ATP for active transport, then a similar
inhibition would be seen in normal incubations. This inhibition of active

transport in normal incubations would be seen as an increase in intracellular
sodium and a decrease in intracellular potassium, an effect similar to that
seen in the presence of ouabain, when the sodium pump is
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pharmacologically inhibited (Macknight et al, 1974). It is possible that flame
photometry was not sensitive enough to be able to measure these changes.
However, an effect of ouabain can be seen on the intracellular sodium, but
not potassium, content measured by flame photometry so an effect of
cyanide on intracellular sodium, but not potassium, would be expected.

The inhibition of CPZ activation of sodium transport by cyanide indicates
some requirements for cellular energy. Cellular energy can be derived from

anaerobic glycolysis or from oxidative phosphorylation. Inhibitors of cellu
energy were used to determine how the energy required for CPZ activation
of sodium transport was derived. The inhibitor, 2,4-dinitrophenol (DNP,
0.5mM), an uncoupler of oxidative phosphorylation, has been used in
previous investigations, to see if the energy rich products of oxidative
phosphorylation are linked to cation transport in rat liver slices (Elshove
van Rossum, 1963). DNP was used for a similar reason in these experiments.

In addition to oxidative phosphorylation, cells can obtain energy from
anaerobic glycolysis. In some mammalian cells, the energy obtained from

glycolysis alone is insufficient to provide the sustained energy required fo
active cation transport (Judah & Ahmed, 1964; Whittam, 1964). However in

other cells, renal cortical slices (Macknight, 1968) and red blood cells (Ma
1951) anaerobic metabolism, or glycolysis, has been shown to be able to

provide the energy required for active transport of ions. Anaerobic glycolys
may be inhibited by iodoacetate (ImM) due to its action on the glycolytic
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enzyme, phosphoglyceraldehyde dehydrogenase (Seidman

&

Cascarano,

1966). Iodoacetate has been used in liver cells to inhibit glycolysis
(Macknight & Leaf, 1977) while cyanide and DNP have little effect on

anaerobic glycolysis (Hodkin & Keynes, 1955). Results from experiments

using DNP and iodoacetate on isolated rat liver cells are shown in fi

It can be seen from figure 4.3 that neither DNP or iodoacetate had an
on CPZ activated cation transport (p>0.2 compared to CPZ without

inhibitors) while they did have some, although not a significant effec

normal levels of intracellular cations. It can also be seen from figur
both DNP and iodoacetate caused a decrease in intracellular potassium

(p>0.13 for both DNP and iodoacetate) and an increase in intracellular
sodium (p=0.3 for both DNP and iodoacetate) compared to normal
incubations in the absence of the inhibitors.
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Figure 4.3 Effect of 2,4-dinitrophenol and iodoacetate on CPZ activated c
transport
Isolated rat liver cells were incubated, for 20 minutes, with 2,4-dinitrophenol (0.5mM)
and iodoacetate (ImM) in either normal (BEM alone) or incubations containing C P Z
(5mM) and ouabain (ImM) and the effect on intracellular cation content determined. The
effect of the metabolic inhibitors co sodium content is shown in the upper panel and on
potassium content in the lower panel. (N=3, values are mean±SEM)
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Cyanide decreases A T P production by inhibiting metabolism at a cellular
level while DNP decreases ATP production by uncoupling mitochondrial
oxidative phosphorylation. The difference the inhibition profile of cyanide

and DNP affect their ability to inhibit active transport. In liver slices pr

from foetal rats, inhibitors or uncouplers of oxidative phosphorylation, suc
as oligomycin and DNP, have been shown to inhibit only 50% of active
transport, where cyanide inhibits 90% (van Rossum, 1962: van Rossum,

1976). The fact that DNP did not effect CPZ activated sodium transport, whil

cyanide did, suggests that the end products of oxidative phosphorylation may
not be involved in active transport stimulated by CPZ.

The assumption that ion transport specifically requires ATP generated by
oxidative phosphorylation as an energy source (Hoffman, 1962) can be
refuted by evidence suggesting that intermediates in the oxidative
phosphorylation sequence, not just ATP, may be involved in the support of
active cation transport (van Rossum, 1962). It has been suggested that
oxidative phosphorylation proceeds according to the following equation:

glycolytic products -(a)-> l<-(b)-> 2<-(c)-> 3<-(d)->ATP Formula 4.1
Uncouplers of oxidative phosphorylation, such as DNP, could block the

equation at (b), (c) or (d) while the energy required for cation transport m
be derived from 1, 2 or 3. In contrast, cyanide would block the reaction at

blocking oxidative phosphorylation at the initial stages, therefore blocking
the production of phosphorylated intermediatories and ATP. This
hypothesis could explain the difference in the effect of cyanide and DNP on
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C P Z activated cation transport. Conversely, the difference between the effect
of cyanide and DNP on CPZ activated sodium transport could also be
explained by a requirement for a pre-incubation of the isolated liver cells
with DNP, in a similar manner to that used in the experiments with cyanide.

The inability of iodoacetate to inhibit CPZ activated sodium transport is no
surprising because cyanide, which does inhibit CPZ activated sodium
transport, does not effect anaerobic glycolysis which is inhibited by
iodoacetate (Hodkin & Keynes, 1955). In addition, Elshove and van Rossum
(1963) found little cyanide resistant sodium transport in liver slices

suggesting that anaerobic glycolysis does not contribute significant amounts
of energy to liver cell ion transport.

4.1.2 Effect of CPZ on oxygen consumption of liver cells

The inhibition of CPZ activated lowering of intracellular cations by cyanide
pre-incubation indicates a possible requirement for cellular energy. These

results are in contrast to the inhibition of ATPase activity seen in liver a
kidney homogenates. To further study the energy requirements of CPZ

activated cation transport, the oxygen consumption of isolated rat liver cel
in the presence and absence of CPZ was determined. If CPZ was utilising an
active transport mechanism to remove sodium and potassium, then it
would be expected that the increased energy requirement would lead to an
increase in oxygen consumption in the presence of CPZ. Results from these
experiments are shown in figure 4.4.
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Figure 4.4 Effect of CPZ on the oxygen consumption of liver cells
The oxygen consumption of isolated rat liver cells was determined over 20 minutes in
normal (BEM alone) or C P Z (5mM) containing medium. (N=3, values are mean±SEM)

Liver cells incubated with CPZ had a evident, although not significantly

(p<0.07), reduced oxygen consumption. This result is highly unusual becaus

an increase in active transport would be expected to be associated with an
increased oxygen consumption. However, CPZ has previously been shown
to reduce the oxygen consumption of liver and brain mitochondria
(Byczowski, 1983; Chazotte & Vanderkooi, 1981). The reduction in oxygen
consumption described in the presence of CPZ is thought to be due to the

ability of CPZ to inhibit the respiratory chain at multiple sites (Spirtes
Guth, 1963). CPZ has been shown to inhibit oxidation of NADH-dependent
substrates (Byczowski, 1983) including, in rat liver mitochondria,
durohydroquinone oxidase (IC50 0.4mM) and cytochrome C oxidase (IC50
LOmM, Chazotte & Vanderkooi, 1981).
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The inhibition of mitochondrial function, and oxygen consumption, by C P Z
is inconsistent with the increase in active transport suggested by the
inhibitory effect of cyanide on liver cell cation transport seen in the presence
of CPZ. However, a number of investigators have shown mitochondrial
A T P production not coupled to oxygen consumption (Hunter, 1949; Sanadi
& Fluharty, 1963; Seidman & Cascarano, 1966; Seidman & Entner, 1961). In
addition, anaerobic glycolysis m a y provide energy for ion transport in some
tissues such as renal cortical slices (Macknight, 1968) and red blood cells
(Maizels, 1951). It is unlikely that this is the type of transport that is activated
by C P Z because it is not inhibited by cyanide and is inhibited by iodoacetate.

4.1.3 Effect of concentration gradients on CPZ activated cation
transport

The third characteristic of active transport is the ability to move i
a concentration gradient. The efflux of intracellular sodium occurs against
the naturally occurring sodium

concentration gradient. This gradient

develops because cells have a low level of intracellular sodium (20mM) and
exist in an environment of high extracellular sodium (150mM). Therefore,
energy is required to extrude sodium from within the cell. The activation of
sodium efflux by C P Z was shown to be potentially dependent on energy as
shown by the inhibition by cyanide. This result was not surprising, but the
ability of cyanide to alter the potassium efflux seen in the presence of CPZ
was unexpected (see figure 4.2). In liver cells there is a high intracellular
potassium

concentration

(140mM)

against

an

environment

of

low

extracellular potassium (5mM). This means that potassium is able to leave
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the cell passively, moving d o w n its concentration gradient. The passive
movement of potassium out of the cell does not require energy and

therefore is not inhibited by metabolic inhibitors such as cyanide (Hod

Keynes, 1955). The partial sensitivity of CPZ activated potassium efflux
investigated further by incubating rat liver cells in medium of altered
potassium concentration (5-150mM) while maintaining medium osmolarity
by altering the sodium concentration (150-5mM). Results from these
experiments are shown in figure 4.5.

It can be seen from the upper panel of figure 4.5 that as the extracellu
concentration of potassium increases from 5 to 150mM, the intracellular

potassium content of cells treated with medium alone also increases. Th

suggests that as the extracellular concentration of potassium increases

passive efflux of potassium is decreased, if not reversed. Additionally
5mM extracellular potassium, intracellular potassium is lower in

incubations containing monensin than in normal incubations (p<0.025). Th
decrease in intracellular potassium in monensin containing incubations

could possibly be due to passive efflux of potassium through the monens

pore. The decrease in intracellular potassium in the presence of monens

diminished as the concentration of extracellular potassium increases (p
by 50mM potassium).

77

IOOO-

Potassium

800-

600-

• Normal
H Monensin
• CPZ

400"
2000'
5
50
100
150
Extracellular Potassium Concentration ( m M )
250
Sodium
200'
150

O Normal

A CPZ
100
50
0

—i

5
150
100
50
Extracellular Sodium Concentration (mM)

Figure 4.5 Effect of extracellular cation concentration
transport.

on CPZ acti

Rat liver cells were incubated, for 20 minutes, in medium of varying cation conte
Incubations included normal (medium alone) or medium supplemented with C P Z (5mM)
or monensin (80|ig/mL). Potassium content varied from 5 to 150mM with sodium content
varying inversely 150 to 5 m M . The effect of varying extracellular cation content cn
intracellular cations was determined. The effect on intracellular potassium is in the
upper panel and intracellular sodium in the lower panel. (N>4, values are mean±SEM)
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Therefore, the results in monensin and normal incubations indicate that as
the extracellular potassium concentration increases, there is a decrease in
the passive efflux of potassium. If CPZ was activating potassium efflux by a
passive means then it would be expected that the effect of CPZ on
intracellular potassium would also decrease. However, it can be seen from

figure 4.5 that CPZ is able to lower intracellular potassium regardless of th
concentration of extracellular potassium suggesting that CPZ induced
potassium efflux can occur against a concentration gradient.

In the lower panel of figure 4.5, the effect of changing the extracellular
sodium concentration is shown. The level of extracellular sodium had an

insignificant effect on the level of intracellular sodium in either normal or

CPZ incubations (p>0.5). It is also interesting that the level of extracellul
potassium did not affect the activation of sodium transport seen in the
presence of CPZ. This result taken together with the results presented in
figure 3.7, that the efflux of sodium from sodium loaded cells occurring in
the absence of extracellular potassium, provides further evidence that the
sodium pump may not be involved in CPZ activated sodium transport.

Incubating liver cells with increasing concentrations of extracellular
potassium would lead to membrane depolarisation. It is possible that this
depolarisation (inside less negative) could activate potassium channels
leading to potassium efflux which could be blocked by potassium channel
blockers such as BaCLz (Xu et al, 1995). If depolarisation was leading to
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potassium efflux, then this effect would be expected to be seen in normal

cells as well as in CPZ treated cells. This is not seen, therefore depolaris

driven efflux of potassium is unlikely to underlie the CPZ effect, (the effe

of BaCl2 on CPZ activated potassium efflux is discussed in chapter 6). The f
that depolarisation does not affect CPZ activated efflux of intracellular
cations provides additional support for the involvement of an active
transporter, as this mode of transport is largely insensitive to membrane
potential (Hodkin & Keynes, 1955).

4.1.4 Effect of temperature on CPZ activated cation transport

The final characteristic of active transport is the sensitivity to changes i
temperature. The initial studies identifying active transporters were
performed on cells (or tissue slices) that had been incubated at low
temperatures (1°C). This incubation results in an inhibition of active
transport leading to an increase in intracellular sodium and a decrease in
intracellular potassium (Berthon et al, 1980; Russo et al, 1977; Seidman &
Cascarano, 1966). On rewarming, active transport is reactivated and sodium
efflux can be measured. The effect of low temperatures on the activation of
sodium and potassium transport by CPZ was determined by incubating

isolated rat liver cells for 20 minutes at 0°C in the presence or absence of
Results of these experiments are shown in figure 4.6.
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Figure 4.6 Effect of temperature on CPZ activation of cation transpor

Isolated rat liver cells were incubated, for 20 minutes, in either normal (BEM alon
CPZ (5mM) containing medium at 37°C or 0°C and the effect cn sodium and potassium
content determined. (N>5, values are mean±SEM)

It can be seen from figure 4.6 that incubation of liver cells in the
minutes causes a decrease in intracellular potassium (p<0.26) and a
significant increase in intracellular sodium (p<0.03). This result

demonstrates an equilibration of ions across the cell membrane as ion

move down their concentration gradients in the absence of active tra

activity. Incubations in the cold removes the ability of CPZ to lower

intracellular sodium and potassium (p>0.25 for both sodium and potas

compared to cold incubations without CPZ). This effect is similar to
with cyanide pre-incubation (figure 4.1 and 4.2).
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Studies measuring intracellular levels of A T P before and after incubations at

1°C show that liver slice ATP synthesis and use is completely arrested at lo
temperatures (Russo et al, 1977; van Rossum, 1972). This provides evidence

that the inability of CPZ to lower intracellular sodium and potassium at low

temperatures is likely to be due to inhibition of an energy requiring proces

such as an active transporter. If the activity of cellular proteins such as
transporters were involved in the removal of intracellular sodium and

potassium then it would be expected that the removal of intracellular cation
by CPZ would be reactivated by rewarming. Results from experiments where
isolated rat liver cells were incubated in the cold (0°C) and then rewarmed
(37°C) are shown in figure 4.7.

It can be seen from figure 4.7 that during the first 30 minutes of the
incubation, when cells are incubated at 0°C, there is an inhibition of CPZ

activation of sodium transport (upper"panel) and a partial inhibition of CPZ
activated potassium transport (lower panel). This is the same as the result
seen in figure 4.6. However, when cells are rewarmed, to 37°C, there is an
activation of CPZ lowering of intracellular sodium and potassium. This

result not only indicates that the ability of CPZ to lower intracellular ca

is dependent on the availability of active proteins, but also that the prese
of CPZ in the incubation medium for 30 minutes, at low temperatures, has

not resulted in cell death as the cells are still are responsive to the incr
in temperature.
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Figure 4.7 Effect of rewarming on CPZ activation of cation transport.
Isolated rat liver cells were incubated, for 30 minutes, in either normal (BEM alone) or
C P Z (5mM) containing medium at 0°C. At the conclusion of the cold incubations cells
were rewarmed by incubation in either normal (BEM alone) or C P Z containing medium a t
37°C. The effect of cooling and rewarming on sodium and potassium content was
determined. The effect on sodium content is shown in the upper panel and potassium
content in the lower panel. (N>5, values are mean+SEM)
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The effect of temperature on cation transport activated by C P Z was
determined by calculating the thermal quotient value, that is the Q10/
according to the following formula:

QlO = (Rate 2/Rate 1)10/(T2-T1) Formula 4.2
Where Tl = 0°C, Rate 1 = CPZ activated cation transport at 0°C

T2 = 37°C, Rate 2 = CPZ activated cation transport at 37°C

The average Q10's for CPZ activated sodium efflux was 1.315 + 0.12 in
monensin plus ouabain containing incubations and 1.553 ± 0.14 for CPZ
activated potassium efflux in normal incubations. The Qio was calculated for
these incubations because these were the treatments where the activation of
transport by CPZ was most pronounced. A Qio of 1.48 had been calculated for
Na+/K+-ATPase activity in rat liver (Else et al, 1996). The Qio's determined

for CPZ activated cation transport in isolated liver cells are similar to tha
described for active transport in liver providing further support that an
active transport mechanism may be responsible for this transport.

4.2 Conclusions

Active transport has been characterised according to four specific attributes
first, active transport is dependent on cellular energy and can be inhibited
metabolic inhibitors. Second, active transport is linked to cellular oxygen
consumption. Third, active transport occurs against a chemical or electrical

gradient and finally, active transport is sensitive to temperature. These fou
attributes have been used to characterise the cation transport activated by
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CPZ. In this chapter, C P Z activated cation transport has been shown to be

sensitive, or partially sensitive in the case of potassium, to inhibit
metabolic poison, cyanide. CPZ activated cation transport has not been

linked to increased oxygen consumption, in contrast oxygen consumption

decreased in CPZ treated cells. However, CPZ activated cation transpor
occur against a concentration gradient, and is sensitive to incubation

temperature. Therefore, it can be concluded that, with the exception of
increased oxygen consumption, CPZ activated sodium and potassium
transport has characteristics of active transport.

CPZ activated cation transport occurs in the presence of ouabain. This

unusual because some investigators have described the sodium pump as th
only transporter available for active sodium extrusion (Ewart & Amira,

1995). This conclusion is not supported by the initial studies on sodiu

efflux and volume regulation carried out in the 1960's and 70's. In the

studies rat liver and kidney slices were incubated in the cold (1°C) f

90 minutes, resulting in cell swelling and an increase in intracellular

sodium. After cold incubation, slices were returned to normal physiolo

temperatures (37°C) and sodium efflux measured in the presence or abse

of ouabain (Elshove & van Rossum, 1963; Macknight, 1968; Macknight et a

1974; McLean, 1963; Russo et al, 1977; Seidman & Cascarano, 1966). Thes
studies consistently measured a sodium efflux that was insensitive to

ouabain, independent of potassium uptake but was sensitive to inhibiti

cyanide. In short, this mode of efflux was similar to that seen in the

of CPZ in this study. This possibility is pursued further in chapter 6.
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CHAPTER 5

EFFECT OF CELL TREATMENT

ON CPZ ACTIVATION OF
SODIUM TRANSPORT

'Reality is that which, when you stop
believing in it, doesn't go away"
Philip K Dick

86

In the previous chapter the ability of C P Z to activate sodium transport was
shown to be sensitive to factors that may impinge upon the availability of
metabolic energy; for example, CPZ activated sodium transport could be

inhibited by cyanide, was found to display a sensitivity to temperature and t
proceed against an inwardly directed concentration gradient. In short, CPZ
activated sodium transport was shown to have some of the characteristics of
active transport. However, a paradox exists where the ability of CPZ to
activate sodium transport can be seen in whole cells but an enhancement of
active transport, which might be expected to be demonstrated by an increased
ATPase activity in tissue homogenates, cannot be seen. Instead CPZ was
found to inhibit ATPase activity of liver and kidney homogenates (see figure
3.10). The different effects of CPZ on whole cells and tissue homogenates
suggests that something present in whole cells, but missing from
homogenates, is required by CPZ in order to activate cation transport.

5.1 Effect of cell treatment on CPZ activation of cation transport
5.1.1 Effect of cell treatment on CPZ activation of sodium transport

In order to determine if liver cells confer upon CPZ, the ability to activate

sodium transport, CPZ was treated with isolated liver cells for varying times

and then the cell-treated CPZ was examined for its ability to activate sodium
transport. In these experiments, 5mM CPZ was exposed to cultured liver cells
for varying periods of time, from 0 - 120 minutes. The liver cells were then
removed from the CPZ containing medium. This CPZ containing medium
was then referred to as cell-treated CPZ and was diluted 1:5 into incubation
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m e d i u m containing monensin (80|ig/mL), ouabain ( I m M ) and

22

N a + and

incubated with fresh liver cells for a short period of time (5 minutes).
Monensin and ouabain were included in the incubation mix because they
increase the level of intracellular sodium, therefore providing a greater
potential sodium difference on which the sodium lowering effect of celltreated CPZ could be examined. The effect of cell-treated CPZ on sodium
activity was measured over 5 minutes, instead of 20 minutes, in order to

minimise any further cell treatment of CPZ, while allowing sufficient time

for accumulation of 22Na+ within the cells. A flow diagram of this protocol
shown in figure 5.1.

CPZ (5mM, in BEM) is incubated at 37°C
with isolated liver cells for 0 to 120 minutes.

Fresh liver cells are exposed to cell treated CPZ
(diluted 1:5) in incubation media containing
monensin (80fig/mL), ouabain ( I m M ) and
22
N a + for 5 minutes and sodium activity
measured.

f
Cells are washed (5 x 30seconds) and the
amount of 2 2 N a + accumulated and protein
content determined

H

Figure 5.1 A flow diagram of experiments where CPZ is treated with liver
cells prior to sodium lowering effect being examined.
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The results from experiments carried out according to the method described

above are shown in figure 5.2. The results demonstrate the effect of c
treated CPZ on liver cell sodium activity over a 5 minute period. For

example, CPZ that has not been cell-treated (0 minutes) shows the effe

ImM CPZ (a 1:5 dilution of 5mM CPZ) on the sodium activity of isolated
cells (measured using

22

Na+ over 5 minutes). The point at 20 minutes

shows the effect of a 1:5 dilution of CPZ that has been exposed to liv
for cell treatment for 20 minutes.

It can be seen from the upper panel of figure 5.2 that as the time of

treatment increases, up to 15 minutes, there is an increase in the abi

CPZ to decrease sodium activity (p<0.03, comparing the sodium activity

cells incubated with CPZ without cell treatment (0 minutes), and cells

incubated with CPZ that has undergone cell treatment for 10 minutes or

longer). The only difference in the cell-treated CPZ and the initial t

(0 minutes) is the duration of cell treatment. It can be inferred from

experiments that treatment of CPZ with isolated liver cells alters CPZ

way that increases the ability of CPZ to lower intracellular sodium. I

rat and toad, the enhancement of CPZ activation of sodium transport is
maximal after 15 minutes of cell treatment and is maintained for the

remaining 2 hours, as indicated by a flattening of the curves in figur
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Figure 5.2 Effect of cell-treated CPZ on sodium activity of liver cells
In the upper panel, C P Z is treated with rat or toad liver cells for 0 to 120 minutes and
then the ability of cell-treated C P Z to activate sodium transport measured, during a 5
minute incubation on fresh rat or toad liver cells, in the presence of monensin (80|ig/mL),
ouabain (ImM) and 2 2 N a + . In the lower panel, the intracellular sodium remaining in
the presence of cell-treated C P Z is shown as a percent of the sodium that was present
following incubation with C P Z that had not been cell treated (N>7, values are
mean±SEM).
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Another way of looking at the same experimental data is to examine the

percent of intracellular sodium that remains in incubations where live

are exposed to cell-treated CPZ, as compared to those incubated with C

has not undergone cell treatment (0 minutes). This data is presented i

lower panel of figure 5.2. Cell-treated CPZ is able to activate sodium

to such a degree that after 2 hours of cell treatment only 60% and 46%

intracellular sodium remains (in rat and toad liver cells respectively

conclusion of the 5 minute incubation, compared to that which would be

present if CPZ that had not undergone cell treatment was used (0 minut

The decrease in intracellular sodium seen in the lower panel of figure

not as large as that shown previously where less than 40% of intracell

sodium remains when CPZ is included in incubations containing monensin

and ouabain (see figure 3.5). This is possibly due to the reduced time

incubation is carried out over (5 minutes rather than 20 minutes). Thi

reduced time could also explain the flattening of the curves in figure

is possible that the pathway activated by CPZ is working at maximal ca

and is unable to remove any more sodium during the 5 minute incubation
period.

5.1.2 Effect of cell treatment on CPZ activation of potassium transpor

Results of the experiments presented in figure 5.2 demonstrate that ce

treatment of CPZ appears to enhance the sodium lowering potential of C

possibly by an enhancement of the active transport mechanism underlyin

this effect. CPZ has also been shown to activate potassium efflux (see
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3.7). Activation of potassium efflux, in the presence of C P Z , results in the
movement of potassium ions down a concentration gradient, therefore it
could be postulated that this efflux occurs via a passive mechanism.
However, CPZ activated potassium transport has been shown to be partially
sensitive to both cyanide and cold, suggesting the possible involvement of
an active transport component in CPZ activated potassium efflux.
Additionally, CPZ activated potassium efflux can occur in the presence of

high extracellular potassium, where the driving force for passive potassium

efflux would be removed. These results suggest that CPZ activated potassium
efflux may occur via either passive or active transport, depending on the
incubation conditions. If CPZ activated potassium efflux could occur by

active transport, then the same paradox exists for potassium as for sodium,
that is, a possible active transport mechanism stimulated by CPZ without a
corresponding increase in ATPase activity seen in tissue homogenates. The
possible involvement of an active transport mechanism in CPZ activated

potassium transport led to an examination of the effect of cell treatment o
CPZ on potassium transport.

These experiments were carried out in a similar manner to the previous

experiment (see figure 5.1) except that the cell-treated CPZ was diluted (1
into normal BEM (no monensin, ouabain or 22Na+). Liver cells have their
highest potassium content in normal incubations therefore an enhanced

activation of potassium content by cell-treated CPZ would be seen maximally

in normal incubations. The results of experiments determining the effect of

cell-treated CPZ on potassium content of rat liver cells is shown in figure
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Figure 5.3 Effect of cell-treated CPZ on potassium content of rat live
CPZ was treated with rat liver cells for 0 to 120 minutes and then the ability of celltreated C P Z to activate potassium transport measured, during a 5 minute incubation on
fresh liver cells, in B E M supplemented with a 1:5 dilution of cell-treated CPZ. (N=8,
values are mean±SEM).

The results shown in figure 5.3 demonstrate the effect of CPZ on liver

potassium content over a 5 minute period following varying times of c

treatment. In contrast to the result shown for sodium (figure 5.2), re

figure 5.3 demonstrate that cell treatment of CPZ does not appear to l
consistent enhancement of the ability of CPZ to lower intracellular
potassium (p>0.08, comparing the potassium content of cells incubated

CPZ without cell treatment to cells incubated with cell-treated CPZ).

This result was unexpected, as CPZ activated lowering of both sodium

potassium had previously occurred concurrently. It was considered poss

that flame photometry was not sufficiently sensitive to detect any cha

intracellular potassium over 5 minutes. However a decrease in intracel
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potassium in the presence of C P Z is seen in these experiments. The normal
potassium level for the cells, in the absence of CPZ, used in these
experiments was 441.5+27.2 nmoles K+/mg protein (N=8). Therefore,
although there was a consistent decrease in intracellular potassium

demonstrated in incubations containing cell-treated CPZ, this decrease is no

as large as that seen, even in a 5 minute incubation, in the presence of hig
concentrations of CPZ (see figure 3.8). Therefore, it was concluded that it
unlikely that cell treatment of CPZ enhances the ability of CPZ to lower
intracellular potassium. The activation of potassium efflux in the presence
of CPZ results in the movement of potassium ions down their concentration

gradient in the conditions used in these experiments. Therefore, it is possi
that the efflux of potassium activated by CPZ maybe occur via a passive
mechanism not requiring the interaction between CPZ and intact cells
during cell treatment.

5.2 Effect of cell treatment on CPZ inhibition of ATPase activity

These results suggest that active transport of sodium in the presence of CPZ
can be enhanced by cellular pre-treatment of CPZ. Therefore, it is possible
that using cell-treated CPZ in an ATPase assay would result in the
appearance of an enhanced ATPase activity rather than the inhibition of
ATPase activity previously described (see figure 3.10). These experiments
were carried out in a similar manner to that outlined in figure 5.1, except
that the cell-treated CPZ was diluted 1:10 info ATPase assay medium and the
effect of cell-treated CPZ on ATPase activity of rat kidney homogenates was
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determined, rather than an effect of cell-treated C P Z on sodium activity in

isolated rat or toad liver cells. Kidney homogenates were chosen for t

experiments, rather than liver, due to their higher intrinsic ATPase a
(see figure 3.10).

The results from experiments determining the effect of cell-treated C
the ATPase activity of kidney homogenates are shown in figure 5.4. In

upper panel of figure 5.4 the ATPase activity of rat kidney homogenat

plotted against time of CPZ cell treatment. In the lower panel the ch

ATPase activity that is seen following ceil treatment has been plotte

time of CPZ cell treatment. The change in ATPase activity seen follow

treatment was determined by subtracting the ATPase activity in incuba

containing CPZ without cell treatment from the activity seen in the p
of cell-treated CPZ.

As the duration of cell treatment of CPZ increases, there is an incre
kidney homogenate ATPase activity when compared to the activity that

would be present with CPZ that has not undergone cell treatment (compa

ATPase activity seen at 0 minutes to 60 minutes). This change in ATPas

activity in the presence of cell-treated CPZ is shown more directly i

lower panel of figure 5.4 where the change in the effect of CPZ on ATP

activity following cell treatment is shown. From the lower panel of f

it can be seen that as the time of cell treatment increased, there was

increase in the change in ATPase activity. By 40 minutes of cell trea
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there is a significant increase in kidney homogenate ATPase activity (p 0.03),
and by 60 minutes of cell treatment, there is a difference in ATPase activity of
3.9±1.0 umoles P i / m g protein.hour.

0

20
40
60
Time for Cell Treatment of C P Z (minutes)

Figure 5.4 Effect of cell-treated
homogenates

CPZ on ATPase

activity of rat kidne

CPZ was treated with rat liver cells for 0 to 60 minutes. The cell-treated C P Z was
diluted 1:10 into ATPase assay medium and the effect on ATPase activity of rat kidney
homogenates measured. In the lower panel the effect of cell-treated C P Z is shown as a
change in ATPase activity from that seen in the presence of C P Z which has not
undergone cell treatment. (N=5, values are mean±SEM).
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The results s h o w n in figure 5.4 indicate that there was an increase in kidney
homogenate ATPase activity in the presence of cell-treated CPZ. However,
this could also be interpreted as a decrease in the inhibition of kidney
homogenate ATPase activity that is usually seen in the presence of CPZ. Rat
kidney ATPase activity in normal incubations (no drugs present) was
previously determined to be 18.5±2.2 jimoles Pi/mg Protein.hour (see figure
3.10). By comparing the ATPase activity of rat kidney homogenates in figure
5.4 to that seen in figure 3.10 it can be seen that even in the presence of

treated CPZ, a significant decrease in ATPase activity remains (p 0.009) wit
52% of the kidney homogenate ATPase activity still inhibited. While an .

apparent activation of ATPase activity was found following cell treatment of

CPZ, this level of activity remained far below that seen in the absence of a
drug treatment (normal). However, cell-treated CPZ did increase ATPase

activity, suggesting that cell treatment of CPZ may induced an alteration in
the effect of CPZ on an ATP utilising mechanism. This possibility was a
promising explanation for the difference between the activation of sodium
transport seen in whole cells and the inhibition of ATPase activity seen in
liver and kidney homogenates.
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5.2.1 Effect of cell treatment on m e d i u m concentration of C P Z

While it was promising that cell treatment of CPZ could induce an alterati

in the effect of CPZ on ATPase activity, it was considered possible that t

concentration of CPZ was decreasing during the cell treatment, and therefo

a simple decrease in CPZ concentration could be responsible for the appare
activation of ATPase activity.

CPZ is a highly lipophilic compound that will partition into the cell
membrane (Cornelius et al, 1994; Thompson et al, 1993; Yamaguchi et al,

1985). It was possible therefore, that the concentration of CPZ could be .
decreasing during cell treatment due to absorption of CPZ into the cell
membranes. A simple method for measuring the concentration of CPZ in
the medium needed to be determined. From an investigation into the
absorbance spectrum of CPZ it was found that the concentration of CPZ in
the medium could be determined spectrophotometrically due to the strong
absorbance of CPZ at 307nm. The results from these experiments are shown
in figure 5.5.
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Figure 5.5 Spectrophotometric determination of CPZ concentration
C P Z was dissolved in B E M at a concentration of 500^iM and the absorbance spectrum
determined for wavelengths between 200 and lOOOnm (left hand

panel). The

relationship between C P Z concentration and absorbance at 307nm was determined by
dissolving C P Z in B E M at different concentrations (50ixM to I m M ) and measuring the
absorbance at 307nm (right hand panel, N=5, values are mean+SEM).

In the left hand panel of figure 5.5 the absorbance spectrum for 500uM CPZ
presented. It can be seen that CPZ demonstrates a strong absorbance at
307nm. Furthermore, it can be seen from the right hand panel of figure 5.5
that a linear relationship exists between CPZ concentration (ImM to 50uM)
and absorbance at 307nm. The standard curve determined in figure 5.5 was
used to determine if there were any changes in the concentration of CPZ in

the medium following cell treatment. To do this cell-treated CPZ was dilute
1:10 in distilled water and the absorbance measured. Results for these
experiments are shown in figure 5.6.
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Figure 5.6 Effect of cell treatment of CPZ on the medium concentration o
CPZ

CPZ (5mM) was exposed to cells for 0 to 60 minutes. Cell-treated CPZ was diluted 1:
with distilled water and the concentration of C P Z determined spectrophotometrically
by measuring the absorbance at 307nm. (N>3, values are mean+SEM)

Figure 5.6 shows that the medium concentration of CPZ decreases with tim
of cell treatment. The question remained whether the decrease in CPZ

concentration was sufficient to explain the alteration in kidney homogen
ATPase activity seen following cell treatment of CPZ. The dose response
relationship between CPZ and kidney homogenate ATPase activity was
determined and results from these experiments are shown in figure 5.7.
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Figure 5.7 Dose response relationship for CPZ inhibition of rat kidney
ATPase activity
The ATPase activity of rat kidney homogenates was determined in the presence of
varying concentrations of C P Z (5mM to luM). The open triangles (A) represent the
ATPase activity of rat kidney homogenates in the presence of cell-treated C P Z (1:10
dilution after 60 minutes) plotted against the concentration of C P Z in those incubations.
(N>7, values are mean+SEM)

It can be seen from the results present in figure 5.7 that the inhibition
kidney homogenate ATPase activity decreases as the concentration of CPZ
decreases. This could also be seen as a relative increase in kidney
homogenate ATPase activity with decreasing CPZ concentrations. It can also

be seen from figure 5.7 that the concentration of CPZ present in the medium
following 60 minutes of cell treatment was found to fit into the dose

response curve. This result could be taken to indicate that the increase in
kidney homogenate ATPase activity seen in the presence of cell-treated CPZ
(see figure 5.4), could simply be due to a decreasing concentration of CPZ
the medium. However, the increase in liver cell sodium activity, seen in
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figure 5.2, could not be explained by the decrease in C P Z concentration
following cell treatment. The dose response relationship determined for CPZ
concentration and sodium activity (see figure 3.2) indicates that as the

concentration of CPZ decreases there is a decrease, rather than increase, in
the ability of CPZ to activate sodium transport.

Further explanations for the paradoxical relationship between activation of
sodium transport and inhibition of ATPase activity were considered by
examining the differences between these experiments and those carried out
by others. In these experiments, a high concentration of CPZ (up to 5mM) is

required to elicit the activation of sodium transport seen in the liver cell
while previously an inhibition of sodium transport has been reported (Van
Dyke & Scharschmidt, 1987) using lower concentrations of CPZ (<300|iM).
However, an IC50 for CPZ activation of sodium transport of IOOJXM was
determined (see figure 3.2) therefore some activation of sodium transport
would have been expected at 300|a.M. While a difference in concentration
could not completely explain the differences in results it was considered

possible that the high concentration of CPZ was a vital factor in these resu
The high CPZ concentration could be required because the cell treatment of

CPZ resulted in the production of a factor which was then responsible for th
enhanced activation of liver cell sodium activity.
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5.3

Effect of light on C P Z activation of sodium transport

One possibility was that during cell treatment, CPZ undergoes

photodegredation. In this hypothesis it is not the cells themselves which

responsible for the change in CPZ but the exposure to light which CPZ wou

undergo during the cell treatment. The exposure of CPZ to light would the
result in photodegredation of CPZ and the production of CPZ breakdown

products which could be responsible for the activation of liver cell sodi

transport. There is some literature support for this hypothesis as exposu

CPZ to light (with the intensity of sunlight) has been shown to result in
production of oxidised CPZ products such as CPZ-sulphoxide and CPZ-Noxide (Chagonda & Millership, 1989; Usdin & Forrest, 1971; Van Den Broeke
et al, 1994) which have been shown to affect membrane transport proteins
and ATPases (Akera & Brody, 1970; Mazumder et al, 1990). The
photodegredation of CPZ occurs rapidly, with only 20% of CPZ remaining

unchanged after less than 10 minutes of light exposure (Van Den Broeke et
al, 1994). It is therefore possible that exposure of CPZ to ambient light
the experiments could result in the production of breakdown products

which interact with sodium transport proteins in a manner different to CP
itself.

To examine if light exposure was responsible for the enhancement of CPZ
activation of sodium transport seen after cell treatment, CPZ (5mM) was
exposed to, or protected from, ambient room light for between 0 and 30

minutes. Following light exposure, or protection, the CPZ was diluted (1:5
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into B E M and the effect on rat liver cell sodium activity measured over a 5
minute period in the presence of monensin (80ug/mL), ouabain ( I m M ) and
22

Na+. Light exposed CPZ was diluted 1:5 to provide continuity with the

results from previous experiments where the effect of cell-treated C P Z was
examined.

200
Light exposed
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Figure 5.8 Effect of light exposure of CPZ on rat liver sodium activity
C P Z was exposed to or protected from light, for 0 to 30 minutes, without cells, and then
the ability to activate liver cell sodium transport measured, during a 5 minute
incubation, in the presence of monensin (80|ig/mL), ouabain (ImM) and

22

Na + . (N=4,

values are mean+SEM).

Figure 5.8 shows the results from experiments examining the effect of lig
exposure, or protection, of CPZ on rat liver sodium activity. In these

experiments CPZ was exposed to ambient room light. This is the light that
CPZ would have been exposed to during cell treatment and therefore the

light that would have been responsible for any photodegredation occurring

during cell treatment. Results presented in figure 5.8 indicate that pro
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from or exposure to light did not alter the effect of C P Z on sodium activity of

rat liver cells. In these experiments there was no significant enhancement of

the ability of CPZ to activate sodium transport as time of protection from or

exposure to light increased, that is, there was no difference in the effect o
CPZ on sodium activity in the presence of CPZ which had been exposed to

light for 5 to 30 minutes from that seen at 0 minutes (p>0.42). Additionally,
there was no significant difference between the effect of light protected or

light exposed CPZ on sodium activity of rat liver cells (p>0.73). The results
presented in figure 5.8 suggest that photodegredation of CPZ was not
responsible for the enhancement of the ability of CPZ to activate sodium

transport ( shown in figure 5.2) found following cell treatment. Additionally

these experiments indicate that the incubation of CPZ at 37°C, without cells,
was not enough to induce an activation of liver cell sodium transport. From
these experiments it can be concluded that in order to activate liver cell
sodium transport CPZ and liver cells need to be incubated together.

5.4 Effect of cell viability on cell treatment of CPZ
The next experiments were aimed at determining if the cell treatment of CPZ

required living liver cells. In order to examine this, liver cells were kill
either heating (100°C for 10 minutes) or fixation (4% paraformaldehyde for
30 minutes, followed by 10 minutes with 0.4M perchloric acid). Both of these
procedures were used because they would kill the liver cells and denature
the cellular proteins. Following either method, cells were washed in BEM for
1 hour in order to remove any contaminants prior to use in the experiments.
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The heat treated or fixed cells were then used to treat C P Z for between 0 and
60 minutes. The effect of cell-treated C P Z , from heat treated, fixed and
normal (viable) cells, on sodium activity of liver cells w a s then determined.
Results from these experiments are presented in figure 5.9. The effect of celltreated C P Z on the sodium activity of rat liver cells is presented as a
percentage of the activity that w a s present in incubations containing C P Z
that had not undergone cell treatment (0 minutes).
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Figure 5.9 Effect of cell viability on cell treatment of CPZ
Liver cells were killed by either fixation (4% paraformaldehyde for 30 minutes, 10
minutes in 0.4M perchloric acid) or heating (100°C for 10 minutes) followed by a 1 hour
wash in balanced electrolyte medium. C P Z was then treated with either viable, fixed
or heated cells for 0 to 60 minutes. The effect of cell-treated C P Z on rat liver cell sodium
transport was measured in a 5 minute incubation in the presence of monensin (80jig/mL),
ouabain (ImM) and 2 2 Na + . Results are presented as a percentage of the sodium activity
seen at 0 minutes (N>4, values are mearttSEM).
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It can be seen from figure 5.9 that cell-treated C P Z is only able to activate

liver cell sodium transport if CPZ has been treated with normal, living cel
When CPZ which has been treated with living cells, for 60 minutes, was

used to activate liver cell sodium transport, only 60% of the intracellular
sodium remained, after the 5 minute incubation period, compared to that in
the presence of CPZ without cell treatment (0 minutes). Conversely, if CPZ

exposed to fixed or heat treated cells for 60 minutes, then greater than 8
the intracellular sodium remains at the conclusion of the 5 minute

incubation period. Therefore, in order to activate liver cell sodium trans
CPZ needs to be incubated with living cells.

5.5 Metabolism of CPZ
One possible explanation for the requirement of living cells is that cell
treatment of CPZ results in the production of a metabolite of CPZ. The
phenothiazine, CPZ is extensively metabolised in the body predominantly by
cytochrome P450 dependent breakdown in the endoplasmic reticulum of the
liver (Axelrod, 1983; Daniel, 1995). Microsomal enzymes such as cytochrome
P450 are the main components of the mixed function oxidase system (Daniel,

1995) and as such, are responsible for the metabolism and detoxification of
many drugs and other foreign compounds with which the body comes in
contact. Mixed function oxidase or cytochrome P450 drug metabolism
requires the presence of specific co-factors including NADPH and oxygen.
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Cytochrome P450 metabolism is responsible for the first phase of drug
metabolism which results in the production of reactive groups, such as

sulphoxide or hydroxyl groups in the metabolised drug. Following phase I
metabolism, the partially metabolised drugs may then undergo phase II
metabolism which is primarily involved with conjugation and
detoxification of the drug to produce water soluble compounds which can

easily excreted (Gibson & Skett, 1994). Figure 5.10 outlines some possib
outcomes of phase I metabolism of CPZ and the cytochrome P450 isozymes
thought to be responsible for those reactions.
Phase II
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Norl-CPZ, Nor2-CPZ

70H-CPZ, 60H-CPZ,
20H-CPZ

N-desmethylation
CYP1A2, CYP2C
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Figure 5.10 Possible outcomes of phase I metabolism of CPZ
Phase I metabolism of C P Z proceeds predominantly by oxidation, hydroxylation and N -

desmethylation reactions carried out by specific cytochrome P450 (CYP) isomers o

cytochrome P450 dependent reactions. Following phase I metabolism the metabolites
formed can then proceed into phase II metabolism.
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The metabolism of C P Z has been associated with the production of a few
primary metabolites, CPZ-S-Oxide, Nori-CPZ, Nor2-CPZ or CPZ-OHs, which
can be further metabolised to many secondary metabolites (Hartmann et al,
1983; Usdin & Forrest, 1971). More than 45 different metabolites have been
identified to be released into human biofluids (urine, plasma and CSF) and

these metabolites appear in measurable quantities within 15 minutes of oral
or intravenous administration of CPZ (Hubbard et al, 1993; Keefe et al,
1980). CPZ metabolism has also been shown to occur in rats with CPZ
metabolites, Nori-CPZ, Nor2-CPZ, CPZ-S-Oxide, Nori-CPZ-S-Oxide, CPZ-NOxide and 70H-CPZ-glucuronide, being produced in isolated liver or
microsomal preparations (Usdin & Forrest, 1971). In other experiments the
CPZ metabolites CPZ-OH, CPZ-S-Oxide, CPZ-N-Oxide and N-desmethyl CPZ
were measured in rat and toad urine following oral CPZ administration
(Dixon, 1984).

An important factor in the paradox of CPZ action is that the alteration of
occur in whole cells but not in tissue homogenates. However, drug
metabolism, by cytochrome P450 dependent reactions, has been studied at

many different levels: whole animal, isolated organ, liver slices, isolated

liver cells or liver microsomal fractions (Gibson & Skett, 1994). For examp
Jurima-Romet and associates (1991) used isolated rat hepatocytes to study
cytochrome P450 mediated metabolism of xenobiotics, while Usdin and
Forrest, (1971) studied phenothiazine metabolism in isolated perfused rat
livers and microsomes. As drug metabolism has been studied both at the
whole cell and microsomal fraction level it is unusual that CPZ was not
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altered in the homogenates used in the ATPase assays. A n explanation for
this is that cytochrome P450 metabolism can only be seen in microsomal
fractions, in the presence of oxygen, in medium supplemented with
NADPH.

The ATPase assays of liver and kidney homogenates did occur in the
presence of oxygen but the medium was not supplemented with NADPH

and therefore metabolism via cytochrome P450 activity would be unlikely
occur.

A second factor important in the speculation that a metabolite of CPZ is

responsible for the enhanced activation of sodium transport seen follow

cell treatment is that the metabolite must be produced rapidly. The res

experiments shown in figure 5.2 suggest that the enhancement of CPZ acti

occurs in the first 10 or 15 minutes of cell treatment. This would requ
to be absorbed by the cells, metabolised by cytochrome P450, or another

metabolising system, and then released back into the medium within 10 or
15 minutes. CPZ metabolites can be measured in body fluids within 15
minutes of administration (Hubbard et al, 1993). This suggests that not
is CPZ absorbed and metabolised quickly by the liver but also that the
metabolites produced are quickly released from the liver.

A third important factor is that the metabolite of CPZ produced followin

cell treatment must react with the sodium transport pathway, responsibl
the decrease in intracellular sodium, in a different way to CPZ itself.
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Metabolism of C P Z results in structural changes to the C P Z molecule which
are associated with alterations in the pharmacological profile of C P Z
metabolites compared to that seen with C P Z itself. For example, receptor
binding

studies

have

found

CPZ

metabolites

to

interact

with

neurotransmitter receptors differently to CPZ. These differences include
changes in binding characteristics such as receptor specificity and changes in
chemical properties such as polarity. Table 5.1 describes the differences in the
pharmacological profiles for some c o m m o n C P Z metabolites.

Receptor

CPZ

Dopamine

+++

++++

+

+

++++

Histamine

+++

++++

+

+

++

++

+++ +

+++

++

++++

++++

+++

++

+

++

a-adrenergic

Muscarinic

7-OH-CPZ CPZ-S-oxide CPZ-N-oxide Nori-CPZ

Table 5.1 Receptor binding characteristics

of CPZ and common

CPZ

metabolites
The receptor binding characteristics for C P Z and some C P Z metabolites have been
described in the literature (Chetty et al, 1994; Palmer et al, 1988). The compound with
the highest

receptor

affinity is indicated by ++++ while the lowest affinity is

indicated by +..

It can be seen from table 5.1 that different metabolites of CPZ bind with
different affinities to neurotransmitter receptors compared to CPZ itself.
has long been known that the presence of different metabolites has been
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associated with differences in the pharmacological success of psychotherapy
with CPZ. For example, the presence of 7-OH-CPZ or Nori-CPZ, in plasma or

CSF, of patients being treated with CPZ has been associated with successful
psychotherapy while the presence of CPZ-S-oxide or CPZ-N-oxide is often
associated with the failure of psychotherapy (Dahl & Strandjford, 1976;

Daniel, 1995; McKay et al, 1983; Midha et al, 1987; Zhang et al, 1996). The
association of psychotherapy success with the presence of some CPZ

metabolites and psychotherapy failure with others can be traced back to the

different pharmacological profiles of the different metabolites. It can be
from table 5.1 that 7-OH-CPZ and Nori-CPZ have relatively high affinities

for neurotransmitter receptors, particularly dopamine receptors, while CPZS-oxide and CPZ-N-oxide have lower affinity.

A change in the pharmacological profile of CPZ metabolites with respect to
neurotransmitter receptor binding has been extensively studied but changes
in the interaction with membrane transport proteins, such as the sodium

pump, has not received the same scrutiny. Keefe and associates, (1980) have

investigated the effect of some CPZ metabolites, CPZ-S-oxide, 7-OH-CPZ, 7,8
diOH-CPZ, on ATPase activity of rat liver plasma membranes. Their results
are summarised in table 5.2.
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Na+K+-ATPase

Mg2+-ATPase

CPZ

90uM

120M-M

CPZ-S-oxide

200uM

-30% at 200uM

7-OH-CPZ

120^iM

200uM

7,8-diOH-CPZ

40|iM

<10% at 50uM

Table 5.2 Effect of CPZ metabolites on rat liver plasma membrane A
activity

The concentration of CPZ or CPZ metabolites required to inhibit 50% of rat liver pla
membrane ATPase activity has been determined by Keefe et al., (1980). If 5 0 %
inhibition was not achieved with the maximal concentration examined then the
inhibition at that concentration is shown. (N=6-12, values taken from figure 4 Keefe e t
al, 1980).

It can be seen from table 5.2 that there are differences in the

CPZ metabolites interact with membrane ATPases although all appe

result in inhibition of ATPase activity. When considering inhibi

Na+K+-ATPase activity, 7,8-diOH-CPZ was most effective and CPZ-S

least effective. For inhibition of Mg2+-ATPase activity, 7-OH-CPZ

most effective inhibitor while CPZ-S-oxide and 7,8-diOH-CPZ were

inhibit 50% of the Mg2+-ATPase activity. Similar inhibition profi

also been described by other authors (Palmer & Manian, 1974; Sam

Carey, 1978). Nori- and Nor2-CPZ have been shown to share many of

same pharmacological effects of CPZ itself (Sgaragli et al, 1995)
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C P Z and Nori-CPZ have been reported to inhibit 5 0 % of rat brain
microsomal Na+K+-ATPase activity at 150uM (Hackenberg & Krieglstein,

1972), a concentration similar to that described for CPZ inhibition o
plasma membrane ATPase activity (Keefe et al, 1980).

In summary, the evidence indicates that the rapid metabolism of CPZ i
predominantly carried out by the liver and occurs in rats and toads
in humans. Furthermore, CPZ metabolites have been shown to have

pharmacological profiles that vary from CPZ itself. Therefore, it was

considered possible that metabolism of CPZ could be occurring during
treatment of CPZ.

5.5.1 Effect of CPZ metabolites on sodium activity

In order to investigate the effect of CPZ metabolites on sodium acti

liver cells, CPZ metabolites were obtained from National Institute of

Health in the United States (NIMH,USA). Four metabolites of CPZ, CPZ-

oxide, CPZ-N-oxide, Nor 1- and Nor 2-CPZ, were provided as a gift fro
NIMH,USA. Other CPZ metabolites, 2-OH-CPZ, 6-OH-CPZ and 7-OH-CPZ,
were a gift from the pharmaceutical company Rhone-Poulenc. All

metabolites were investigated for the capacity to lower intracellula

Initially, the metabolites were assayed at 500|iM. This is a 10 fold

from the concentration of CPZ routinely used. A lower concentration w

chosen for the metabolite analysis because if metabolites of CPZ were

produced by liver cells during the experiment then they would be prod
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at a lower concentration than the parent compound. In addition the limited

availability of these metabolites made it impossible to examine the effects
higher metabolite concentrations on the sodium activity of liver cells.

In initial experiments metabolites obtained from NIMH,USA (500uM) were

assayed against the increase in intracellular sodium seen in the presence of
monensin (80|ig/mL) and ouabain (ImM) in toad liver cells. At high
concentrations (5mM), CPZ was able to lower intracellular sodium even in
the presence of monensin and ouabain (see figure 3.5) and if a CPZ
metabolite was responsible for this effect then this compound would also
have this ability. In further experiments the hydroxy metabolites of CPZ
(500uM) were assayed for sodium lowering ability in the presence of ouabain
(ImM) with rat liver cells. Results from these experiments are shown in
figure 5.11.
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+

Figure 5.11 Effect of CPZ metabolites on sodium activity of liver cells

The ability of CPZ metabolites (500|jM) to lower intracellular sodium was examined

rat (against ImM ouabain) or toad (against 80|ng/mL monensin and ImM ouabain) live
cells. (N>5, Values are mean+SEM)

From the results presented in figure 5.11 it can be seen that not all CP

metabolites have the ability to lower intracellular sodium in rat or toa

cells. Of the metabolites tested only CPZ itself, Nori-, Nor2-, 2-OH and 7

CPZ were able to significantly reduce intracellular sodium (p<0.04) whil

CPZ-S-oxide and CPZ-N-oxide did not have the ability to reduce intracell
sodium (p>0.8). Furthermore, only Nori- and Nor2- were able to reduce
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intracellular sodium significantly below that seen in the presence of C P Z
(p<0.05). Although some metabolites were capable of activating liver cell

sodium transport to lead to a significant decrease in intracellular sodium th
decrease seen was not as great as that seen in the presence of high
concentrations of CPZ. Interestingly, it was the CPZ metabolites which have
been associated with successful psychotherapy, 7-OH-CPZ and Nori-CPZ,
which demonstrated an ability to lower intracellular sodium while those
associated with failure of psychotherapy, CPZ-S-oxide and CPZ-N-oxide,
were unable to reduce intracellular sodium.

The fact that CPZ metabolites associated with psychotherapeutic success also
showed the ability to activate sodium transport is interesting when
considered in conjunction with the Na+K+-ATPase hypothesis of bipolar
disorders. This hypothesis is based on the elevated total body and
intracellular (red blood cell) sodium reported in psychotic patients (ElMallakh & Wyatt, 1995; Meltzer, 1991). The Na+K+-ATPase hypothesis of
bipolar disorders proposes that manic symptoms of psychosis are related to a
modest decrease in sodium pump activity, while depression is thought to be
due to a greater decrease in sodium pump activity resulting in a decrease in
neurotransmitter release (El-Mallakh et al, 1993; El-Mallakh & Jaziri, 1990;
El-Mallakh & Li, 1993; Hokin-Neaverson & Jefferson, 1989). It is interesting
therefore that the metabolites of CPZ which are associated with successful
psychotherapy are also capable of activating sodium transport and decreasing
intracellular sodium.
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5.5.2 Effect of phenothiazines and tricyclic compounds on sodium
activity
Metabolism of CPZ leads to a change in the structure of the compound. It is
this structural change which is thought to be responsible for the differences
in pharmacological profiles. C P Z is one of m a n y

structurally related

phenothiazine compounds. In addition, phenothiazine compounds are
related

structurally

to

the

tricyclic antidepressants.

This

structural

relationship led to an investigation into the sodium lowering capacity of
other phenothiazine and tricyclic compounds. In these experiments the
phenothiazines,
perphenazine

chlorpromazine
and

fluphenazine,

(CPZ), chlorprothixene,
and

the

tricyclic

thioridazine,

antidepressants,

clomipramine, imipramine and amitriptyline, were assayed at I m M

and

their ability to lower the intracellular sodium levels of toad liver cells
determined in the presence of monensin (80p,g/mL) and ouabain ( I m M ) .
Results from these experiments are s h o w n in figure 5.12.
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Figure 5.12 Effect of phenothiazine and tricyclic drugs on intracellu
sodium levels of toad liver cells.

The effect of phenothiazines and tricyclic antidepressants (ImM) co toad liver cell
sodium activity was examined in the presence of monensin (80|ig/mL) and ouabain
(ImM). (N>5, Values are mean+SEM)
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Surprisingly, none

of the phenothiazines

or tricyclic antidepressants

examined were able to significantly reduce the intracellular sodium level o
toad liver cells (p>0.11). However, the phenothiazines, fluphenazine and
perphenazine, were able to lower intracellular sodium to a greater degree
than CPZ at the concentrations used in this experiment. Once the
mechanism utilised by CPZ to lower intracellular cations has been
determined these phenothiazines should be investigated for a similar
action.

5.6 Identification of CPZ metabolites in cell treated medium
5.6.1 Spectrophotometric identification
After determining that some CPZ metabolites possessed the ability to lower
intracellular sodium, attempts were made to identify metabolites that were
present in the medium following cell treatment of CPZ. As the
concentration of CPZ in the medium had previously been determined
spectrophotometrically (see figure 5.5) the absorption spectrums for the
available CPZ metabolites were determined. These absorption spectrum are
shown in figure 5.13.
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Figure 5.13 Absorbance spectrum for CPZ and major CPZ metabolites

CPZ and CPZ metabolites were dissolved in distilled water at a concentratio
and the absorbance was measured at wavelengths between 200 and lOOOnm.
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It can be seen from the results in figure 5.13 that both C P Z and all the C P Z
metabolites tested have absorbance peaks at around 307nm. Therefore, none
of the CPZ metabolites had absorbance spectrums that were different enough
from CPZ to allow this method to be used to identify the presence of CPZ
metabolites in the medium following cell treatment.

5.6.2 Identification by solvent extraction and HPLC

The identification of CPZ and CPZ metabolites in biological fluids, that is
plasma, CSF and urine, has been achieved by solvent extraction followed by
HPLC (Gruenke et al, 1985; Smith et al, 1987; Usdin & Forrest, 1971).
Preliminary attempts to identify the CPZ metabolites produced during cell
treatment using HPLC and mass spectroscopy were made by Tamantha
Littlejohn, during her Medicinal Chemistry Honours project (Littlejohn,

1997). In these experiments possible CPZ metabolites were extracted from th
medium using the extraction procedure described by Gruenke and associates
(1985). This extraction procedure is outlined in figure 5.14.

Using the extraction profile described in figure 5.14 no CPZ metabolites we
able to be isolated from cell-treated CPZ. These experiments involved a
complicated extraction procedure and it is possible that CPZ metabolites

could have been lost during the extraction or that the extraction procedure
required further refinement to allow for the isolation of CPZ metabolites
from the medium used.

122

Sample
+ N a O H (pH12)
+1.5% isoamyl alcohol in hexane
Shake and centrifuge
Aqueous Phase

Organic Phase

+ dichloromethane
shake at 0°C, centrifuge

Aqueous Phase

+2N Acetic acid
Shake and centrifuge

Organic Phase

Aqueous
Phase

I
pH to 9.5
+ ethyl acetate
shake at 0°C,
centrifuge

Wash with p H 12
water, reduce to
dryness, reconstitute
with 100|xL
dichloromethane

1
1

Discard
Organic phase

+NaOH (pH12)
+1.5% isoamyl
alcohol in hexane
Shake and centrifuge

r
CPZ-N-oxide

Discard
ueous Phase

Organic Phase

Discard
Aqueous Phase

I
0.1N HC1
Shake and centrifuge

Aqueous Phase
pH to 9.5
+ ethyl acetate
shake at 0°C,
centrifuge

Discard
Aqueous Phase

Organic Phase
reduce to
lOO^L

i

Discard
Organic Phase

CPZ
Nori-CPZ
Nor2-CPZ
CPZ-S-oxide

Organic Phase
70H-CPZ
other OH-CPZ's

Figure 5.14 Method
medium.

for extracting CPZ metabolites from

cell-treated CPZ

The method used for extracting CPZ metabolites from cell-treated CPZ medium as
described by Gruenke and associates (1985).
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5.7

Inhibition of C P Z metabolism by cytochrome P450 inhibitors

While preliminary experiments aimed at isolating CPZ metabolites from the

medium following cell treatment were unsuccessful this does not mean that
CPZ metabolites were not generated during cell treatment of CPZ. CPZ

metabolism is carried out predominantly by cytochrome P450 in liver cells.
These cytochromes can be inhibited pharmacologically. One of the most
common inhibitors of cytochrome P450 activity is proadifen (SKF525A,
Axelrod, 1983). This compound has been used to inhibit cytochrome P450

metabolism of many drugs in liver slices (Cooper et al, 1954) and to inhi
xenobiotic metabolism in isolated liver cells (Jurima-Romet et al, 1991).
More importantly, proadifen (0.5mM), used in combination with anaphthoflavone (27jig/mL), has been shown to block 50 to 90% of CPZ
metabolism in guinea pig hepatocytes (Hartmann et al, 1983). Other
inhibitors of cytochrome P450 metabolism include a-naphthoflavone and
metyrapone. Metyrapone was used in combination with proadifen to inhibit
CPZ metabolism in Cunninghamella elegans (Zhang et al, 1996).

5.7.1 Effect of P450 inhibitors on CPZ activated sodium transport

The pharmacological inhibitors, a-naphthoflavone (10uM), metyrapone
(0.5mM) and proadifen (2Q|j,M) were used to examine the effect of

cytochrome P450 on CPZ activation of liver cell sodium activity. Initiall

cytochrome P450 inhibitors were added to liver cells during incubation wi
CPZ however this was found to be unable to block CPZ activated sodium
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lowering. Since some investigators (Jurima-Romet et al, 1991) pre-incubated
liver cells with cytochrome P450 inhibitors, a 10 minute pre-incubation of
liver cells with cytochrome P450 inhibitors was also tested. Once again this
was found not to be able to block CPZ activated sodium transport. Finally,
liver cells were incubated overnight with cytochrome P450 inhibitors and
then the ability of CPZ to activate sodium transport examined. Results from
overnight incubation with P450 inhibitors are shown in figure 5.15.

The hypothetical basis for these experiments is that if cytochrome P450
mediated metabolism of CPZ was responsible for the enhanced ability of CPZ
to activate sodium transport following cell treatment, then pharmacological
inhibition of cytochrome P450 would result in the inability of the cells to
produce CPZ metabolites, which would be seen as an inability of CPZ to
activate liver cell sodium transport.
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Figure 5.15 Effect of cytochrome P450 inhibitors on CPZ activation of sodiu
transport
Liver cells were incubated overnight with the cytochrome P450 inhibitors, anaphthoflavone (lOpM), metyrapone (0.5mM) and proadifen (20\iM), then the effect of
CPZ on liver cell sodium activity examined in either normal (BEM alone) or ouabain
(ImM) containing incubations. The graph in the top left hand panel shows the effect of
CPZ in normal or ouabain incubations in control cells. (N>3, values are mean+SEM)

It can be seen from the results presented in figure 5.15 that inhibition of
cytochrome P450 does not alter the ability of CPZ to lower intracellular
sodium. These inhibitors, at the concentrations used, have been shown
previously to inhibit the metabolism of C P Z in liver cells from guinea pig
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(Hartmann et al, 1983), and the cytochrome P450 metabolism of other drugs
in rat hepatocytes (Jurima-Romet et al, 1991). Therefore, it would seen

reasonable to assume that the concentration of P450 inhibitors used would be
sufficient to inhibit metabolism of CPZ in the isolated liver cells used in
these experiments.

However, the pharmacological inhibitors used affect different isomers of

cytochrome P450 and hence inhibit the generation of different metabolites to
different extents. For example, proadifen inhibits hydroxylation, Ndesmethylation and S-oxidation (Coccia & Westerfield, 1967) while anaphthoflavone inhibits N-desmethylation (Jurima-Romet et al, 1991) and
metyrapone inhibits N-desmethylation and hydroxylation (Jurima-Romet et
al, 1991). While none of the pharmacological inhibitors have been shown to
inhibit the generation of CPZ-N-oxide as this occurs by a mechanism not
dependent on cytochrome P450 (Hartmann et al, 1983). Therefore, it is

possible that the inhibitors were simply unable to inhibit the production of
the metabolite/s responsible for the activation of sodium transport seen
following cell treatment of CPZ. However, if we consider the results shown
in figure 5.11 then the metabolites of CPZ which were able to significantly
lower intracellular sodium were the hydroxylated (7-OH, 6-OH, 2-OH) and
N-desmethylated (Nori-, Nor2-) metabolites while the N-oxides and S-oxides

were unable to lower intracellular sodium. If the metabolite produced by cel
treatment of CPZ was hydroxylated or N-desmethylated metabolites, then
proadifen and metyrapone should have inhibited their production. The
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production of CPZ-N-oxide would not have been blocked with the inhibitors
used but CPZ-N-oxide was unable to significantly lower intracellular
sodium.

The experimental results suggest that it is possible that a metabolite of
not produced during cell treatment. Although some CPZ metabolites were

able to lower intracellular sodium, none of the metabolites tested (at 500

were able to reduce intracellular sodium to the extent seen in the presence
5mM CPZ. However, it is likely that some metabolites, for example the
hydroxylated (7-OH, 6-OH, 2-OH) and N-desmethylated (Nori-, Nor2-)

metabolites, would be able to reduce intracellular sodium further at higher
concentrations. Furthermore, in preliminary experiments, CPZ metabolites
were unable to be isolated from cell-treated medium. Finally,
pharmacological inhibition of cytochrome P450 was unable to inhibit the
activation of sodium transport seen in the presence of CPZ suggesting that
the enhancement of CPZ action does not occur by a cytochrome P450
dependent mechanism. While, the inhibitors used (proadifen and ocnaphthoflavone) have been shown to inhibit 50 to 90% of CPZ metabolism

in guinea pig liver cells (Hartmann et al, 1983) some CPZ metabolites (CPZN-oxide and conjugation products) can be produced by non-cytochrome P450
dependent mechanisms and this can not be ruled out.

Another possibility is that enhancement of CPZ action is not due to a

metabolite of CPZ at all but a different cellular component. Similar to CPZ
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other compounds, such as insulin are able to stimulate sodium transport in
whole cells while this stimulation is not seen in tissue homogenates (Dorup
& Clausen, 1995; Fehlmann & Freychet, 1981). It has been suggested that
insulin may be acting via a receptor or second messenger system, possibly
mediated by protein dephosphorylation, (McGill & Guidotti, 1991) rather
than having a direct effect on sodium transport, via the sodium pump.
Another possibility suggested for insulin stimulated increase in sodium

transport in skeletal muscle is that insulin stimulates the translocation of
sodium pumps to the cell membrane (Grinstein & Erlij, 1974). There are
similarities between insulin stimulation of sodium pump activity and CPZ

activation of sodium transport. Both require the presence of whole cells and
are not seen in homogenates. Therefore, it is possible that CPZ and insulin
could be utilising similar mechanisms to stimulate active sodium efflux.

5.8 Conclusions and Future work
The results outlined in this chapter attempt to unravel the paradox which
exists when looking at CPZ stimulated sodium transport in liver cells. In
previous chapters CPZ has been shown to activate sodium transport in
whole cells. Sodium transport activated by CPZ has been shown to have
characteristics which suggest an active transport mechanism is responsible.
However, an enhancement of active transport, which should be able to be
demonstrated by an increased ATPase activity in tissue homogenates, can
not be seen. The different effects of CPZ on whole cells and tissue
homogenates led to the suggestion that something, that was required by CPZ
to activate cation transport, a possible factor X, was missing from
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homogenates but w a s present in whole cells. Results in this chapter have

indicated that CPZ is altered during cell treatment and that the altered CPZ
has an ability to activate sodium transport that exceeds that seen with CPZ
itself. This result led to an expansion of the hypothesis so that it was

suggested that factor X, present in whole cells, alters CPZ to produce facto
which -is responsible for the activation of liver cell sodium transport.

This can be expressed in the following equation:

CPZ + Factor X —> Factor Y —> activation of sodium transport Equation 6.1

Several possibilities were considered for the identity of factor X. Firstly,

considered that factor X could be light leading to a photodegredation produc
of CPZ, that is factor Y. However, light exposed and light protected CPZ

showed the same ability to reduce intracellular sodium levels. It was furthe
considered that factor X could be cytochrome P450, responsible for the
metabolism of CPZ, leading to the production of factor Y, CPZ metabolites.
However, preliminary experiments aimed at isolating CPZ metabolites from
cell treated medium were unsuccessful and pharmacological inhibition of
cytochrome P450 was unable to effect the ability of CPZ to activate sodium
transport. Therefore the identity of factor X remains unknown.

Future experiments could be performed using subcellular fractions,
microsomes, mitochondria etc, to determine which part of the cell,

containing factor X, is required to alter CPZ action. In these experiments C

would be treated with the different subcellular fractions and the ability to
activate sodium transport determined, in a similar manner to the
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experiments outlined in figure 5.1. These experiments would have to

consider the cofactors that could be required by different cellular systems.
example, cytochrome P450 metabolism can occur in microsomal fractions but
only in the presence of NADPH and oxygen. These considerations would
make these experiments complicated.

The identity of factor Y also remains unknown. It is likely that factor Y is
a metabolite of CPZ although further experiments aimed at isolating CPZ
metabolites from cell treated medium could be performed. The experiments
performed involved a complicated extraction procedure, see figure 5.14, and
it is possible that CPZ metabolites could be lost during the extraction. In
order to determine the reliability of the extraction procedure medium could
be "spiked" with known quantities of CPZ metabolites and the success in
extracting these metabolites from BEM examined.

In further experiments the characteristics of factor Y could be determined.
Cell treated medium could be exposed to acid, to high temperatures or to

dialysis. This would enable us to know the acid or heat liability of factor Y
and dialysis, or molecular weight filters, could provide information about

the size of factor Y giving some indication of it's identity. For example a C
metabolite would have a relatively low molecular weight while a protein
induced during cell treatment of CPZ would be expected to have a relatively
high molecular weight. While not identifying factor Y directly, these
procedures would shed light on the characteristics of the putative factor Y.
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CHAPTER 6

CPZ, CELL D A M A G E
AND
CELL VOLUME REGULATION

"Be patient towards all that is
unsolved in your heart and try to love
the questions themselves"
Ranier Maria Rilke, Letters to a Young Poet
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6.1

Effect of cell d a m a g e on intracellular cations

CPZ activation of cation transport, sodium and potassium, is elicited i
presence of high concentrations of CPZ (5mM). CPZ is a lipophilic,
membrane soluble, compound that is able to accumulate within the cell

membrane (Cornelius et al, 1994; Thompson et al, 1993; Yamaguchi et al
1985). The interaction between CPZ and the cell membrane has been
associated with an increase in membrane permeability (Holmsen & Rygh,
1990; Zilberstein et al, 1990), possibly via the production of membrane

(Holmsen & Rygh, 1990; Jozwiak & Watala, 1993; Lake et al, 1985; Lieber
al, 1984; Morimoto et al, 1994), leading to cell swelling (Cornelius et

Thompson et al, 1993). In addition, the lipophilic nature of CPZ has bee

associated with detergent like, membrane perturbing, actions leading to

damage, and even lysis, of red blood cells (Cornelius et al, 1994; Mori
al, 1994; Spirtes & Guth, 1963).

6.1.1 Effect of detergent treatment on intracellular cations

Based on these experiments it is possible that the cation lowering eff

CPZ may be a secondary effect associated with the detergent-like actio

CPZ. That is, the cation lowering effect of CPZ could occur because of

decrease in cell viability, or an increase in cell permeability, associ

treatment of cells with high concentrations of CPZ. In order to test t

possibility isolated rat liver cells were treated with the ionic deterg

sodium deoxycholate (DOC) in order to determine the effect of detergen
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cell damage on intracellular cation content. Results from experiments where
rat liver cells were incubated with increasing concentrations of D O C (0.5 5 m M ) are shown in figure 6.1.
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treatment -of liver cells on intracellular catio

content.

In order to examine the effect of membrane perturbing agents, on intracellular catio
rat liver cells were treated with sodium deoxycholate (DOC, 0.5 to 5 m M ) and the effect
on sodium activity (22Na+) and potassium content (flame photometry) measured after 20
minutes. (N=5, Values are mean±SEM)

Treatment of rat liver cells with sodium deoxycholate causes alteration in

the intracellular cation content of isolated liver cells indicating an incr
in membrane permeability. In the presence of increasing concentrations of
the detergent DOC (0.5 to 5mM), an increase in intracellular sodium and a
decrease in intracellular potassium is seen. These changes in intracellular
cations demonstrate the changes that would be expected to occur as ions
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move

down

their concentration

gradients, following

an

increase in

membrane permeability. The decrease in intracellular potassium is simil

to that which is seen with CPZ, however the increase in intracellular s

is opposite to the effect seen in the presence of CPZ. Therefore, it is

that the decrease in intracellular potassium could be due to a membrane
perturbing action of CPZ. However, our previous experiments have shown
that CPZ is able to remove intracellular potassium against an inwardly

directed potassium concentration gradient (see figure 4.5), making it u

that the decrease in intracellular potassium seen in the presence of CP

the result of a simple increase in membrane permeability. Additionally,

even at high CPZ concentrations, the membrane perturbing, detergent lik

effects of CPZ have been reported to only occur at temperatures below 3

(Luxnat & Galla, 1986). As our incubation temperature is 37°C it is unli
that the detergent like properties of CPZ would be responsible for the

activation of cation transport seen following CPZ treatment of rat live

6.1.2 Effect of pore forming agents on intracellular cations

The interaction between CPZ and the cell membrane has been reported to

result in the production of pores or holes in platelet and red cell mem
(Holmsen & Rygh, 1990; Jozwiak & Watala, 1993; Lieber et al, 1984;

Morimoto et al, 1994). It is possible that the formation of membrane po
following incubation with CPZ could be responsible for the decrease in

intracellular cations. To examine this possibility, liver cells were tr

the pore forming agent saponin (100ug/mL), which has been shown to resu
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in the release of intracellular potassium from cultured rat hepatocytes
(Wassler et al, 1990). The efflux of potassium d o w n its concentration
gradient, through membrane pores is also seen in monensin containing
incubations (see figure 4.5). The effect of pore forming agents on intracellular
cation content of rat liver cells was measured and compared to the effect of
CPZ. Results of these experiments are shown in figure 6.2.
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Figure 6.2 Effect of pore forming agents on cation content of liver cells
In order to determine the effect of pore forming agents cn intracellular cations, rat liver
cells were treated with monensin (80|ig/mL) or saponin (100(J.g/mL) and the cation
content (sodium and potassium determined by flame photometry) measured after 20
minutes. In addition liver cells were incubated in normal (BEM alone) or C P Z (5mM) and
the effect on cation content determined. (N>3, Values are mean±SEM)

Results in figure 6.2 demonstrate the difference in the effect of CPZ o

content of liver cells compared to the pore forming agents, monensin and
saponin. In the case of the pore forming agents, monensin (80(Xg/mL) or
saponin (lOOfig/mL), it can be seen that cations move down their

concentration gradients, resulting in an increase in intracellular sodi
a decrease in intracellular potassium. In contrast, in the presence of
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sodium and potassium are decreased, suggesting that any membrane pores

formed by CPZ are not responsible for the effect of CPZ on intracellula

sodium, but may be responsible for the decrease in intracellular potass
seen following CPZ treatment.

It is possible that in the presence of membrane pores intracellular cat

could leave the cell during the wash protocol, which is required to rem

extracellular cations. However, this is unlikely to explain the lowerin
intracellular cations seen in the presence of CPZ. If CPZ was inducing

membrane pores which were responsible for the decrease in intracellular

cations then the same effect would be expected with the known pore form
agents, monensin and saponin. In the presence of monensin and saponin
there is an increase, rather than a decrease, in intracellular sodium,

suggesting that the presence of membrane pores does not lead to an effl
intracellular sodium during the wash.

To confirm that the decrease in intracellular cations seen in the prese

CPZ is not the result of cations leaving the cell during the wash proto

cation content of the wash medium in the presence and absence of CPZ ha

been determined. The results from these experiments are presented in fi
6.3.
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~~*^ Normal

-A— CPZ

Figure 6.3 Effect of CPZ on removal of cations during the wash protocol.
The cation content (22Na+, sodium and potassium) of the wash medium was determined
following a 20 minute incubation in either normal (BEM alone) or C P Z (5mM) containing
medium. The cation content of the wash medium is presented as a percentage of the
cation content present in the first wash. (N>4, Values are mean±SEM)
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It can be seen from the results in figure 6.3 that the wash out curves for
normal and CPZ treated cells are almost indistinguishable. This result
indicates that the removal of extracellular cations during the wash was not
affected by the presence of CPZ and also that the decreased intracellular

cation content of CPZ treated cells was not the result of the CPZ treated cell
losing additional intracellular cations during the wash protocol.

In addition to the membrane perturbing, detergent like actions of CPZ,
interaction between CPZ and the cell membrane have been linked to cell
swelling. CPZ associated cell swelling has been shown to be dependent on
the number of cells (volume of membrane) present (Cornelius et al, 1994;
Thompson et al, 1993). The correlation between the number of rat liver cells
(mg Protein/coverslip) and the ability of CPZ to lower intracellular sodium
was determined and the results are shown in figure 6.4.

In these experiments, the amount of protein (mg) per coverslip was taken to

be representative of the number of rat liver cells present. It can be seen fro
figure 6.4 that the ability of CPZ to lower intracellular sodium decreases as
the amount of protein, or number of cells, increases (r2 = 0.510). As the
number of cells increases, the amount of cell membrane would also increase.

Therefore, it is possible that the ability of CPZ to activate sodium transpor
dependent on an interaction between CPZ and the cell membrane possibly
via the stimulation of a volume regulatory mechanism which leads to
activation of cation transport.
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y = 3.7283 + 36.681x
r2 = 0.510

0

1
2
3
4
5
N u m b e r of cells (mg Protein/coverslip)

Figure 6.4 Correlation between number

of cells and activation of sodium

transport by CPZ.
The sodium activity was determined from the effect of CPZ (5mM) on normal cells (BEM
plus C P Z ) during a 20 minute incubation. The number of cells was considered to be
indicated by the m g protein associated with each coverslip. Each point cn the figure
indicates the sodium activity associated with a particular coverslip in the presence of
CPZ.

These results indicate agents which act to perturb membrane ion gradients
form pores in the cell membrane result in an increase in intracellular

sodium and a decrease in intracellular potassium. Conversely, CPZ acts to

decrease intracellular sodium and potassium therefore it is unlikely that

is activating cation transport simply by perturbing membrane ion gradient

or forming pores in the cell membrane. However, the high concentrations o
CPZ used in these experiments could lead to a decrease in cell viability
itself could be responsible for the unusual cation lowering effects seen
presence of CPZ. If cell viability is decreased then cells are unable to

active transport leading to a running down of the concentration gradients

sodium and potassium. This results in an increase in intracellular sodium
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and a decrease in intracellular potassium, suggesting that unless energy is
available cells will gain sodium and lose potassium (Graf et al, 1988). In the
presence of CPZ, there is a decrease in intracellular sodium, along with
potassium, suggesting that a decrease in liver cell viability would be unable
to explain this effect. In addition the cyanide and temperature sensitivity of

the CPZ effect suggests that energetically viable cells are required for cation
transport activation.

The detergent like properties of CPZ could explain the ability of CPZ to lower
intracellular potassium, but the decrease in intracellular potassium seen in
the presence of CPZ has been shown to proceed against a potassium
concentration gradient. The ability to remove potassium against a
concentration gradient provides evidence that membrane pores are not
responsible for the decrease in intracellular potassium. A reversal of the
potassium concentration gradient was able to reverse the potassium

lowering effect of monensin (see figure 4.5), but had no effect on the decrease
in intracellular potassium seen in the presence of CPZ.

The cation transport activation seen in the presence of CPZ appears not to be

associated with either a decrease in cell viability or due to the detergent lik
properties of CPZ. However, the interaction between CPZ and the cell
membrane, which has been shown to lead to red blood cell swelling
(Cornelius et al, 1994; Thompson et al, 1993) could be important. In chapter
4, sodium efflux in the presence of CPZ was shown to be ouabain-insensitive
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and potassium-independent. A similar type of sodium efflux has been
described previously to occur in liver and kidney slices as a volume

regulatory response triggered by cell swelling (Berthon et al, 1980; Came
al, 1995; Elshove & van Rossum, 1963; Macknight, 1968; Macknight et al,

1974; McLean, 1963; Morimoto et al, 1994; Proverbio et al, 1988; Proverbio
al, 1991; Russo et al, 1977). It is possible therefore that CPZ activates
response.

6.2 Regulation of cell volume
Regulation of cell volume is a fundamental property of all animal cells,
although the mechanisms utilised by animal cells to maintain cell volume
are not fully understood however a number of factors have been determined
to be important. Among these is the requirement for water to be in

equilibrium across the cell membrane. Therefore, cell volume is determined

by cell solute content which is in turn controlled by both the permeant an

impermeant cations and anions. Cell solutes tend to move until the product

of activities on both sides of the membrane are equal in order to maintain
electroneutrality (Hoffmann, 1987). Taking these factors into account one
the most popular hypotheses for cell volume regulation is the pump/leak
hypothesis (Leaf, 1956). In the pump/leak hypothesis, the sodium pump
plays a central role in cell volume regulation. As cell volume increases,
there is an activation of the sodium pump (Na+/K+-ATPase) which removes
intracellular sodium leading to a subsequent decrease in volume and
therefore, cell volume is controlled by a balance between the ion leak,
through transporters and exchangers, and the activity of the sodium pump.
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6.2.1 Ion transport pathways involved in cell volume regulation
Mammalian cells, for example liver and kidney, are able to maintain their
volume even w h e n the sodium p u m p is completely inhibited by ouabain
(Berthon et al, 1980; Camejo et al, 1995; Macknight, 1968; Macknight et al,
1974; McLean, 1963; Proverbio et al, 1988; Proverbio et al, 1991; Russo et al,
1977; Seidman & Cascarano, 1966). W h e n the sodium p u m p is inhibited the
volume regulatory decrease, in response to cell swelling, results in a net
decrease in intracellular sodium and potassium (Gilles, 1988). The ability of
cells to respond to changes in volume, even in the presence of ouabain,
indicates that the sodium p u m p is not the only pathway responsible for cell
volume

regulation. The

ion transporting pathways that have

been

implicated in cell volume regulation are depicted in figure 6.5.

Figure 6.5 Ion transport pathways^otmtiallyammbTejuracilvation
regulatory volume decreases
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during

Ion transport pathways, other than the sodium p u m p (Na+K + -ATPase, 1 in

figure 6.5), can be stimulated to cause a decrease in intracellular sodiu
potassium, leading to a decrease in cell volume. The ouabain-insensitive
sodium-only ATPase (Na+-ATPase, 2 in figure 6.5) has been described in

mammalian liver, kidney, small intestine, brain and red blood cells (Camej

et al, 1995; Del Castillo et al, 1982; Del Castillo & Robinson, 1985; Mor
al, 1991; Proverbio et al, 1988; Whittembury & Proverbio, 1970). The Na+ATPase, together with the sodium pump, are active (energy dependent)
forms of sodium extrusion. The Na+-ATPase is distinct from the sodium

pump in that it provides a mode of sodium efflux that is ouabain-insensiti
although it has been reported to be inhibited by ethacrynic acid (~2mM,
Proverbio et al, 1989). In addition the Na+-ATPase does not require
extracellular potassium and does not demonstrate complete selectivity for

intracellular sodium, that is, it can also transport other cations out of
(sodium>»potassium>rubidium>ammonia>caesium). The characteristics
of the Na+K+-ATPase (sodium pump) and the Na+-ATPase are compared in
table 6.1 (taken from Proverbio et al, 1989).
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Table 6.1 Differential characteristics of the Na+K+-ATPase

and the Na+-

ATPase.
Na+-only ATPase

Na+K+-ATPase

M g 2 + requirement

yes

yes

K requirement

no

yes

Na+>Li+

Na+ > » K +

Characteristic

Cation stimulation

>Rb+>NH4 + >Cs +
Anion stimulation
Substrate

no

no

ATP

A T P > » G T P , ITP,
ADP, CTP

Optimal p H

6.9

7.2

Ouabain Sensitivity - 7 m M

0%

100%

100%

60%

Ethacrynic Acid sensitivity - 2 m M

Cell volume regulation has also been attributed to activation of transporters

other than active transporters. Activation of potassium channels (3 in figure

6.5) can lead to a decrease in cell volume (Henderson et al, 1989) as a resul
of potassium efflux, down its concentration gradient. Potassium channels
have been described in rat hepatocytes and are inhibited by barium (BaCl2,
Graf et al, 1988; Graf & Haussinger, 1996; Xu et al, 1995). Some potassium
channels have been found to be sensitive to membrane stretch (Beck et al,
1994) such as may occur in the presence of CPZ. As well as stretch activated
potassium channels, stretch activated non-specific cation channels (4 in
figure 6.5) have also been described for rat hepatocytes (Graf & Haussinger,
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1996). This channel is permeable to sodium, potassium and calcium and is
reported to be inhibited by gadolinium.

Co-transporters such as the potassium/chloride (K+/CL, 5 in figure 6.5) and
sodium/potassium/ chloride (Na + /K+/Cl") co-transporter, (6 in figure 6.5)
have also been implicated in cell volume regulation (Geek & Heinz, 1986).
Co-transporters m o v e more than one ion in a direction that is governed by
the net concentration gradients present at the time (Chipperfield, 1986).
While this is usually driven by the inwardly directed sodium concentration
gradient co-transporters can m o v e ions in either direction. The N a + / K + / C L
and K+/C1" co-transporters are inhibited by the loop diuretic bumetanide
(Chipperfield, 1986; Jayme et al, 1984; X u et al, 1995).

Besides co-transport, ions may also undergo countertransport or exchange.
O n e c o m m o n exchanger is the sodium/hydrogen (Na + /H + ) exchanger (7 in
figure 6.5). This exchanger has been identified in rat hepatocytes (Arias &
Forgac, 1984; Moseley et al, 1986). The N a + / H + exchanger is inhibited by
amiloride (Strazzabosco & Boyer, 1996) and has been implicated both in
volume regulatory responses (Grinstein & Weiczorek, 1994) and regulation
of intracellular p H (Gleeson et al, 1990).

Cells may also regulate their volume through alterations in the intracellul
content of amino acid (8 in figure 6.5), especially the content of the amino
acid taurine (Ballatori & Boyer, 1992; Hoffmann & Hendil, 1976; Hoffmann &
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Lambert, 1983; Macknight & Leaf, 1985; Thurston et al, 1981). The efflux of
taurine in response to cell swelling is an active process, not dependent on
concentration gradients but dependent on ATP and inhibited by metabolic
inhibitors such as cyanide and cold (Ballatori & Boyer, 1992).

6.2.2 Involvement of ion transport pathways in CPZ activated cation
transport
The involvement of the many ion transporting pathways, described in figure
6.5, in CPZ activated cation transport was determined by utilising
pharmacological inhibitors of these pathways. Results from these are shown

in figure 6.6. Similar to the results shown in figure 3.1, the results in fig
6.6 show that ouabain (ImM) is unable to inhibit CPZ activated cation
transport, suggesting that the Na+K+-ATPase is not involved in CPZ
activated cation transport. In a similar manner, ethacrynic acid (ImM), an
inhibitor of Na+-ATPase, did not inhibit CPZ activated cation transport
leading to the conclusion that the Na+-ATPase is not the mechanism utilised
by CPZ. The potassium channel inhibitor barium chloride (ImM) had no
effect on CPZ activated potassium, or sodium efflux, suggesting, that a
simple increase in the permeability of potassium channels in not

responsible. Inhibition of the stretch activated non-specific cation channel
gadolinium (50uM) did not inhibit cation transport in the presence of CPZ.
In addition, bumetanide (O.lmM) which inhibits Na+/K+/CL co-transport

had no effect on CPZ activated cation transport, suggesting that activation o
Na+/K+/Cl" co-transport was not involved in the efflux of cations by CPZ.
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Figure 6.6 Effect of pharmacological inhibitors on CPZ activate
transport.
Rat liver cells were treated with pharmacological inhibitors of cation transport
pathways. Ouabain (ImM) was used to inhibit Na + K + -ATPase, ethacrynic acid (ImM)
was used to inhibit Na+-ATPase, BaCl2 (ImM) was used to inhibit potassium channels,
gadolinium (50|iM) was used to inhibit stretch activated non-specific cation channels
and bumetanide (O.lmM) was used to inhibit Na + /K + /Cl" co-transport. With

the

exception of ouabain, none of the inhibitors affected intracellular cation levels alone,
results not shown. (N>5, Values are mean+SEM)
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6.2.3 Effect of C P Z on intracellular taurine content
While

the results from these experiments indicate that ion transport

pathways were unlikely to be involved in CPZ activated cation transport, the
question remained whether CPZ was activating a volume regulatory
mechanism. Therefore, the effect of CPZ on the taurine content of rat liver
cells was determined. To do this, cells were loaded with taurine (0.5mM with
3

H-taurine as a radioactive tracer) for 1 hour and then treated with CPZ to

determine the effect of CPZ on taurine efflux. Results from these
experiments are shown in figure 6.7.
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Figure 6.7 Effect of CPZ on taurine content of rat liver cells

Rat liver cells were loaded with taurine during a 1 hour incubation at room temperat
in BEM supplemented with 0.5mM taurine (and 0.5|iCi/mL 3H-Taurine). Taurine loaded
cells were then incubated for 0 to 20 minutes in either normal (BEM alone) or CPZ
containing medium and the amount of taurine remaining at the conclusion of the
experiment determined. (N=4, Values are mean±SEM)
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From figure 6.7 it can be seen that C P Z is able to activate the removal of
taurine from rat liver cells. The taurine content at time 0 is the content of
the liver cells following the 1 hour incubation in the loading medium. After
loading, cells were incubated in either normal (BEM alone) or C P Z
containing medium for up to 20 minutes. In normal incubations the taurine
content remained constant (p 0.16), but in C P Z containing incubations the
taurine content decreased significantly (p 0.0001) over the incubation time.
The effect of C P Z on liver cell taurine content is similar to the effect of C P Z
on intracellular cations. In figure 6.8 the effect of C P Z on intracellular
sodium and taurine is compared.
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Figure 6.8 Comparison of the effect of CPZ on intracellular sodium an
taurine content of liver cells
Rat liver cells were loaded with taurine and
temperature in B E M

22

Na+ during a 1 hour incubation at roo

supplemented with 0.5mM taurine (0.5uCi/mL

22

Na+

and

0.5(J.Ci/mL 3H-Taurine). Loaded cells were then incubated for 20 minutes in C P Z
containing medium and the amount of intracellular

22

N a + and taurine remaining at the

conclusion of the experiment determined. (N=4, Values are mean±SEM)
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It can be seen from figure 6.8 that after 20 minutes, C P Z is able to drastically
reduce the intracellular sodium and taurine content of rat liver cells from

that which would be seen in loaded cells following the loading incubation. A
decrease in the intracellular level of the amino acid taurine commonly

occurs when cells are reducing their volume (Ballatori & Boyer, 1992; Gilles

1988; Graf et al, 1988). The similar relative reduction in intracellular sod
activity and taurine content suggests that CPZ could be activating a volume
reducing mechanism leading to a decrease in intracellular osmolytes.

6.3 Mechanisms of ouabain-insensitive cell volume regulation
6.3.1 Cytoplasmic vesicles
Although ion transport pathways have been implicated in cell volume

regulation, none of the inhibitors tested were able to inhibit the activatio
cation transport seen with CPZ treatment. Additionally, none of the

inhibitors, with the possible exception of ethacrynic acid (Kleinzeller, 1972
have been reported to be able to block the ouabain-insensitive, potassium
independent, sodium efflux seen with volume regulation following cell
swelling. Figure 6.9 outlines the mechanisms that have been proposed for
the ouabain-insensitive control of cell volume.
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Figure 6.9 Possible mechanisms

of ouabain-insensitive cell

volume

regulation.
Ouabain-insensitive volume regulation has been hypothesised to occur by a variety of
mechanisms; 1) activation of ion transport pathways (Kleinzeller, 1972), 2) exocytosis
of cytoplasmic vesicles (van Rossum & Russo, 1984) and 3) a mechanism dependent cn
activity of cytoskeletal proteins (Kleinzeller, 1972; Mills, 1987).

The most popular hypothesis for ouabain-insensitive volume regulation is
simple activation of ion transport pathways (pathway 1 in figure 6.9),
however mechanisms other than ion transport pathways have been
proposed. The first of these (pathway 2 in figure 6.9) came about from

observations of an increase in the number of cytoplasmic vesicles following

cell swelling in the presence of ouabain (Garfield & Daniel, 1977; Russo et
1977; van Rossum & Russo, 1984; van Rossum et al, 1987). This mechanism

involves vesicles accumulating intracellular ions and water with subsequent
exocytosis of accumulated material.
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6,3.2 Appearance of C P Z treated liver cells
The presence of cytoplasmic vesicles in CPZ treated cells was examined by
light microscopy. Isolated rat liver cells were incubated in normal (BEM
alone) or CPZ for 20 minutes then fixed with glutaraldehyde and stained
with a modified Papanicolau stain before being examined under the light
microscope. Light micrographs of normal and CPZ treated cells are shown in

Figure 6.10. Micrographs of normal cells, at 400x magnification, are in pane
A. Panels B and C shows CPZ treated cells, at 400x and lOOOx magnification
respectively.

From the micrographs in figure 6.10 it can be seen that there are definite
changes in the appearance of rat liver cells following 20 minutes of
incubation in CPZ containing medium. In comparison to normal cells, CPZ

treated cells appear to have lost their cytoplasmic fringe region, suggestin
that the CPZ treated cells are rounder in appearance. The CPZ treated cells

also appear to be more basophilic (bluer) and vesicular or granular than the
normal cells.
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Figure 6.10 Light micrographs of normal and CPZ treated rat liver cells.
Isolated rat liver cells were incubated in normal (BEM alone) or C P Z for 20 minutes then
fixed with glutaraldehyde and stained with Papanicolau stain before being examined
under the light microscope.

Panel A is a micrograph of normal cells at 400x

magnification. Panel B and C shows C P Z treated cells, at 400x and lOOOx magnification
respectively.
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The loss of the cytoplasmic fringe following C P Z treatment appears to result

in cells which are smaller than those following normal treatment. In order
to determine if there were any changes in cell volume following CPZ
treatment the diameter of the liver cells were measured microscopically
using a microscope connected to a computer running the Magellan
computer program. Using this program the diameter of the whole cell and
the diameter of the cell nucleus was measured. Following CPZ treatment
there was no significant change in the total cell diameter (p 0.12, N>30)
the diameter of the nucleus (p 0.09, N>30).

The increase in vesicularisation seen in CPZ treated cells in figure 6.10,

suggests that it is possible that a vesicle driven decrease in cell volume
maybe occurring in the presence of CPZ. It has been suggested that such
vesicles may accumulate ions by an ATP dependent mechanism as hydrogen
ions are initially accumulated within the vesicles via hydrogen-ATPase
activity. The intravesicular hydrogen ions are then exchanged for sodium

and potassium, leading to the uptake of water (van Rossum et al, 1987). Th

increased basophilia seen in CPZ treated cells could be taken to be indica

of a decrease in intracellular pH, possibly due to activation of the Na+/H+
exchangers in the vesicle membranes exchanging intravesicular hydrogen
ions for cytoplasmic sodium ions.
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To determine any participation of N a + / H + exchangers in C P Z activated
cation transport amiloride (ImM) was used to inhibit the Na+/H+

exchanger. Rat liver cells were treated with amiloride and the accumulat
of

22

Na+ measured in the presence and absence of CPZ. If the Na+/H+

exchanger was responsible for CPZ activated accumulation of sodium within
cytoplasmic vesicles, then it would be expected to be inhibited in the

presence of amiloride. Results from these experiments are shown in figure
6.11.
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Figure 6.11 Effect of amiloride on CPZ activated sodium transport
Rat liver cells were incubated, for 20 minutes in the presence of

22

Na+, in normal (

alone) or medium supplemented with combinations of ouabain (ImM), amiloride (ImM,
an inhibitor of N a + / H + exchange) and C P Z (5mM) and the effect of drug treatment on
sodium activity determined. (N=8, Values are mean+SEM)

The presence of amiloride in ouabain containing incubations causes a

decrease in the amount of sodium that accumulates within the liver cells

This decrease is presumably due to inhibition of sodium entry through th
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Na+/H+

exchanger. W h e n

the N a + / H +

exchanger

is inhibited

the

characteristic decrease in intracellular sodium seen in CPZ treated cells is
still present, suggesting that the Na+/H+ exchanger is not underlying CPZ
activated sodium transport.

6.3.3 Cytoskeletal proteins
The second mechanism suggested for ouabain-insensitive volume
regulation involves cytoskeletal proteins (pathway 3 in figure 6.9). This

hypothesis is based on the ability of the cytoskeleton to not only influence

the activity of membrane bound proteins, but also inflict a force on the cel
membrane that can lead to changes in cell shape (Kleinzeller, 1972; Mills,
1987). Both of the mechanisms suggested for ouabain-insensitive volume

regulation, vesicles and cytoskeleton, depend on the activity of cytoskeleta
proteins (Garfield & Daniel, 1977; Kleinzeller, 1972; Mills, 1987; Russo et
1977; van Rossum & Russo, 1984). The first to move vesicles to the cell
membrane, and the second to contract the cell membrane. Therefore, both
cell volume regulatory mechanisms should be able to be inhibited by the
same treatment, that is, incubation with cytochalasins or colchicine.
Cytochalasins and colchicine have been reported to reduce both endo- and

exocytosis (Sandvig & Van Deurs, 1990). This action is due to the disruption
of the microfilaments which make up the cytoskeleton (Brinkley et al, 1980;
Busch et al, 1994; Lowe et al, 1985; Weber & Osborn, 1979). The effect of
cytochalasins and colchicine on CPZ activated cation transport was
determined and the results are shown in figure 6.12.
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Figure 6.12 Effect of microtubule
transport.

+ CPZ

j
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inhibitors on CPZ activated cation

Rat liver cells were treated with the microtubule inhibitors colchicine, cytochalasin E
and cytochalasin B. In the right hand panels, liver cells were treated with
cytochalasins E (50(Xg/mL) and B (100|xg/mL) in incubations containing either normal
(BEM alone) or medium supplemented with ouabain (ImM) and/or C P Z (5mM). In the
lower left hand panel, liver cells were treated with colchicine (ImM) in either normal
(BEM alone) or medium supplemented with ouabain (ImM) and monensin (80ug/mL) in
the presence or absence of C P Z (5mM). In all experiments the effect of microtubule
inhibitors on sodium and potassium content of liver cells at the conclusion of the 20
minute incubation was determined. (N>3, Values are mean+SEM)
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The results in figure 6.12 are derived from experiments where rat liver cells
were treated with the microtubule inhibitors, such as cytochalasins
(cytochalasin B at lOOug/mL and cytochalasin E at 50fig/mL) or colchicine
(ImM). These concentrations of cytochalasins and colchicine have been used
previously to inhibit microtubule functions (Sandvig & Van Deurs, 1990)
and to inhibit ouabain-insensitive volume regulation (van Rossum et al,
1987). By comparing the effect of CPZ in control experiments (upper left
panel) with the other panels in figure 6.12 it can be seen that the

cytochalasins and colchicine were unable to inhibit cation transport activate
by CPZ. These results suggest that microtubule function or vesicle
movement is not required for the decrease in intracellular cations seen in
the presence of CPZ.

There are three hypothesised mechanisms for the ouabain-insensitive
decrease in cell volume which have been considered as possible mechanisms
by which CPZ could decrease intracellular cations. The first involved
activation of ion transporting pathways leading to a direct decrease in
sodium, potassium, chloride and water. The second involved release of ions
following accumulation within intracellular vesicles, and the third
hypothesis involves cell constriction by cytoskeletal proteins leading to a
decrease in cell size. Experimental results indicate that although CPZ was

able to decrease the intracellular content of the osmotically active amino ac
taurine, the activation of cation transport by CPZ was not inhibited by
treatments that are normally associated with inhibition of cell volume
regulation.
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6.4

Effect of C P Z on cell volume

6.4.1 Effect of CPZ on cell diameter

These results were unexpected because in the presence of CPZ a decrease in

the intracellular sodium and potassium content, along with a decrease in th

intracellular content of the amino acid taurine is seen. All of these resul
suggest that the cell size should be reduced with the loss of the major
intracellular osmolytes. For this reason, the direct effect of CPZ on cell
was determined. This was initially done by measuring the diameter of
isolated rat liver cells that had been prepared for scanning electron
microscopy. Scanning electron micrographs of normal and CPZ treated rat

cells are shown in figure 6.13. It can be seen from the micrographs that t

liver cell treated with CPZ was smaller than normal liver cells. On average
there is a decrease in cell diameter from 21.5±0.4um in normal cells, to
15.2+0.3um in CPZ treated liver cells (N>100, p<0.0001). The volume of
isolated liver cells was determine according to the formula:

Volume = (4 % r3)/3 Equation 6.1

Using this formula, assuming that the liver cells are spherical, the decrea
in diameter corresponds to a three fold decrease in cell volume. This
decrease in cell volume was seen in liver cells that had been fixed with
glutaraldehyde, dehydrated in ethanol and acetone and coated with gold
before being scanned in the electron microscope. Therefore, it is possible

the decrease in cell volume in the electron micrographs could be partly an
artefact following fixing and dehydration.
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Figure 6.13 Scanning electron micrographs of normal and CPZ treated liver
cells
Isolated rat liver cells were incubated in normal (BEM alone) or C P Z for 20 minutes then
fixed with glutaraldehyde and dehydrated with a graded series of ethanol (50%, 75%,
95%, 100%, 100%) followed by acetone (2x 100%) washes before being coated with gold
and examined by scanning electron microscopy. The upper panels show micrographs of
normal cells while the lower panels shows C P Z treated cells.
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6.4.2 Effect of C P Z on intracellular water

When

cation content is measured, cells are isolated and then cultured

overnight onto collagen coated plastic coverslips. The usual methods for
measuring cell volume, flow cytometry or coulter counting, requires cells
free in solution. This would require the liver cells to be trypsinised to
remove them from the coverslip and would introduce another variable into
the results. Therefore, intracellular volume was measured using 3-O-

methyl-D-glucose as described by Kletzien and associates (1975). This method
has been specifically designed to measure the intracellular water space of

isolated rat liver cells, when cells are attached to collagen coated covers
and has been used previously in conjunction with measurement of
intracellular sodium to obtain a measure of intracellular sodium
concentration (Scharschmidt et al, 1986; Van Dyke & Scharschmidt, 1987).

Intracellular water, and sodium, were measured in the presence of 1 and
5mM 3-O-methyl-D-glucose (with 3-0-[3H-methyl]-D-Glucose used as a
radioactive tracer) over a 20 minute period in the presence and absence of
CPZ. 3-O-methyl-D-glucose is indicative of intracellular water content when

influx and efflux are in equilibrium. Although a longer period of incubation
is commonly used (up to 60 minutes), 20 minutes has been shown

previously to be sufficient to allow for equilibration of 3-O-methyl-D-glu

in isolated rat liver cells (Kletzien et al, 1975; Scharschmidt et al, 198
Dyke & Scharschmidt, 1987; Van Dyke & Scharschmidt, 1983). Additionally,
20 minutes was chosen to provide continuity with the effects of CPZ on
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cation content determined throughout this study. Results from experiments
where intracellular water and sodium content of isolated rat liver cells was
measured are shown in figure 6.14.
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Figure 6.14 Effect of CPZ on intracellular water and sodium activity of liv
cells
Intracellular water and sodium were measured in rat liver cells, in incubations
containing 1 and 5 m M 3-O-methyl-D-glucose (with 3-0-[3H-methyl]-D-Glucose and
22

N a + ) over a 20 minute period in normal (BEM alone) or medium supplemented with

C P Z (5mM). 3-O-methyl-D-glucose and sodium activity were determined after washing
(5x30 seconds) to remove extracellular label. (N=4, Values are mean±SEM)

It can be seen from figure 6.14 that liver cells in normal (BEM) incubations
have an intracellular water volume of 2.1±0.3|iL/mg protein. This volume is
similar to that reported for isolated rat liver cells by other investigators
(1.9±0.2uL/mg protein, Scharschmidt et al, 1986; 2.48uL/mg protein,
Kletzien et al, 1975; 2.8±0.1uL/mg protein, Van Dyke & Scharschmidt, 1987).
The volume of the liver cells decreased significantly following treatment
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with C P Z (1.5±0.07|iL/mg protein, p=0.04). Although intracellular water did

decrease significantly following CPZ treatment, the decrease in intracell

water was not as great as the decrease in intracellular sodium seen follow

CPZ treatment (p<0.001). Therefore, a decrease in the intracellular sodium
concentration is seen following CPZ treatment of liver cells, from
37.8±6.2mM in normal cells to 18.7±5.9mM in CPZ treated cells.

The intracellular sodium concentration measured in isolated rat liver cell
in these experiments is higher than the accepted concentration of

intracellular sodium in rat liver cells or slices (10-20mM, Graf et al, 19
Van Dyke & Scharschmidt, 1987; Van Dyke & Scharschmidt, 1983;
Woodbury, 1965). However, a sodium concentration higher than the

generally accepted value is not unusual. High concentrations of intracell

sodium have been reported for a variety of isolated cell systems including

renal tubule cells (ll-30mM, Gullans et al, 1985) separated red blood cell
(40mM, Pike et al, 1984), nerve axons (43mM, Hodkin & Keynes, 1955) and
cultured mouse fibroblasts (40-50mM, Jayme et al, 1984).

The high level of intracellular sodium in these experiments may be the

result of an underestimation of the intracellular volume due to loss of 3methyl-D-glucose during the wash procedure. In the original method
(Kletzien et al, 1975) the wash medium contained phloretin (ImM) to
inhibit the efflux of glucose during the wash. The cost of phloretin
prohibited its use in these experiments so washes were performed at 0°C
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w h e n transporters would be inhibited by the low temperature. The a m o u n t
of 3-O-methyl-D-glucose in the wash solution w a s measured, and the results
of these experiments are shown in figure 6.15.

Figure 6.15 Amount

of 3-O-methyl-D-glucose in the wash medium

The amount of 3-O-methyl-D-glucose in each wash (20mL) was determined by taking a
sample of wash medium and measuring the amount of 3-0-[3H-methyl]-D-Glucose
present in the wash. (N=16, Values are mean+SEM)

It can be seen from the results in figure 6.15, that the amount of glucose
the wash m e d i u m decreases rapidly over the first few washes, and then very

slowly in the final washes. This is a typical wash protocol for the removal
an extracellular label. Therefore, it can be concluded that 3-O-methyl-D-

glucose is minimally released from the cells during the wash procedure. Thi
would not be likely to lead to an underestimation of liver cell volume.

The

use of 3-O-methyl-D-glucose

to measure

liver

cell volume is

complicated by the fact that 3-O-methyl-D-glucose measures the cytosolic
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water volume, not the volume occupied by cellular organelles, that is, not

the total cell volume (Kletzien et al, 1975). The largest cellular organelle
the nucleus, therefore we corrected the volume of CPZ and normally
incubated cells, according to the amount of space taken up by the nucleus.
The amount of intracellular volume occupied by the nucleus was
determined from measures of nuclear and total cell diameter, see discussion
of figure 6.10.

In normal cells, the nucleus filled 4.1±0.5% of the total cell volume, while
CPZ treated cells, the area filled by the nucleus was increased to 7.3+0.9%
0.004). Taking these results into consideration, the total amount of

intracellular water could be recalculated (2.2+0.3uL/mg P in normal cells an
1.6±0.1uX/mg P in CPZ treated cells). These changes in cell volume, taking
into account the percent of the volume occupied by the nucleus, do not

significantly alter the intracellular concentration of sodium. Therefore, e
considering the changes in the nucleus to cytoplasm ratio of normal and CPZ

treated cells, and correcting intracellular water for the volume filled by t
nucleus, the concentration of sodium in our cells remains higher than the
accepted values.

One other possible explanation for the differences in intracellular sodium
concentration determined in these experiments, and that determined by
other investigators (Van Dyke & Scharschmidt, 1987; Van Dyke &
Scharschmidt, 1983), is that these investigators routinely used an 8 wash
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protocol to remove

extracellular sodium. Therefore, the intracellular

sodium levels determined might be expected to be lower than those
measured in the current investigation. The purpose of the wash protocol at
the conclusion of the experiment is to remove extracellular radioactive
sodium, while allowing intracellular radioactive sodium to remain. Results
shown in figure 2.2 indicate that 5 washes were sufficient to remove
extracellular sodium, and that further washes resulted in the release of

intracellular sodium. Therefore, it is possible that intracellular sodium ha
been under estimated when an eight wash protocol is used and therefore a
lower intracellular sodium concentration is derived.

6.5 Conclusions
The initial examinations in this chapter were aimed at determining if

activation of cation transport seen in the presence of CPZ could be due to c
damage induced by the high concentration of CPZ required to elicit these
effects. Examinations using agents which cause cell damage, that is the

detergent deoxycholate, or agents which lead to a disruption of the cellular
concentration gradients for sodium and potassium, that is the pore forming
agents monensin and saponin, led to the conclusion that cell damage, or

disruption of the cellular concentration gradients, leads to the accumulatio
of intracellular sodium and loss of intracellular potassium. It is possible

therefore, that CPZ could be causing cell damage, resulting in a decrease in
intracellular potassium, by simply increasing the permeability of the cell
membrane for potassium. However, results in chapter 4, such as those
shown in figure 4.5, indicate that CPZ is able to activate potassium efflux
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even

in the presence of high extracellular potassium concentrations.

Therefore, it is unlikely that a simple increase in potassium permeability
responsible for the potassium efflux seen in the presence of CPZ.

Further experiments in this chapter were aimed at determining the effect o
CPZ on cell volume. The results were somewhat contradictory. If

intracellular taurine content was considered as an indicator of cell volum

then CPZ activates a volume regulatory mechanism to result in a decrease i
the intracellular levels of taurine and sodium. However, if cell diameter

considered as an indicator of cell volume, then a three fold decrease in c
volume was observed, when diameter was measured by scanning electron

microscopy, but not by light microscopy. Furthermore, if accumulation of 3
O-methyl-D-glucose was taken as an indicator of intracellular water, and

therefore of cell volume, then a decrease in cell volume in CPZ treated ce
was seen, however, this decrease was not as great as that seen in cells
examined by scanning electron microscopy.

Taken together, there does appear to be a decrease in liver cell volume
following incubation in CPZ. However, the decrease in cell volume was not
sufficient to account for the decrease in intracellular cations measured
following CPZ treatment, as indicated by the decrease in the estimated
sodium concentration measured in normal (37.8mM), and CPZ treated cells
(18.7mM). When estimating cellular sodium concentration, the cell volume
was determined by 3-O-methyl-D-glucose accumulation, as this method
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measures intracellular water under the same conditions that intracellular
sodium is routinely measured. It can be concluded that while CPZ treatment

of liver cells does result in a decrease in cell volume, that decrease is no
large enough to account for the decrease in intracellular sodium measured,

therefore, it is likely that CPZ is activating a sodium transport pathway. T
pathway by which CPZ is activating sodium, and potassium, transport
remains unknown, although it is unlikely to be a commonly known
pathway inhibited by current pharmacological inhibitors.

6.6 Future Work
Throughout this study the effect of CPZ on intracellular cations has been
determined and expressed as nmoles of cation/mg protein. Because of the
unusual nature of the experimental results it would be pertinent to examine

the effect of CPZ on intracellular cations relative to a different denominat
To do this preliminary experiments were begun attempting to determine the
number of cells present per mg protein, allowing the denominator to be
converted from mg protein to number of cells.

It proved difficult to determine the number of cells (per mg protein)
following CPZ treatment. In order to determine the number of cells per mg
protein, cells had to first be removed from the collagen coated coverslips.
The CPZ treated cells were more fragile than the normally treated cells and
they were therefore difficult to remove from the coverslips intact. Another

possibility considered was to express the level of intracellular cations per
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weight of tissue. However, any change in intracellular protein would be
expected to be mimicked by a change in dry weight, therefore it would be

preferable to determine the effect of CPZ on intracellular cations relativ
something that is unlikely to change, such as DNA.

It is also possible that the effect of CPZ on intracellular cations is the
the environment. It is possible, although unlikely (see results in figure
that intracellular cations could be leaving the cell during the wash
procedure. The wash procedure was necessary to remove extracellular
cations, therefore a method that is capable of distinguishing between

intracellular and extracellular cations without using a wash protocol woul
be an advantage.

The most feasible method to examine intracellular sodium, without washes
would be NMR (nuclear magnetic resonance). This method can measure the
23

Na nuclear magnetic resonance to measure the movement of sodium

across the cell membrane (Tanaka et al, 1994). Anionic paramagnetic shift
reagents, for example dysprosium (III) triethylene-tetra-aminehexaacetate
(DyTTHA3-), can be added to the incubation medium to separate the

resonance of extracellular sodium from intracellular sodium (Bansal et al,
1993).

This method has been used to measure intracellular sodium in isolated red
blood cells, yeast, skeletal muscle and kidney (Gullans et al, 1985). The
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N M R and shift reagents requires the use of isolated cells in suspension,

rather than attached to collagen coated coverslips, and has not been reporte

to be used with isolated liver cells. A complication of the use of shift re
with liver cells is that although shift reagents do not cross biological
membranes easily (Pike et al, 1984), it is possible that liver cells, which

highly endocytotic could absorb the reagents. This possibility would need to
be explored before using shift reagents to determine any effect of CPZ on
liver cell sodium content. One advantage of the use of NMR in the present
study would be that 31P- and 23Na-NMR could be measured simultaneously

(Ouwerker et al, 1989; Pike et al, 1984), to give an indication of any chang
in ATP utilisation together with changes in intracellular sodium in the
presence of CPZ. This would allow the energetic requirements of CPZ
activated sodium transport to be determined and would provide a means of
determining a possible explanation to the paradox of CPZ activated sodium
transport without an apparent increase in ATP breakdown.

171

CHAPTER 7

CONCLUSIONS

"I have not failed 10 000 times. I
have successfully found 10 000
ways that will not work."
Thomas A Edison
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This study investigated the mechanism by which C P Z lowered the cation
content of rat and toad liver cells. Results indicated that, even in the
presence of ouabain, high concentrations of CPZ were able to decrease the
intracellular sodium content of isolated liver cells by activating a sodium
efflux pathway. CPZ was able to decrease total intracellular sodium (flame

photometry), as well as sodium activity (22Na+), indicting that the activatio
of sodium efflux was not due to an enhancement of sodium: sodium
exchange activity. Although sodium efflux occurred in the presence of
saturating concentrations of ouabain, or in the absence of potassium,
activation of the sodium pump by CPZ was considered as a possible
mechanism. However, CPZ was seen to decrease intracellular potassium,
along with sodium, and inhibit ATPase activity in liver and kidney
homogenates, therefore, it was considered unlikely that the sodium pump
was involved in the activation of sodium efflux by CPZ.

While the sodium pump was unlikely to be involved in CPZ activated

cation transport, the fact remained that CPZ was able to activate the efflux
sodium, against an inwardly directed sodium concentration gradient. The
involvement of an energy requiring system, such as an active transporter
was investigated. Historically, active transporters have been characterised
according to four specific attributes: 1) their sensitivity to metabolic
inhibition, 2) their dependence on cellular oxygen consumption, 3) their
ability to transport ions against a concentration gradient and 4) their
temperature sensitivity.
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The sensitivity of C P Z activated cation transport to treatments which inhibit
active transport was determined. Sodium efflux in the presence of CPZ

occurs against the natural sodium concentration gradient that exists in livi

cells. In addition, CPZ activated sodium transport was seen to be completely

inhibited by pre-incubation of liver cells in cyanide or by incubation of li
cells in the cold (0°C). In contrast, CPZ activated potassium efflux occurs
down a naturally occurring concentration gradient. The decrease in
intracellular potassium seen in the presence of CPZ, showed partial
sensitivity to cyanide and the cold. However, the CPZ induced potassium
efflux was not affected by increasing concentrations of extracellular
potassium (5 to 150mM) suggesting that potassium efflux in the presence of
CPZ can occur against an inwardly directed potassium concentration
gradient.

Therefore, the ability of CPZ to activate sodium and potassium transport in
liver cells shows most of the characteristics of active transport. However,

increase in active transport, to the extent activated by CPZ, would be expec
to require a large expenditure of cellular energy. An increase in cellular
energy usage would be expected to be manifested as an increase in ATP
utilisation or an increased oxygen consumption, neither of which were seen

in incubations containing CPZ. CPZ was seen to inhibit ATPase activity of ra
liver and kidney homogenates and to decrease oxygen consumption of rat

liver cells. Therefore, a paradox exists where CPZ activated cation transpor
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appears to be due to activation of an active, energy requiring mechanism, but
no increase in energy utilisation can be seen.

Inhibition of cellular oxygen consumption by CPZ was not unsupported

the literature, as CPZ has previously been shown to reduce the oxygen

consumption of liver and brain mitochondria (Byczowski, 1983; Chazot

Vanderkooi, 1981). The reduction in oxygen consumption described in t

presence of CPZ is thought to be due to the ability of CPZ to inhibit
respiratory chain at multiple sites (Spirtes & Guth, 1963). However,
inhibition of mitochondrial function, and oxygen consumption, by CPZ
inconsistent with the increase in active transport suggested by the
effect of cyanide and cold on liver cell cation transport activated

was possible that liver cells could be obtaining energy from anaerobi
glycolysis, which has been shown to provide energy for ion transport

some tissues, such as renal cortical slices (Macknight, 1968) and red

cells (Maizels, 1951). However, this is unlikely as CPZ activated cat
transport was not inhibited by iodoacetate, which inhibits anaerobic
glycolysis. It remains possible that an inhibition of CPZ activated

transport by iodoacetate would have been seen if liver cells were pre

incubated with iodoacetate, in a similar manner to the pre-incubation
required for cyanide inhibition of CPZ activated cation transport.

In addition to decreasing cellular oxygen consumption, CPZ has been

to activate cation transport in whole liver cells without increasing
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breakdown in tissue homogenates. The different effect of C P Z on whole cells
and tissue homogenates led to the suggestion that something, a possible
factor X, present in whole cells, was required by CPZ to activate cation
transport. Results indicated that CPZ was altered during cell treatment and

that the altered, or cell treated CPZ had an ability to activate sodium, but

potassium, transport that exceeded that seen with CPZ itself. This result le

to an hypothesis suggesting that factor X, present in whole cells, alters CP

produce factor Y which is responsible for the activation of liver cell sodiu
transport (CPZ + Factor X —> Factor Y —> activation of sodium transport).

It was considered that cell treatment of CPZ altered the interaction of CPZ
with an active transport mechanism leading to the activation of cation
transport and the increased energy requirements. Furthermore, it was
possible that cell treatment of CPZ did not occur in tissue homogenates

(factor X is not present in homogenates) and therefore an increase in ATPase
activity was not seen with homogenates. The use of cell treated CPZ in
ATPase assays on tissue homogenates was not able to demonstrate an
increase in ATP utilisation. However, the identity of the putative factor Y

remains unknown and until it is identified an increase in ATP utilisation in
the presence of factor Y cannot be ruled out.

An additional paradox also exists as CPZ activated cation transport occurs i

the presence of ouabain (and in the absence of extracellular potassium). Thi
is unusual because some investigators have described the sodium pump as
the only transporter available for active sodium extrusion (Ewart & Amira,
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1995). A review of the literature indicted that while this conclusion is

popular it was not supported by the initial studies on sodium efflux
out in the 1960's and 70's.

Efflux of sodium in the presence of ouabain, or ouabain-insensitive s

efflux, has been previously described in liver (Claret & Mazet, 1972;
al, 1977) and kidney tissue slices (Macknight, 1968). Using isolated

rat liver and radioactive tracers, Claret & Mazet (1972) found that 5

sodium efflux was inhibited in the presence of ouabain, 28% was depen

on sodium: sodium exchange and was inhibited when extracellular sodiu
was removed, and the remaining 21% of sodium efflux remained
unexplained.

In other studies, rat liver and kidney slices were incubated in the c
for up to 90 minutes, resulting in cell swelling and an increase in
intracellular sodium (sodium loading). After cold incubation, slices

returned to normal physiological temperatures (37°C) and sodium efflu

measured in the presence or absence of ouabain (Elshove & van Rossum,
1963; Macknight, 1968; Macknight et al, 1974; McLean, 1963; Russo et

Seidman & Cascarano, 1966). These studies consistently measured a sod

efflux that was insensitive to ouabain, and independent of potassium,

sensitive to inhibition by cyanide. In short, this mode of efflux was

that seen in the presence of CPZ in this study. In addition to loadi

with sodium, the incubation of liver and kidney slices in the cold (

minutes results in cell swelling. Therefore it was considered possib
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ouabain insensitive sodium efflux, described in these studies and seen in the
presence of CPZ, was a volume regulatory mechanism.

Experiments aimed at determining the effect of CPZ on cell volume wer

somewhat contradictory. If intracellular taurine content was conside

indicator of cell volume then CPZ activates a volume regulatory mech

to result in a decrease in the intracellular levels of taurine and so

However, if cell diameter was considered as an indicator of cell volu

then a three fold decrease in cell volume was observed, when diameter

measured by scanning electron microscopy, but not by light microscopy
Furthermore, if accumulation of 3-O-methyl-D-glucose was taken as an
indicator of intracellular water, and therefore of cell volume, then
in cell volume in CPZ treated cells was seen, however, this decrease

as great as that seen in cells examined by scanning electron microsco

Taken together these results do appear to indicate a decrease in liv
volume following incubation in CPZ.

A decrease in cell volume following CPZ treatment was not surprising

reduction in intracellular cations in liver cells incubated in CPZ w

expected to significantly reduce intracellular volume. However, the d

in cell volume was not sufficient to account for the decrease in int

cations measured following CPZ treatment, as indicated by the decrea

the sodium concentration measured in normal (37.8mM), and CPZ treated

cells (18.7mM). Therefore, it can be concluded that while CPZ treatme
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liver cells does result in a decrease in cell volume, that decrease is not large
enough to account for the decrease in intracellular sodium measured,
therefore, it is likely that CPZ is activating a sodium transport pathway.

The decrease in the intracellular sodium concentration, following CPZ
treatment, (from 37.8mM to 18.7mM, estimated above) would be the
minimal change in sodium concentration expected. CPZ activated sodium
transport has been shown to have a large capacity, in that CPZ can decrease
intracellular sodium even in the presence of monensin when intracellular
sodium concentrations would be greatly increased. Furthermore, the change
in intracellular potassium content of liver cells following CPZ treatment "
greatly exceeds the change in intracellular sodium suggesting that an even
greater decrease in potassium concentration could be expected.

It was considered possible that the large decrease in intracellular sodium a
potassium seen in the presence of CPZ could be due to cell damage induced
by the high concentration of CPZ required to elicit these effects.
Examinations using agents which cause cell damage, that is the detergent
deoxycholate, or agents which lead to a disruption of the cellular
concentration gradients for sodium and potassium, that is the pore forming
agents monensin and saponin, led to the conclusion that cell damage, or

disruption of the cellular concentration gradients, leads to the accumulatio
of intracellular sodium and loss of intracellular potassium. It is possible

therefore, that CPZ could be causing cell damage, resulting in a decrease in
intracellular potassium, by simply increasing the permeability of the cell
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m e m b r a n e for potassium. However, results indicate that C P Z is able to
activate potassium efflux even in the presence of high extracellular

potassium concentrations. Therefore, it is unlikely that a simple increase i
potassium permeability is wholly responsible for the potassium efflux seen
in the presence of CPZ.

In attempting to identify the pathways responsible for CPZ activated cation
transport pharmacological inhibitors were used. None of the known

inhibitors were able to block the ability of CPZ to lower intracellular sodi
and potassium suggesting that CPZ does not utilise a known pathway to
remove intracellular sodium or potassium.

Considering the results of this investigation it is possible that a non-spe
cation transport mechanism may exist in liver cells and may be activated by
CPZ to lower intracellular sodium and potassium. It is postulated that this
transport mechanism is active because of the sensitivity of CPZ activated
sodium and potassium transport to cyanide and cold, and the ability of CPZ

to activate removal of intracellular cations against a concentration gradien
The partial cyanide sensitivity of CPZ activated potassium transport can be
explained by some potassium efflux occurring simply through increased
membrane permeability due to detergent like properties of CPZ and the
remaining (the cyanide sensitive portion) occurring through the postulated
non-specific cation transport mechanism. The existence of a non-specific
cation transport mechanism also explains the greater decrease in potassium
than sodium following CPZ activation of transport. Not only could some
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potassium be leaving the cell due to increased m e m b r a n e permeability but
also a non-specific cation transporter would be more likely to bind, and
transport, potassium than sodium due to the higher intracellular potassium

concentration. This hypothesis is depicted diagrammatically in figure 7.1 an
the results which led to this conclusion are summarised in table 7.1.
Furthermore a flow diagram of results is presented in figure 7.2.

Figure 7.1 A diagrammatic representation of the hypothesised mechanism of
CPZ action.
It can be seen from figure 7.1 that CPZ is hypothesised to act in two ways.
The first, a in figure 7.1 is via the membrane perturbing action of CPZ
leading to a passive efflux of potassium ions down their concentration
gradient. In the second hypothesised action of CPZ, b in figure 7.1 CPZ is

suggested to enter the cell and react with factor X to produce factor Y. Fac
Y is then responsible for activation of a non-specific cation transport
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mechanism. A

mechanism

which binds and transports sodium and

potassium ions. This transport mechanism is suggested to be an active
transporter as it is capable of transporting ions against a concentration
gradient and is dependent on cellular energy, that is, it can be inhibited
metabolic inhibitors and decreased incubation temperature.

Table 7.1 Summary of Results
Sodium

Potassium

IC50

lOOuM

lOOuM

Cyanide sensitivity

Yes

Partial

D N P sensitivity

No

No

Iodoacetate sensitivity

No

No

Temperature

Yes

Yes

Yes

Yes

Yes

Not shown

K + Dependent

No

-

Significantly different

20 minutes

10 minutes

Ouabain sensitive

No

No

Ethacrynic acid

No

No

BaCl 2 sensitive

No

No

Bumetanide sensitive

No

No

Gadolinium sensitive

No

No

Amiloride sensitive

No

Cytochalasin sensitive

No

Colchicine sensitive

No

sensitivity
Against a concentration
gradient
Dependent on cell
treatment

to normal by

sensitive
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|

No

Not Sodium Pump

C P Z decreases
intracellular potassium

C P Z decreases ATPase activity in
tissue homognates

C P Z activates sodium efflux
in the presence of ouabain
Cell Treatment required to activate
sodium transport but not
potassium transport

C P Z decreases intracellular
water but less that it decreases
intracellular sodium therefore
C P Z decreases intracellular
sodium concentration

i

Potassium transport partialy
sensitive to cyanide,
sensitive to cold and can occur
against a concentration gradient

Detergents decrease
intracellular potassium
but they increase
intracellular sodium
Sodium transport sensitive to
cyanide and cold, and occurs
against a concentration gradient
C P Z decreases
intracellular potassium by
passive or active transport

Figure 7.2 Flow diagram of results
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